| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Author index
|
|
|
|
32 |
S2 |
p. A479-A504
|
artikel
|
| 2 |
2022-LBA-931-ESGO Adipocytokines in endometrial cancer and their relationship with obesity
|
Ray, Irene
|
|
|
32 |
S2 |
p. A477
|
artikel
|
| 3 |
2022-LBA-1618-ESGO A pilot study of interval cytoreductive surgery and HIPEC for advanced epithelial ovarian cancer in the UK
|
Sap, Katelijn
|
|
|
32 |
S2 |
p. A475
|
artikel
|
| 4 |
2022-LBA-841-ESGO Cosmetic outcome and psychosexual distress after treatment for vulvar intraepithelial neoplasia
|
Trutnovsky, Gerda
|
|
|
32 |
S2 |
p. A477
|
artikel
|
| 5 |
2022-LBA-677-ESGO Distribution and prognostic role of BRCA status in elderly ovarian cancer patients
|
Tortorella, Lucia
|
|
|
32 |
S2 |
p. A473-A474
|
artikel
|
| 6 |
2022-LBA-714-ESGO Full-thickness partial diaphragm resection using an Endo GIA vascular stapler in patients with advanced-stage ovarian cancer: an institutional series
|
Huber, Daniela
|
|
|
32 |
S2 |
p. A474
|
artikel
|
| 7 |
2022-LBA-1382-ESGO Genomic signatures for the prediction of recurrence and metastasis in Endometrial Cancer
|
Farres, Alba
|
|
|
32 |
S2 |
p. A471
|
artikel
|
| 8 |
2022-LBA-607-ESGO How long do our patients stay fasting? a multicentric prospective survey on the perioperative fasting in 924 Patients conducted by the JAGO study group
|
Beck, Maximilian Heinz
|
|
|
32 |
S2 |
p. A471
|
artikel
|
| 9 |
2022-LBA-1282-ESGO Identifying women with early-stage cervical cancer at low risk of lymph node metastases, in a large international cohort – A logistic regression analysis, without sharing privacy-sensitive patient data
|
Wenzel, Hans
|
|
|
32 |
S2 |
p. A467-A468
|
artikel
|
| 10 |
2022-LBA-746-ESGO Implementation of a comprehensive cancer genome profiling programme into clinical practice: an italian experience in a referral centre for gynecological cancers
|
Nero, Camilla
|
|
|
32 |
S2 |
p. A468-A469
|
artikel
|
| 11 |
2022-LBA-1183-ESGO Lymphedema appearance according to nodal staging in endometrial cancer
|
García-Pineda, Virginia
|
|
|
32 |
S2 |
p. A470-A471
|
artikel
|
| 12 |
2022-LBA-751-ESGO Nodal versus peritoneal metastasis on ultrasound
|
Elagwany, Ahmed
|
|
|
32 |
S2 |
p. A474-A475
|
artikel
|
| 13 |
2022-LBA-325-ESGO Patients with newly diagnosed ovarian cancer treated with maintenance rucaparib: exploratory biomarker analysis from the phase 3 ATHENA-MONO study (GOG-3020/ENGOT-ov45; NCT03522246)
|
Oaknin, Ana
|
|
|
32 |
S2 |
p. A472
|
artikel
|
| 14 |
2022-LBA-414-ESGO Preliminary clinical outcome of ADP-A2M4CD8, a next-generation autologous T-cell receptor T-cell therapy, in patients with advanced epithelial ovarian cancer
|
Moore, Kathleen
|
|
|
32 |
S2 |
p. A472-A473
|
artikel
|
| 15 |
2022-LBA-592-ESGO Primary prevention of HPV-related diseases from the patients’ perspective in Poland – an interim analysis
|
Trojnarska, Dominika
|
|
|
32 |
S2 |
p. A476-A477
|
artikel
|
| 16 |
2022-LBA-750-ESGO Rectal cancer versus endometriosis on ultrasound in metastatic ovary
|
Elagwany, Ahmed
|
|
|
32 |
S2 |
p. A474
|
artikel
|
| 17 |
2022-LBA-790-ESGO Sentinel lymph node detection with Magtrace® in cervical cancer
|
Jedryka, Marcin
|
|
|
32 |
S2 |
p. A467
|
artikel
|
| 18 |
2022-LBA-789-ESGO Sentinel lymph node detection with Magtrace® in endometrial cancer
|
Jedryka, Marcin
|
|
|
32 |
S2 |
p. A470
|
artikel
|
| 19 |
2022-LBA-718-ESGO Sentinel node biopsy for endometrial cancer by retroperitoneal transvaginal natural orifice transluminal endoscopic surgery
|
Huber, Daniela
|
|
|
32 |
S2 |
p. A469-A470
|
artikel
|
| 20 |
2022-LBA-1663-ESGO Should delayed debulking/cytoreductive surgery be offered to all advanced ovarian/fallopian tubal cancer patients that did not have surgery?
|
Souza, Natasha D
|
|
|
32 |
S2 |
p. A476
|
artikel
|
| 21 |
2022-LBA-1703-ESGO Survival outcomes in minimally invasive surgery versus abdominal surgery for cervical cancer-retrospective cohort from a high-volume Canadian center (2006–2017)
|
Samouëlian, Vanessa
|
|
|
32 |
S2 |
p. A468
|
artikel
|
| 22 |
2022-LBA-1231-ESGO Use of mass cytometry analysis of human peripheral blood mononuclear cells to identify cell subsets for monitoring combined immunotherapy with CD73 and PD-L1 blockade in HGSOC patients
|
Tandaric, Luka
|
|
|
32 |
S2 |
p. A475
|
artikel
|
| 23 |
2022-LBA-1708-ESGO Will centralization of ovarian cancer treatment be beneficial in Poland ?
|
Sznurkowski, Jacek Jan
|
|
|
32 |
S2 |
p. A478
|
artikel
|
| 24 |
2022-RA-1631-ESGO ABC of surgical teaching: time to consider a global blueprint for holistic education
|
Sideris, Michail
|
|
|
32 |
S2 |
p. A217
|
artikel
|
| 25 |
2022-RA-1319-ESGO A case of isolated inguinal nodal cancer of mullerian origin
|
Wong, Jeslyn JL
|
|
|
32 |
S2 |
p. A372
|
artikel
|
| 26 |
2022-RA-828-ESGO A case of 19 years old, female with malignant spindle cell neoplasm; pelvic monophasic synovial sarcoma arising from the pelvic ligaments
|
Latap, Ronald Rodriguez
|
|
|
32 |
S2 |
p. A191
|
artikel
|
| 27 |
2022-RA-1594-ESGO A case report of a pacient with cervical cancer diagnosed during pregnancy treated with chemoradiation and brachytherapy relapsed after one year
|
Anghel, Beatrice
|
|
|
32 |
S2 |
p. A65-A66
|
artikel
|
| 28 |
2022-RA-184-ESGO Acceptance, awareness and safety of COVID 19 vaccine among gynecological and breast cancer patients, a single Egyptian center experience
|
Korani, Omnia M
|
|
|
32 |
S2 |
p. A184
|
artikel
|
| 29 |
2022-RA-1635-ESGO Accuracy of MRI imaging in preoperative stage assessment of endometrial cancer in determining extension of surgical procedure
|
Zygowska, Paulina
|
|
|
32 |
S2 |
p. A165-A166
|
artikel
|
| 30 |
2022-RA-265-ESGO A clinical study on the application of 3D printing template in brachytherapy of patients with locally advanced cervical cancer
|
Zhang, Yongxia
|
|
|
32 |
S2 |
p. A7
|
artikel
|
| 31 |
2022-RA-1558-ESGO A combination of molecular and clinical parameters provides a new strategy for high-grade serous ovarian cancer patient management
|
Bradbury, Melissa
|
|
|
32 |
S2 |
p. A418-A419
|
artikel
|
| 32 |
2022-RA-1102-ESGO A comparison of end-to-end and end-to-side anastomosis following rectosigmoid resection in ovarian cancer cytoreductive surgery
|
Graham, Radha
|
|
|
32 |
S2 |
p. A299
|
artikel
|
| 33 |
2022-RA-1458-ESGO A comparison of methods to measure surface area of vulvar tumors
|
de Wilde, Kees
|
|
|
32 |
S2 |
p. A447-A448
|
artikel
|
| 34 |
2022-RA-438-ESGO A comparison of survival and recurrence pattern of patients presenting locally advanced cervical cancer according to the histological subtype: a monocentric retrospective study
|
de Cuypere, Marjolein
|
|
|
32 |
S2 |
p. A11
|
artikel
|
| 35 |
2022-RA-1190-ESGO A conservative treatment of CIN II using a Coriolus versicolor-based vaginal gel: an observational study
|
Melic, Nadia Nassar
|
|
|
32 |
S2 |
p. A381
|
artikel
|
| 36 |
2022-RA-1317-ESGO Acupuncture during gynecological oncology surgery: a randomized controlled trial assessing the impact of integrative therapies on perioperative pain and anxiety
|
Marom, Inbal
|
|
|
32 |
S2 |
p. A207
|
artikel
|
| 37 |
2022-RA-1097-ESGO Acute torsion of the enlarged fibroid uterus in a postmenopausal woman
|
Qadir, Dhilshad
|
|
|
32 |
S2 |
p. A203
|
artikel
|
| 38 |
2022-RA-1394-ESGO Adult granulosa cell tumour of the ovary: an unexpected diagnosis
|
Ribeiro Alves, Fernanda Cristina
|
|
|
32 |
S2 |
p. A332-A333
|
artikel
|
| 39 |
2022-RA-1235-ESGO Adult ovarian granulosa cell tumors: clinical and imaging findings characteristics of a Tunisian population sample
|
Bouhmida, Rahma
|
|
|
32 |
S2 |
p. A312
|
artikel
|
| 40 |
2022-RA-1694-ESGO A dynamic, risk-based determination of follow-upintervalsfor advanced epithelial ovarian cancer based on serum ca125 tests
|
Kang, Sokbom
|
|
|
32 |
S2 |
p. A362-A363
|
artikel
|
| 41 |
2022-RA-1322-ESGO A feasibility study of endometrial cavity cytological sampling for precision treatment in endometrial cancer
|
Sobocan, Monika
|
|
|
32 |
S2 |
p. A144
|
artikel
|
| 42 |
2022-RA-641-ESGO A framework for managing inappropriate referral to the gynaecology rapid access clinic
|
Dokmeci, Melin
|
|
|
32 |
S2 |
p. A454
|
artikel
|
| 43 |
2022-RA-670-ESGO Age limits of mammography screening – a decision-analytic evaluation of the benefit-harm balance to inform decision making for the German screening context
|
Sroczynski, Gaby
|
|
|
32 |
S2 |
p. A375
|
artikel
|
| 44 |
2022-RA-1619-ESGO Aggressive vascular resection to achieve complete cytoreduction in gynecologic oncology: a single-center experience
|
Maggi, Veronica
|
|
|
32 |
S2 |
p. A216-A217
|
artikel
|
| 45 |
2022-RA-1074-ESGO AGO-OVAR 2.29 (ENGOT-ov34): atezolizumab in combination with bevacizumab and chemotherapy vs bevacizumab and chemotherapy in recurrent ovarian cancer
|
Harter, Philipp
|
|
|
32 |
S2 |
p. A294-A295
|
artikel
|
| 46 |
2022-RA-909-ESGO AGO-OVAR 28/ENGOT-ov57: niraparib vs niraparib in combination with bevacizumab in patients with carboplatin-taxane based chemotherapy in advanced ovarian cancer (a multicentre randomised phase III trial)
|
Heitz, Florian
|
|
|
32 |
S2 |
p. A277
|
artikel
|
| 47 |
2022-RA-835-ESGO AGO-OVAR 2.34/MIROVA: A randomized phase II trial of Mirvetuximab soravtansine (IMGN853), in folate receptor alpha (FRα) high recurrent ovarian cancer eligible for platinum-based chemotherapy
|
Trillsch, Fabian
|
|
|
32 |
S2 |
p. A268
|
artikel
|
| 48 |
2022-RA-800-ESGO AGO-OVAR 27: window-of-opportunity proof-of-concept, non-randomized, open-label phase ii trial of olaparib given alone or in combination with durvalumab prior to primary debulking surgery in histologically proven high-grade epithelial ovarian cancer
|
Marmé, Frederik
|
|
|
32 |
S2 |
p. A264
|
artikel
|
| 49 |
2022-RA-838-ESGO All-cause and cancer-specific mortality after fertility-sparing surgery for stage I epithelial ovarian cancer
|
Jorgensen, Kirsten
|
|
|
32 |
S2 |
p. A175-A176
|
artikel
|
| 50 |
2022-RA-1241-ESGO A multicentre, open-label phase 1/2 trial evaluating the safety, tolerability, and efficacy of morab-202, a folate receptor alpha-targeting antibody-drug conjugate in patients with selected tumour types
|
Wenham, Robert
|
|
|
32 |
S2 |
p. A312-A313
|
artikel
|
| 51 |
2022-RA-1463-ESGO An algorithm based on CD8 and CD68/PD-1 expression within the tumour immune microenvironment detected by multiplexed immunofluorescence can discriminate FIGO IA and IB endometrioid endometrial carcinomas
|
Sanz, Julian
|
|
|
32 |
S2 |
p. A152
|
artikel
|
| 52 |
2022-RA-983-ESGO Anal high-grade intraepithelial neoplasia in women with cervical high-grade intraepithelial neoplasia
|
Viscardi, Anna
|
|
|
32 |
S2 |
p. A378
|
artikel
|
| 53 |
2022-RA-161-ESGO Analysis of epidemiological data of vaginal malignant neoplasms in the republic of Belarus for a 30-year period
|
Matylevich, Olga P
|
|
|
32 |
S2 |
p. A426-A427
|
artikel
|
| 54 |
2022-RA-1303-ESGO Analysis of hospitalization of patients with malignant vulvar diseases operated between 02.2020 and 04. 2022 in the department of oncological gynecology of the centre of oncology, opole, poland
|
Kalus, Marcin
|
|
|
32 |
S2 |
p. A446
|
artikel
|
| 55 |
2022-RA-1001-ESGO Analysis of postoperative wound infections in malignancies of the female internal tract
|
Eisenhardt, Laura
|
|
|
32 |
S2 |
p. A199
|
artikel
|
| 56 |
2022-RA-853-ESGO Analysis of the gender distribution among the invited speakers at European society of gynaecological oncology (ESGO) biannual congresses 2017, 2019, and 2021
|
Bilir, Esra
|
|
|
32 |
S2 |
p. A192-A193
|
artikel
|
| 57 |
2022-RA-1309-ESGO Analysis of the prognostic value of systemic inflammation markers obtained from the complete blood count in patients treated for advanced ovarian carcinoma at the CUN in the period 2000–2015
|
Jiménez, Jaime Espinós
|
|
|
32 |
S2 |
p. A321
|
artikel
|
| 58 |
2022-RA-1450-ESGO Androgen metabolism and signalling in ovarian cancer
|
Gjorgoska, Marija
|
|
|
32 |
S2 |
p. A337
|
artikel
|
| 59 |
2022-RA-1129-ESGO Anemia of cancer, transfusion rates and frailty status predict survival in women with endometrial cancer
|
Anic, Katharina
|
|
|
32 |
S2 |
p. A136
|
artikel
|
| 60 |
2022-RA-1354-ESGO A new algorithm may highlight benefits from adding HE4 to CA125 in the preoperative assessment of premenopausal patients with pelvic mass
|
Katsyuba, Mikhail
|
|
|
32 |
S2 |
p. A78-A79
|
artikel
|
| 61 |
2022-RA-786-ESGO Angiomyxoma aggressivum – surgical complete resection of extremaly rare tumor of perineum
|
Jedryka, Marcin
|
|
|
32 |
S2 |
p. A190
|
artikel
|
| 62 |
2022-RA-1315-ESGO Anti-LSR monoclonal antibody exerts an antitumor activity associated with apoptosis in endometrial cancer
|
Nagase, Yoshikazu
|
|
|
32 |
S2 |
p. A143
|
artikel
|
| 63 |
2022-RA-945-ESGO Antitumour activity of dostarlimab by PD-L1 and tumour mutation burden in patients with mismatch repair deficient and proficient tumours in the GARNET trial
|
Banerjee, Susana
|
|
|
32 |
S2 |
p. A410
|
artikel
|
| 64 |
2022-RA-464-ESGO A phase i dose escalation and expansion cohort trial of carboplatin and gemcitabine with the ATR inhibitor berzosertib in first or second recurrence platinum sensitive epithelial ovarian, peritoneal, and fallopian tube cancer
|
Wahner Hendrickson, Andrea E
|
|
|
32 |
S2 |
p. A237-A238
|
artikel
|
| 65 |
2022-RA-579-ESGO A phase II study assessing safety and efficacy of cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure (CABOCOL study)
|
Coquan, Elodie
|
|
|
32 |
S2 |
p. A14
|
artikel
|
| 66 |
2022-RA-1091-ESGO A phase II trial of Docetaxel/cisplatin chemotherapy followed by pelvic radiation therapy in patients with high-risk endometrial carcinoma after staging surgery
|
Cho, Yoon-Jung
|
|
|
32 |
S2 |
p. A134
|
artikel
|
| 67 |
2022-RA-1574-ESGO Application of ex-vivo tumour explant cultures to predict platinum responses in high grade serous ovarian cancers within a clinically relevant timeline
|
Ploski, Jennifer
|
|
|
32 |
S2 |
p. A419
|
artikel
|
| 68 |
2022-RA-594-ESGO Application of ultrasound in cervical cancer (a case report and updated literature review)
|
Djokovic, Dusan
|
|
|
32 |
S2 |
p. A16
|
artikel
|
| 69 |
2022-RA-1709-ESGO A predictive model for detection of epithelial ovarian cancer based on methylation landscape
|
Perez Oliveira, Douglas Nogueira
|
|
|
32 |
S2 |
p. A421
|
artikel
|
| 70 |
2022-RA-1081-ESGO A prospective study to evaluate the agreement of high-risk human papillomavirus detections by vaginal self-sampling and physician-sampling
|
Huang, Huei-Jean
|
|
|
32 |
S2 |
p. A42
|
artikel
|
| 71 |
2022-RA-1267-ESGO A randomised clinical Trial Investigating olaparib, durvalumab and an anticancer vaccine, UV1 as maintenance therapy in patients with recurrent ovarian cancer. ENGOT-OV56-NSGO-CTU-DOVACC
|
Mirza, Mansoor R
|
|
|
32 |
S2 |
p. A315
|
artikel
|
| 72 |
2022-RA-1691-ESGO A rare case of the tall cell carcinoma of the breast with reversed polarity
|
Houissa, Ines
|
|
|
32 |
S2 |
p. A220
|
artikel
|
| 73 |
2022-RA-209-ESGO A retrospective study of ovarian cancer among elderly – evaluation and prognosis
|
Brezis, Miriam Rivka
|
|
|
32 |
S2 |
p. A222-A223
|
artikel
|
| 74 |
2022-RA-1406-ESGO A review of ovarian cancer in Northern Ireland: a retrospective cohort study
|
McMullan, Josh Courtney
|
|
|
32 |
S2 |
p. A333-A334
|
artikel
|
| 75 |
2022-RA-687-ESGO ARTISTRY-7: phase 3, multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68)
|
Herzog, Thomas J
|
|
|
32 |
S2 |
p. A255-A256
|
artikel
|
| 76 |
2022-RA-1136-ESGO A single-cell map of rare ovarian cancer
|
Laga, Tina
|
|
|
32 |
S2 |
p. A412-A413
|
artikel
|
| 77 |
2022-RA-991-ESGO Assessment of high-risk human papillomavirus infections and cervical dysplasia in human immunodeficiency virus-positive pregnant women in germany: a prospective cross-sectional two-center study
|
Sophie Metz, Charlotte Kalinka
|
|
|
32 |
S2 |
p. A37-A38
|
artikel
|
| 78 |
2022-RA-629-ESGO Association of folate receptor α expression and tumor immune microenvironment in patients with cervical cancer
|
Yazaki, Shu
|
|
|
32 |
S2 |
p. A18
|
artikel
|
| 79 |
2022-RA-711-ESGO Association of PET-CT tumor metabolic metrics and intraepithelial and stromal tumor-infiltrating lymphocytes in locally advanced cervical cancer prior to concurrent chemo-radiotherapy
|
Martinez, Alejandra
|
|
|
32 |
S2 |
p. A22-A23
|
artikel
|
| 80 |
2022-RA-1302-ESGO Association of SUVmax with survival and known prognostic factors in loco-regionally advanced cervix cancer
|
Narayan, Kailash
|
|
|
32 |
S2 |
p. A53
|
artikel
|
| 81 |
2022-RA-1297-ESGO A subgroup analysis of response rate by patient characteristics in patients with endometrial cancer receiving monotherapy dostarlimab in the GARNET trial
|
Oaknin, Ana
|
|
|
32 |
S2 |
p. A141-A142
|
artikel
|
| 82 |
2022-RA-1409-ESGO Atypical proliferative clear cell tumor originated in endometriosis of the abdominal wall
|
Barrera, Adriana Mayor
|
|
|
32 |
S2 |
p. A334
|
artikel
|
| 83 |
2022-RA-980-ESGO Auranofin as a potential anticancer drug in epithelial ovarian cancer
|
Maccarrone, Claudia
|
|
|
32 |
S2 |
p. A288
|
artikel
|
| 84 |
2022-RA-452-ESGO Automatic semantic segmentation of cervical cancer based on dynamic contrast-enhanced MRI and fully convolutional networks
|
Xia, Shaojun
|
|
|
32 |
S2 |
p. A13
|
artikel
|
| 85 |
2022-RA-198-ESGO A validation study of two pre-operative predictive models in the treatment planning of advanced ovarian cancer
|
Shearer, Amy MacDonald
|
|
|
32 |
S2 |
p. A222
|
artikel
|
| 86 |
2022-RA-926-ESGO Awareness, attitudes and practices of women in relation to cervical cancer screening in mainland China
|
Wang, Sumeng
|
|
|
32 |
S2 |
p. A33-A34
|
artikel
|
| 87 |
2022-RA-675-ESGO Awareness, knowledge and attitudes on primary and secondary prevention of cervical cancer: a survey study
|
Pergialiotis, Vasilios
|
|
|
32 |
S2 |
p. A375-A376
|
artikel
|
| 88 |
2022-RA-1681-ESGO Bacterial vaginosisand hpv-related cervical lesions
|
Muryzina, Iryna
|
|
|
32 |
S2 |
p. A389
|
artikel
|
| 89 |
2022-RA-1116-ESGO Barriers in the cervical cancer screening program and how self-sampling for HPV-testing is experienced as a solution to them
|
Payrich, Eva Maria
|
|
|
32 |
S2 |
p. A380
|
artikel
|
| 90 |
2022-RA-450-ESGO Benefit of adjuvant radiotherapy depends on molecular class of early-stage endometrial cancer
|
Horeweg, Nanda
|
|
|
32 |
S2 |
p. A95-A96
|
artikel
|
| 91 |
2022-RA-1698-ESGO Benign metastasizing leiomyomadiagnosed in postmenopausal patients with suspected malignant ovarian peritoneal carcinoma: report of two cases and review of literature
|
Rangel Neto, Osmar Ferreira
|
|
|
32 |
S2 |
p. A220-A221
|
artikel
|
| 92 |
2022-RA-947-ESGO Bi allelic loss of MSH2 in endometrial carcinoma, a case report
|
Redmond, Aisling E
|
|
|
32 |
S2 |
p. A122
|
artikel
|
| 93 |
2022-RA-757-ESGO Bioimpedance screening for cervical cancer
|
Zhang, Tingting
|
|
|
32 |
S2 |
p. A72
|
artikel
|
| 94 |
2022-RA-1519-ESGO Biomarker testing and first line maintenance treatment patterns in a real-world US cohort of patients with advanced ovarian cancer
|
Veljovich, Dan S
|
|
|
32 |
S2 |
p. A346
|
artikel
|
| 95 |
2022-RA-818-ESGO BIUXX
|
Choi, Bo Young
|
|
|
32 |
S2 |
p. A408
|
artikel
|
| 96 |
2022-RA-1176-ESGO Borderline ovarien tumor management in a tunisian hospital
|
Bouhmida, Rahma
|
|
|
32 |
S2 |
p. A308-A309
|
artikel
|
| 97 |
2022-RA-1259-ESGO Brachytherapy and surgery versus surgery alone for IB2 (FIGO 2018) cervical cancers: A FRANCOGYN study
|
Aissaoui, Othman
|
|
|
32 |
S2 |
p. A50
|
artikel
|
| 98 |
2022-RA-1114-ESGO BRCA I, BRCA II mutation in high grade ovarian cancers, fallopian tube cancer, primary peritoneal carcinoma
|
Trukhan, Hanna
|
|
|
32 |
S2 |
p. A301
|
artikel
|
| 99 |
2022-RA-440-ESGO BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients
|
Lanjouw, Lieke
|
|
|
32 |
S2 |
p. A454
|
artikel
|
| 100 |
2022-RA-1612-ESGO Breast angiosarcoma: experience of a Tunisian anti-cancer center
|
Chalouati, Takoua
|
|
|
32 |
S2 |
p. A216
|
artikel
|
| 101 |
2022-RA-162-ESGO Breast cancer in young women under 30 years old in western Algeria; experience of radiotherapy oncology department of cancer center tlemcen
|
Mous, Asma
|
|
|
32 |
S2 |
p. A366-A367
|
artikel
|
| 102 |
2022-RA-1693-ESGO Breast carcinoma arising within fibroadenomas: report of seven observations
|
Jellali, Amani
|
|
|
32 |
S2 |
p. A220
|
artikel
|
| 103 |
2022-RA-1632-ESGO Breast carcinosarcoma: a report of an extremely rare entity with a review of the literature
|
Chalouati, Takoua
|
|
|
32 |
S2 |
p. A217
|
artikel
|
| 104 |
2022-RA-1119-ESGO Burdened family history in patients with ovarian cancer: retrospective monocentric study
|
Trukhan, Hanna
|
|
|
32 |
S2 |
p. A302
|
artikel
|
| 105 |
2022-RA-366-ESGO Calcium activated potassium channels (KCNMA1) as biomarker of pre invasive and invasive cervical cancer
|
Gupta, Bindiya
|
|
|
32 |
S2 |
p. A404
|
artikel
|
| 106 |
2022-RA-1068-ESGO Canadian practice patterns of primary treatment in advanced (stage III-IV) low grade serous ovarian carcinoma
|
Brodeur, Melica
|
|
|
32 |
S2 |
p. A294
|
artikel
|
| 107 |
2022-RA-962-ESGO Cancer in pregnancy: message in a bottle from tertiary center of Milan
|
Michela Matozzo, Cristina Maria
|
|
|
32 |
S2 |
p. A176-A177
|
artikel
|
| 108 |
2022-RA-981-ESGO Can misdiagnosis be avoided in case of intestinal-type carcinoma of the vagina?A literature comprehensive review
|
Perotto, Stefania
|
|
|
32 |
S2 |
p. A437
|
artikel
|
| 109 |
2022-RA-1105-ESGO Can preoperative FDG-PET/CT help to predict complete resection at primary citorreductive surgery in highly pre-selected patients?
|
Boria, Felix
|
|
|
32 |
S2 |
p. A300
|
artikel
|
| 110 |
2022-RA-1170-ESGO Can serum level of WT1 gene replace gene expression in the diagnosis of ovarian cancer?
|
Ranjan, Amar
|
|
|
32 |
S2 |
p. A77
|
artikel
|
| 111 |
2022-RA-1365-ESGO Can we reduce the risk of anastomotic leakage in the bowel surgery based on 100 cases of modified ICG technique used in deep infiltrated endometriosis?
|
Milnerowicz-Nabzdyk, Ewa
|
|
|
32 |
S2 |
p. A209
|
artikel
|
| 112 |
2022-RA-1528-ESGO Carcinoid tumors of the ovary, a rare neoplasm: description of cases and review of literature
|
García, Marta Heras
|
|
|
32 |
S2 |
p. A347
|
artikel
|
| 113 |
2022-RA-183-ESGO Carcinoma clitoris in a 27-year-old girl; a case report
|
Krsic, Vesna
|
|
|
32 |
S2 |
p. A427
|
artikel
|
| 114 |
2022-RA-1648-ESGO Cardiophrenic lymph node involvement for ovarian cancer
|
Postupalenko, Olena
|
|
|
32 |
S2 |
p. A357
|
artikel
|
| 115 |
2022-RA-1287-ESGO Case report of a patient with relapsed ovarian cancer and therapy with all three approved PARP-inhibitors
|
Keller, Katharina Franziska
|
|
|
32 |
S2 |
p. A317
|
artikel
|
| 116 |
2022-RA-1053-ESGO Cases of bariatric surgery in Korean women with endometrial cancer; preliminary results
|
Jo, Hagyeong
|
|
|
32 |
S2 |
p. A133
|
artikel
|
| 117 |
2022-RA-1111-ESGO Case studies as a valuable tool to improve physician competence regarding identification of patients and selection of treatment for newly diagnosed advanced ovarian cancer
|
Johnson, Ben
|
|
|
32 |
S2 |
p. A300-A301
|
artikel
|
| 118 |
2022-RA-569-ESGO CD133, CD47, and PD-L1 expression in ovarian high-grade serous carcinoma and its association with metastatic disease
|
Masadah, Rina
|
|
|
32 |
S2 |
p. A369
|
artikel
|
| 119 |
2022-RA-200-ESGO Cell cycle regulatory marker as a potential prognostic biomarker in uterine carcinosarcoma
|
Baek, Min-Hyun
|
|
|
32 |
S2 |
p. A92
|
artikel
|
| 120 |
2022-RA-1536-ESGO Cervical adenocarcinoma: application of the Silva criteria and correlation with prognostic factors, recurrence rate and survival
|
García, Marta Heras
|
|
|
32 |
S2 |
p. A63
|
artikel
|
| 121 |
2022-RA-1223-ESGO Cervical cancer in pregnancy: what are the challenges?
|
Buruiana, Felicia Elena
|
|
|
32 |
S2 |
p. A47
|
artikel
|
| 122 |
2022-RA-228-ESGO Cervical cancer in Tunisia: multicentric epidemiological study
|
Garci, Mariem
|
|
|
32 |
S2 |
p. A5
|
artikel
|
| 123 |
2022-RA-693-ESGO Cervical cancer: the effect of cone biopsy in surgical specimen after radical hysterectomy
|
Mendes, Inês Azevedo
|
|
|
32 |
S2 |
p. A21-A22
|
artikel
|
| 124 |
2022-RA-1189-ESGO Challenges for a new robotic surgery program in gynaecological oncology at a cancer center in the United Kingdom during COVID-19 pandemic
|
Abdelbar, Ahmed
|
|
|
32 |
S2 |
p. A459-A460
|
artikel
|
| 125 |
2022-RA-801-ESGO Challenge to individualize surgical treatment for uterine cancer by intraoperative-prediction of lymph node metastasis using mRNA biomarker and clinical variables
|
Yoshida, Emiko
|
|
|
32 |
S2 |
p. A111-A112
|
artikel
|
| 126 |
2022-RA-1478-ESGO Change of anti-mullerian hormone levels in patients with gestational trophoblastic neoplasia and molar pregnancy – a case-control study
|
Tse, Ka Yu
|
|
|
32 |
S2 |
p. A426
|
artikel
|
| 127 |
2022-RA-1486-ESGO Characteristics, treatment patterns and outcomes of patients with newly diagnosed advanced ovarian cancer (aOC) in England
|
Whittle, Angela
|
|
|
32 |
S2 |
p. A342-A343
|
artikel
|
| 128 |
2022-RA-660-ESGO Characterization of extended treatment benefit from three phase 1 and 3 clinical trials examining patients with folate receptor alpha-positive recurrent ovarian cancer treated with single-agent mirvetuximab soravtansine
|
Oaknin, Ana
|
|
|
32 |
S2 |
p. A251-A252
|
artikel
|
| 129 |
2022-RA-837-ESGO Characterization of long-term survivor and maintenance therapy in relapsed ovarian cancer (CAROLIN)- Intergroup study NOGGO/A-AGO
|
Grabowski, Jacek
|
|
|
32 |
S2 |
p. A269
|
artikel
|
| 130 |
2022-RA-1487-ESGO Chemo-induced amenorrhea in young women treated for breast cancer
|
Benzebida, Hanane
|
|
|
32 |
S2 |
p. A181
|
artikel
|
| 131 |
2022-RA-1453-ESGO Chemotherapy response score as a predictor of survival among patients undergoing interval debulking surgery for ovarian cancer
|
Rodolakis, Ioannis
|
|
|
32 |
S2 |
p. A338
|
artikel
|
| 132 |
2022-RA-1088-ESGO Chitinase response after 3 cycles of chemotherapy as a promising marker of chemosensitivity an ancillary analysis of the GINECO-ENGOT EWOC-1 trial
|
Chikh, Karim
|
|
|
32 |
S2 |
p. A296-A297
|
artikel
|
| 133 |
2022-RA-295-ESGO Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer
|
Ronchetti, Livia
|
|
|
32 |
S2 |
p. A93-A94
|
artikel
|
| 134 |
2022-RA-1048-ESGO Circulating HPV cell-free DNA in cervical cancer
|
Mittelstadt, Suzana
|
|
|
32 |
S2 |
p. A40
|
artikel
|
| 135 |
2022-RA-205-ESGO Circulating HPV DNA in cervical cancer: a marker for early detection of relapse
|
Jeannot, Emmanuelle
|
|
|
32 |
S2 |
p. A404
|
artikel
|
| 136 |
2022-RA-1360-ESGO Circulatory HMGB-1 as a plausible diagnostic marker in liquid biopsy of cervical cancer
|
Sharma, Alpana
|
|
|
32 |
S2 |
p. A416
|
artikel
|
| 137 |
2022-RA-1367-ESGO Clinical and survival data of early-stage tubo-ovarian carcinoma according to BRCA mutational status. A large, multicenter, retrospective study
|
Marchetti, Claudia
|
|
|
32 |
S2 |
p. A330
|
artikel
|
| 138 |
2022-RA-1464-ESGO Clinical behavior of high-grade ovarian cancer (HGOC) patients with non contributive GIS results (NA) by Myriad
|
Blanc-Durand, Felix
|
|
|
32 |
S2 |
p. A339-A340
|
artikel
|
| 139 |
2022-RA-215-ESGO Clinical cases of atypical polypoid adenomyoma: single- center report
|
Potkonjak, Ana-Meyra
|
|
|
32 |
S2 |
p. A367-A368
|
artikel
|
| 140 |
2022-RA-1324-ESGO Clinical characteristics and treatment outcomes of patients with gestational trophoblastic disease
|
Lukinovic, Nusa
|
|
|
32 |
S2 |
p. A424
|
artikel
|
| 141 |
2022-RA-1608-ESGO Clinical implications of genomic intratumoural heterogeneity in high grade serous ovarian cancer
|
Cunnea, Paula
|
|
|
32 |
S2 |
p. A419-A420
|
artikel
|
| 142 |
2022-RA-449-ESGO Clinical-molecular correlations of endometrial cancer. Retrospective study
|
Rodríguez, Natalia Pérez
|
|
|
32 |
S2 |
p. A95
|
artikel
|
| 143 |
2022-RA-1172-ESGO Clinical outcomes of ovarian cancer management: a single tertiary referral centre experience
|
Zaim, Onur Can
|
|
|
32 |
S2 |
p. A308
|
artikel
|
| 144 |
2022-RA-721-ESGO Clinical outcomes of SBRT boost to the cervix as an alternative to intracavitary brachytherapy in locally advanced cervical cancer: Retrospective analysis from the West of Scotland
|
Amali, Nasibah Kharul
|
|
|
32 |
S2 |
p. A23-A24
|
artikel
|
| 145 |
2022-RA-988-ESGO Clinical over and under estimation in patients who underwent hysterectomy for atypical endometrial hyperplasia
|
Atalay, Funda
|
|
|
32 |
S2 |
p. A124-A125
|
artikel
|
| 146 |
2022-RA-1333-ESGO Clinical practice patterns in advanced ovarian cancer: A national survey
|
Khandelwal, Richi
|
|
|
32 |
S2 |
p. A325
|
artikel
|
| 147 |
2022-RA-783-ESGO Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma
|
Drouyer, Aurélien
|
|
|
32 |
S2 |
p. A110
|
artikel
|
| 148 |
2022-RA-999-ESGO Clinical relevance of clinicopathological and molecular factors in women with surgically treated stage IV endometrial cancer
|
Nooij, Linda
|
|
|
32 |
S2 |
p. A128-A129
|
artikel
|
| 149 |
2022-RA-1313-ESGO Clinical significance of Her2/Neu, Muc1, estrogen and progesterone receptor expression in malignant epithelial ovarian tumors
|
Cataldegirmen, Ahmet
|
|
|
32 |
S2 |
p. A323
|
artikel
|
| 150 |
2022-RA-376-ESGO Clinicopathological characteristics of ‘multiple-classifiers’ in endometrial cancer
|
de Vitis, Luigi Antonio
|
|
|
32 |
S2 |
p. A94-A95
|
artikel
|
| 151 |
2022-RA-431-ESGO Clinicopathologic features and outcomes of mucinous ovarian tumours: a retrospective study
|
Katsanevakis, Emmanouil
|
|
|
32 |
S2 |
p. A232
|
artikel
|
| 152 |
2022-RA-1255-ESGO Clinicopatological features and treatment outcomes of ovarian clear cell carcinoma: the pan-birmingham gynaecological cancer centre experience
|
Tranoulis, Anastasios
|
|
|
32 |
S2 |
p. A314
|
artikel
|
| 153 |
2022-RA-1358-ESGO Cloud-Based Web Application to Reduce Delay in Cancer Treatment
|
Bon, Jack Le
|
|
|
32 |
S2 |
p. A461
|
artikel
|
| 154 |
2022-RA-1145-ESGO Cognitive function performance in gynecological cancer patients admitted to the high dependency unit postoperatively
|
Papadatou, Konstantina
|
|
|
32 |
S2 |
p. A398
|
artikel
|
| 155 |
2022-RA-1151-ESGO Cognitive function performance in patients undergoing maximal effort cytoreduction surgery for gynecological cancer management
|
Papadatou, Konstantina
|
|
|
32 |
S2 |
p. A398
|
artikel
|
| 156 |
2022-RA-1070-ESGO Colposcopy clinic referrals & cervical cancer diagnosis at a tertiary gynae-oncology centre covering north & east london during the COVID 19 pandemic
|
Elusoji, Funmilola Abema
|
|
|
32 |
S2 |
p. A41
|
artikel
|
| 157 |
2022-RA-136-ESGO Columnar epithelium is the original site of most cervical squamous cell cancers
|
Reich, Olaf
|
|
|
32 |
S2 |
p. A1
|
artikel
|
| 158 |
2022-RA-773-ESGO Combined urethral and endovascular treatment of arterioureteral fistulae with fully covered stents
|
Neymeyer, Joerg
|
|
|
32 |
S2 |
p. A26-A27
|
artikel
|
| 159 |
2022-RA-585-ESGO Come back to the future: the impact of estrogen receptor profile in the era of molecular endometrial cancer classification
|
Perrone, Emanuele
|
|
|
32 |
S2 |
p. A99
|
artikel
|
| 160 |
2022-RA-622-ESGO Comparation between Bricker vs Double-barreled wet colostomy after pelvic exenteration
|
Lago, Víctor
|
|
|
32 |
S2 |
p. A18
|
artikel
|
| 161 |
2022-RA-993-ESGO Comparing thoracic epidural analgesia to surgeon-administered continuous transversus abdominus plane blocks in gynaecologic oncology patients: a retrospective cohort study
|
Gupta, Vishaal
|
|
|
32 |
S2 |
p. A198-A199
|
artikel
|
| 162 |
2022-RA-253-ESGO Comparison between single versus twice application of topical 85% trichloroacetic acid in the treatmen of cervical intraepithelial neoplasia; A randomized clinical trial on efficacy and tolerability
|
Ayatollahi, Haleh
|
|
|
32 |
S2 |
p. A5-A6
|
artikel
|
| 163 |
2022-RA-1401-ESGO Comparison of ADNEXmodel, O-RADSand the combinedIOTA simple rules with simple rules risk assessment and simple rules with ADNEX model in discriminating between benign and malignant adnexalmasses
|
Spagnol, Giulia
|
|
|
32 |
S2 |
p. A80
|
artikel
|
| 164 |
2022-RA-695-ESGO Comparison of ADNEX model with GI-RADS ultrasonic scoring system in evaluation of adnexal mass
|
Gupta, Bindiya
|
|
|
32 |
S2 |
p. A71
|
artikel
|
| 165 |
2022-RA-951-ESGO Comparison of complications in patients undergoing upper versus lower abdominal cytoreductive surgery in ovarian cancer
|
Kiran, Gurkan
|
|
|
32 |
S2 |
p. A284-A285
|
artikel
|
| 166 |
2022-RA-1029-ESGO Comparison of o-rads and iota adnex model criteria with pathology results in adnexial masses
|
Filiz, Ahmet Arif
|
|
|
32 |
S2 |
p. A291
|
artikel
|
| 167 |
2022-RA-275-ESGO Comparison of patients with trucut biopsy, acid cytology with final pathology results from patients operated with prediagnose of ovarian cancer
|
Tanoglu, Fatma Basak
|
|
|
32 |
S2 |
p. A227
|
artikel
|
| 168 |
2022-RA-755-ESGO Comparison of PD-L1 status between primary and paired recurrent/metastatic cervical cancer
|
Ataseven, Beyhan
|
|
|
32 |
S2 |
p. A25
|
artikel
|
| 169 |
2022-RA-1328-ESGO Comparison of prognostic risk scoring systems to predict outcomes in gynecologic oncology patients
|
Vlachos, Dimitrios-Efthymios
|
|
|
32 |
S2 |
p. A208
|
artikel
|
| 170 |
2022-RA-672-ESGO Comparison of quality of life in patients with platinum-sensitive recurrent ovarian, fallopian tube and peritoneal cancer treated with trabectedin plus pegylated liposomal doxorubicin (PLD) or standard platinum-based therapy: Data look of the NOGGO S16/COMPASS trial
|
Chekerov, Radoslav
|
|
|
32 |
S2 |
p. A252-A253
|
artikel
|
| 171 |
2022-RA-1472-ESGO Comparison of the diagnostic accuracy of contrast-enhanced/DWI MRI & ultrasonography in the differentiation between benign & malignant myometrial tumors
|
Zamani, Narges
|
|
|
32 |
S2 |
p. A81
|
artikel
|
| 172 |
2022-RA-170-ESGO Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: a prospective, open-label, randomized controlled phaseIIstudy
|
Xu, Zhiying
|
|
|
32 |
S2 |
p. A89-A90
|
artikel
|
| 173 |
2022-RA-1446-ESGO Comprehensive assessment of gene mutations revealed overlapping dependencies for PARPi and chemotherapy response in ovarian cancer
|
Tozzi, Alessandra
|
|
|
32 |
S2 |
p. A416
|
artikel
|
| 174 |
2022-RA-1253-ESGO CONCERVE study demonstrates that clinical regression of high-grade cervical intraepithelial neoplasia is associated with absence of FAM19A4/miR124–2 DNA methylation
|
van Trommel, Nienke
|
|
|
32 |
S2 |
p. A49
|
artikel
|
| 175 |
2022-RA-1017-ESGO Concurrent endometrial carcinoma in hysterectomy specimens in patients with atypical endometrial hyperplasia
|
Atalay, Cemal Resat
|
|
|
32 |
S2 |
p. A131
|
artikel
|
| 176 |
2022-RA-646-ESGO Consensus based recommendations for the diagnosis of serous tubal intraepithelial carcinoma, an international delphi study
|
van Bommel, Majke
|
|
|
32 |
S2 |
p. A369
|
artikel
|
| 177 |
2022-RA-1664-ESGO Consensus radiotherapy guidelines vulvar cancer: Spanish GINECOR/SEOR group modified Delphi study
|
Largo, Sofia Cordoba
|
|
|
32 |
S2 |
p. A450-A451
|
artikel
|
| 178 |
2022-RA-1095-ESGO Conservative Management of CIN-2: A Retrospective, Single-Centre Study
|
Lestak, Katalin
|
|
|
32 |
S2 |
p. A42-A43
|
artikel
|
| 179 |
2022-RA-678-ESGO CONTESSA/NEOCON-F trial: Assessing the effectiveness and safety of neoadjuvant chemotherapy followed by fertility-sparing surgery in FIGO 2018 stage IB2 cervical cancer
|
Plante, Marie
|
|
|
32 |
S2 |
p. A20
|
artikel
|
| 180 |
2022-RA-645-ESGO Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers, a systematic review and meta-analysis
|
van Bommel, Majke
|
|
|
32 |
S2 |
p. A249-A250
|
artikel
|
| 181 |
2022-RA-763-ESGO Contrasting outcomes in two cases ofuterinePEComa
|
Tiwari, Mansi
|
|
|
32 |
S2 |
p. A107-A108
|
artikel
|
| 182 |
2022-RA-1603-ESGO Contribution of adding routine endoscopy and colonoscopy to preoperative screening of patients with suspected ovarian cancer on surgical and oncological outcomes
|
Cicek, Yavuz
|
|
|
32 |
S2 |
p. A353
|
artikel
|
| 183 |
2022-RA-661-ESGO Contribution of interstitial needles during Image Guided Brachytherapy IGBT after radiochemotherapy RCT in the management of locally advanced cervical cancer LACC
|
Abel, Cordoba
|
|
|
32 |
S2 |
p. A20
|
artikel
|
| 184 |
2022-RA-1277-ESGO Correlation between CA125 levels & surgical findings in patients undergoing secondary operations for epithelial ovarian cancer
|
Jellali, Amani
|
|
|
32 |
S2 |
p. A316-A317
|
artikel
|
| 185 |
2022-RA-1245-ESGO Correlation between false negatives of FDG-TEP staging in locally advanced cervical cancer and FIGO 2009 clinical staging system. A retrospective single-center cohort
|
Boscher, Adrien
|
|
|
32 |
S2 |
p. A48
|
artikel
|
| 186 |
2022-RA-1225-ESGO Correlation between the immunocytochemistry of the fallopian tube cells and the pathological findings of the ipsilateral ovary
|
Lekka, Sofia
|
|
|
32 |
S2 |
p. A311-A312
|
artikel
|
| 187 |
2022-RA-169-ESGO Correlation between tumor distance from serosa and of myometrial invasion in endometrial cancer measured by transvaginal sonography
|
Cerovac, Anis
|
|
|
32 |
S2 |
p. A89
|
artikel
|
| 188 |
2022-RA-566-ESGO Cost-effectiveness of cervical cancer screnning strategies among women in Cameroon
|
Sormani, Jessica
|
|
|
32 |
S2 |
p. A13-A14
|
artikel
|
| 189 |
2022-RA-193-ESGO Cost-effectiveness of molecular profiling for endometrial neoplasia: a single institution experience
|
Dheur, Adriane
|
|
|
32 |
S2 |
p. A91
|
artikel
|
| 190 |
2022-RA-1272-ESGO Cost-effectiveness of risk-reducing surgery for breast and ovarian cancer prevention: a systematic review
|
Wei, Xia
|
|
|
32 |
S2 |
p. A383-A384
|
artikel
|
| 191 |
2022-RA-1310-ESGO Cost-effectiveness of unselected multigene germline and somatic genetic testing for epithelial ovarian cancer
|
Sun, Li
|
|
|
32 |
S2 |
p. A321-A322
|
artikel
|
| 192 |
2022-RA-1397-ESGO Covering all angles; a case report demonstrating why lateral port entry must be perpendicular
|
Padden, Molly Grace
|
|
|
32 |
S2 |
p. A209-A210
|
artikel
|
| 193 |
2022-RA-1524-ESGO COVID-19 pandemic impact on the availability and implementation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) procedures in patients with peritoneal carcinomatosis at the Wroclaw comprehensive cancer centre – a single-centre study
|
Szewczyk, Krzysztof
|
|
|
32 |
S2 |
p. A214
|
artikel
|
| 194 |
2022-RA-1451-ESGO Critical care management following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: not routinely indicated
|
Aronson, SL
|
|
|
32 |
S2 |
p. A338
|
artikel
|
| 195 |
2022-RA-1043-ESGO CT-guided percutenous radiologic gastrostomy in heavily pretreated patients with late stage ovarian cancer: -the charité experiences-
|
Canaz, Emel
|
|
|
32 |
S2 |
p. A366
|
artikel
|
| 196 |
2022-RA-1602-ESGO Cutaneous metastasis in epithelial ovarian cancer: experience from a tertiary care cancer institute
|
Sehra, Divya
|
|
|
32 |
S2 |
p. A352-A353
|
artikel
|
| 197 |
2022-RA-766-ESGO Cutaneous vulvar metastasis after combined treatment of cervical cancer-case report
|
Aluloski, Igor
|
|
|
32 |
S2 |
p. A432
|
artikel
|
| 198 |
2022-RA-1142-ESGO Cytological features of gynecologic tract carcinomas with neuroendocrine differentiation
|
Dehghani, Amir
|
|
|
32 |
S2 |
p. A371
|
artikel
|
| 199 |
2022-RA-1566-ESGO Cytology and HPV testing in cervical cancer screening: factors determining persistence and clearance
|
Kurt, Gulsah
|
|
|
32 |
S2 |
p. A388
|
artikel
|
| 200 |
2022-RA-369-ESGO Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer 2 year survival analysis
|
Farzaneh, Farah
|
|
|
32 |
S2 |
p. A229
|
artikel
|
| 201 |
2022-RA-1483-ESGO Cytoreductive surgery in advanced ovarian cancer patients
|
Yakovleva, Maria
|
|
|
32 |
S2 |
p. A341-A342
|
artikel
|
| 202 |
2022-RA-135-ESGO Cytoreductive surgery in recurrent endometrial cancer: a new paradigm for surgical management?
|
Dhanis, Joëlle
|
|
|
32 |
S2 |
p. A87-A88
|
artikel
|
| 203 |
2022-RA-1600-ESGO Dabrafenib and trametinib for braf mutant low grade serous ovarian cancer
|
Greenhouse, Inbal
|
|
|
32 |
S2 |
p. A352
|
artikel
|
| 204 |
2022-RA-1576-ESGO Deep-learning-based endometrial segmentation and automated immune profiling from histopathological whole slide images
|
Dzaparidze, Georgi
|
|
|
32 |
S2 |
p. A373
|
artikel
|
| 205 |
2022-RA-421-ESGO DeflaGyn® has cytotoxic, genotoxic and apoptotic effects on human adenocancer cells: an in vitro study
|
Gokmen Karasu, Ayse Filiz
|
|
|
32 |
S2 |
p. A8-A9
|
artikel
|
| 206 |
2022-RA-1431-ESGO Demystifying novel bladder retrofilling approach in nerve sparing radical hysterectomy: a new kid on the block in the era of eras for radical surgeries
|
Tak, Apoorva
|
|
|
32 |
S2 |
p. A59
|
artikel
|
| 207 |
2022-RA-1122-ESGO Dermoscopy for genital lesions
|
Wohlmuth-Wieser, Iris
|
|
|
32 |
S2 |
p. A76
|
artikel
|
| 208 |
2022-RA-1090-ESGO Descriptive study of vulvar cancers according to the vulnerability of patients related to age: multicenter study
|
Raimond, Emilie
|
|
|
32 |
S2 |
p. A440
|
artikel
|
| 209 |
2022-RA-1422-ESGO Detailed profiling of the immune microenvironment in ovarian epithelial cancers; relation to tumour characteristics and impact on prognosis
|
Stout, Annabel
|
|
|
32 |
S2 |
p. A335
|
artikel
|
| 210 |
2022-RA-1058-ESGO Developing infrastructure for molecular profiling for all in ovarian cancer (DEMO)
|
Leung, Elaine
|
|
|
32 |
S2 |
p. A292
|
artikel
|
| 211 |
2022-RA-925-ESGO Development of adjuvant treatment decision support tool for endometrial cancer patients by pooled analysis of data from 2000 women included in the PORTEC-1–3 trials and a prospective cohort study
|
Vermij, Lisa
|
|
|
32 |
S2 |
p. A119-A120
|
artikel
|
| 212 |
2022-RA-935-ESGO Development of an academic genomic instability score for ovarian cancers
|
Leman, Raphaël
|
|
|
32 |
S2 |
p. A280
|
artikel
|
| 213 |
2022-RA-1675-ESGO Development of an intra-operative disease score to predict complete cytoreduction in advanced-stage ovarian cancer by using artificial intelligence
|
Laios, Alexandros
|
|
|
32 |
S2 |
p. A361
|
artikel
|
| 214 |
2022-RA-798-ESGO Diagnosis of first relapse and its impact on quality of life in patients with advanced ovarian cancer (AGO-OVAR 19/II)
|
Harter, Philipp
|
|
|
32 |
S2 |
p. A263-A264
|
artikel
|
| 215 |
2022-RA-1671-ESGO Diagnostic accuracy of different ultrasound signs for detecting adnexal torsion: systematic review andmeta-analysis
|
Almandoz, Isabel Brotons
|
|
|
32 |
S2 |
p. A84
|
artikel
|
| 216 |
2022-RA-1682-ESGO Diagnostic accuracy of three-dimensional transvaginal ultrasound for detecting congenital uterine anomalies: systematic review and meta-analysis
|
Almandoz, Isabel Brotons
|
|
|
32 |
S2 |
p. A85
|
artikel
|
| 217 |
2022-RA-1389-ESGO Diagnostic accuracy of ultrasound O-RADS for classifying adnexal mass: systematic review and meta-analysis
|
Vara, Julio
|
|
|
32 |
S2 |
p. A79
|
artikel
|
| 218 |
2022-RA-1625-ESGO Diagnostic performance of PAP-smear and HPV-testing in the follow-up of patients with cervical cancer
|
Ramirez, Andres Rave
|
|
|
32 |
S2 |
p. A67
|
artikel
|
| 219 |
2022-RA-1336-ESGO Differences in epidemiology, clinical features and prognosis of EOC in arab women as compared with jewish women in Northern Israel
|
Shachar, Inbar Ben
|
|
|
32 |
S2 |
p. A326
|
artikel
|
| 220 |
2022-RA-1386-ESGO Differential diagnosis of endometrial and endocervical adenocarcinoma: is immunohistochemistry useful?
|
Mocuta, Diana
|
|
|
32 |
S2 |
p. A149
|
artikel
|
| 221 |
2022-RA-1495-ESGO Differential metabolism of estrogens in model cell lines and tissues of HGSOC subtypes
|
Pavlic, Renata
|
|
|
32 |
S2 |
p. A343-A344
|
artikel
|
| 222 |
2022-RA-1499-ESGO Differential response of in-vitro mismatch repair-deficient hypermethylated endometrioid endometrial cancer models to DNA-hypomethylating agents
|
Khoury, Louis El
|
|
|
32 |
S2 |
p. A154
|
artikel
|
| 223 |
2022-RA-137-ESGO Differentiated cervical intraepithelial neoplasia (d-CIN) represents a rare HPV-independent precursor lesion of squamous cell cancer
|
Reich, Olaf
|
|
|
32 |
S2 |
p. A1
|
artikel
|
| 224 |
2022-RA-1467-ESGO Digital health-related app support of patients with gynaecological malignancies: results of a pilot study
|
Wolff, Josefine
|
|
|
32 |
S2 |
p. A402
|
artikel
|
| 225 |
2022-RA-575-ESGO Disclosure of our latest data using sentinel lymph nodefor staging all endometrial cancers
|
Manterola, Juan Cespedes
|
|
|
32 |
S2 |
p. A98
|
artikel
|
| 226 |
2022-RA-924-ESGO Distribution of BRCA1/2 mutations and clinical outcomes in epithelial ovarian, peritoneal, fallopian tube cancer: based on multicenter real-world data
|
Song, Heekyoung
|
|
|
32 |
S2 |
p. A279
|
artikel
|
| 227 |
2022-RA-412-ESGO DNA methylation markers in HPV-independent precursors of vulvar squamous cell carcinoma
|
Voss, Féline O
|
|
|
32 |
S2 |
p. A428
|
artikel
|
| 228 |
2022-RA-989-ESGO Does fertility preservation affect the onset of the oncological treatment and the response to neoadjuvant chemotherapy in breast cancer?
|
Baulies, Sonia
|
|
|
32 |
S2 |
p. A177-A178
|
artikel
|
| 229 |
2022-RA-636-ESGO Does heart-rate variability predict prognosis in women with ovarian cancer?
|
Toledano-Hacohen, Mirit
|
|
|
32 |
S2 |
p. A247-A248
|
artikel
|
| 230 |
2022-RA-168-ESGO Does order of adjuvant treatment for high risk endometrial cancer matter? A retrospective review
|
Kulkarni, Anjali
|
|
|
32 |
S2 |
p. A88-A89
|
artikel
|
| 231 |
2022-RA-1143-ESGO Does Robotic surgery improve surgical outcomes and survival compared to conventional laparoscopy in gynecological cancer?
|
Gracia, Myriam
|
|
|
32 |
S2 |
p. A204
|
artikel
|
| 232 |
2022-RA-896-ESGO Does the change in FIGO-2021-proposed method for the measurement of stromal invasion depth lead to downstaging in vulvar cancer?
|
Petukhou, Vitali S
|
|
|
32 |
S2 |
p. A435
|
artikel
|
| 233 |
2022-RA-867-ESGO Does the use of long-term Aspirin reduce risk of post operative VTE in Gynaecological cancer patients
|
Ibrahim, Elzahra
|
|
|
32 |
S2 |
p. A395
|
artikel
|
| 234 |
2022-RA-1610-ESGO Does uterine manipulator really affect overall survival or progression-free survival in endometrial cancer?
|
Ramirez, Andres Rave
|
|
|
32 |
S2 |
p. A164
|
artikel
|
| 235 |
2022-RA-1521-ESGO Do exophytic and endophytic patterns in borderline ovarian tumors have different prognostic implications? A large multicentric experience
|
Capozzi, Vito Andrea
|
|
|
32 |
S2 |
p. A346-A347
|
artikel
|
| 236 |
2022-RA-1352-ESGO Dose received by axillary lymph nodes in breast cancer adjuvant radiotherapy
|
Attia, Najla
|
|
|
32 |
S2 |
p. A78
|
artikel
|
| 237 |
2022-RA-272-ESGO ‘Double O’ technique of bowel anastomosis
|
Shylasree, TS
|
|
|
32 |
S2 |
p. A226-A227
|
artikel
|
| 238 |
2022-RA-821-ESGO Dr., PhD student
|
Schou Karlsen, Nikoline Marie
|
|
|
32 |
S2 |
p. A266
|
artikel
|
| 239 |
2022-RA-733-ESGO Duration of HPV persistence and its relationship with recurrent cervical dysplasia
|
Capalbo, Giuseppe
|
|
|
32 |
S2 |
p. A24-A25
|
artikel
|
| 240 |
2022-RA-225-ESGO Early clinical outcomes of hybrid brachytherapy for locally advanced cervical cancer: making adverse situations in a favourable scenario
|
Cagetti, Leonel Varela
|
|
|
32 |
S2 |
p. A4-A5
|
artikel
|
| 241 |
2022-RA-692-ESGO Early stage cervical cancer: is radial margin an important risk factor for recurrence?
|
Mendes, Inês Azevedo
|
|
|
32 |
S2 |
p. A21
|
artikel
|
| 242 |
2022-RA-1096-ESGO E-cadherin and N-cadherin expression in the endocervium as a predictive factor in patients with endometrial cancer
|
Tylus, Bozydar
|
|
|
32 |
S2 |
p. A134-A135
|
artikel
|
| 243 |
2022-RA-1432-ESGO Economical impact of ERAS implementation in a high-volume gynecologic oncology surgery division in Canada
|
Hillmann, Elise de Castro
|
|
|
32 |
S2 |
p. A462
|
artikel
|
| 244 |
2022-RA-1179-ESGO Efectiveness of a multi-ingredient coriolus versicolor-based vaginal gel in HPV+ and HIV+ patients: a pilot observational study
|
Hijona, Jesús Joaquín
|
|
|
32 |
S2 |
p. A381
|
artikel
|
| 245 |
2022-RA-1340-ESGO Effect of alpha-lipoic acid supplementation on oxidative stress markers in patients with lsil
|
Divković, Anja
|
|
|
32 |
S2 |
p. A54
|
artikel
|
| 246 |
2022-RA-1037-ESGO Effect of alpha-lipoic acid supplementation on regression of low-grade squamous intraepithelial lesions
|
Divković, Anja
|
|
|
32 |
S2 |
p. A39
|
artikel
|
| 247 |
2022-RA-1623-ESGO Effect of bevacizumab and complete cytoreductive surgery in advanced low grade serous ovarian cancer: a secondary analysis of MITO 22
|
Musacchio, Lucia
|
|
|
32 |
S2 |
p. A355
|
artikel
|
| 248 |
2022-RA-954-ESGO Effect of elapsed time after treatment on overall quality of life, neurotoxicity, sexual life, lymphedema, and utility in ovarian cancer survivors (OVQOL)
|
Hyun, Su Min
|
|
|
32 |
S2 |
p. A395
|
artikel
|
| 249 |
2022-RA-1130-ESGO Effect of imiqiumod treatment on HLA-G expression in high-grade cervical lesions
|
Cokan, Andrej
|
|
|
32 |
S2 |
p. A412
|
artikel
|
| 250 |
2022-RA-1306-ESGO Effect of the COVID-19 pandemic on primary therapy and oncologic outcomes in women with advanced stage tubo-ovarian carcinoma in a tertiary cancer center
|
Eriksson, Ane Gerda Z
|
|
|
32 |
S2 |
p. A320-A321
|
artikel
|
| 251 |
2022-RA-154-ESGO Effects of chemotherapy on ovaries of pregnant mice: a pilot study
|
Schuurman, Teska
|
|
|
32 |
S2 |
p. A168-A169
|
artikel
|
| 252 |
2022-RA-447-ESGO Efficacy and safety of VB10.16, a therapeutic DNA vaccine specifically targeting antigen-cell presenting cells, in combination with atezolizumab in patients with advanced HPV16-positive cervical cancer: results from a pre-planned interim analysis
|
Hillemanns, Peter
|
|
|
32 |
S2 |
p. A12
|
artikel
|
| 253 |
2022-RA-1191-ESGO Efficacy of a multi-ingredient coriolus versicolor-based vaginal gel in high-risk HPV women over 40: sub-analysis of the paloma clinical trial & papilobs real-life study
|
Palacios, Santiago
|
|
|
32 |
S2 |
p. A382
|
artikel
|
| 254 |
2022-RA-1194-ESGO Efficacy of dostarlimab in endometrial cancer by molecular subtype: a post hoc analysis of the GARNET study
|
Tinker, Anna V
|
|
|
32 |
S2 |
p. A413
|
artikel
|
| 255 |
2022-RA-1033-ESGO Efficacy of hyperbaric oxygen therapy in vulvectomy healing
|
Zemni, Zeineb
|
|
|
32 |
S2 |
p. A438
|
artikel
|
| 256 |
2022-RA-1604-ESGO Efficiency of simulation program for OB/GYN residents using self-training and supervised sessions: a quantitative study
|
Aissaoui, Othman
|
|
|
32 |
S2 |
p. A464
|
artikel
|
| 257 |
2022-RA-899-ESGO Electrode biochips coupled to isothermal amplification LAMP technique in diagnostics of cervical precancer
|
Bartosik, Martin
|
|
|
32 |
S2 |
p. A75
|
artikel
|
| 258 |
2022-RA-794-ESGO Elucidate the mechanism of lymphedema from the analysis of lymphatic function and morphology before and after pelvic lymphadenectomy using indocyanine green fluorescence lymphangiography
|
Hirayama, Takashi
|
|
|
32 |
S2 |
p. A394-A395
|
artikel
|
| 259 |
2022-RA-701-ESGO Elucidating mechanisms underlying methotrexate resistance via quantitative proteomics analysis of GTN patient samples and choriocarcinoma cell lines: a crucial role for serine metabolism
|
Ntavelou, Panagiota
|
|
|
32 |
S2 |
p. A421
|
artikel
|
| 260 |
2022-RA-1323-ESGO Endometrial cancer aggressiveness may be associated with exposure to phthalates
|
Knez, Jure
|
|
|
32 |
S2 |
p. A144-A145
|
artikel
|
| 261 |
2022-RA-967-ESGO Endometrial cancer: agreement between microsatellite instability in immunohistochemistry and molecular biology?
|
Gennigens, Christine
|
|
|
32 |
S2 |
p. A123-A124
|
artikel
|
| 262 |
2022-RA-580-ESGO Endometrial cancer detection by DNA methylation testing in cervical scrapes, cervicovaginal self-samples and urine
|
Wever, Birgit MM
|
|
|
32 |
S2 |
p. A98-A99
|
artikel
|
| 263 |
2022-RA-815-ESGO Endometrial cancer incidence in patients with atypical endometrial hyperplasia according to mode of management
|
Barakat, Anas
|
|
|
32 |
S2 |
p. A112-A113
|
artikel
|
| 264 |
2022-RA-955-ESGO Endometrial cancer: lymphovascular space invasion is a negative prognostic factor
|
Salmon, Alixe
|
|
|
32 |
S2 |
p. A122
|
artikel
|
| 265 |
2022-RA-1529-ESGO Endometrial Cancer patient-derived explants detect drug-responses to standard-of-care chemotherapies and immunotherapy ex-vivo
|
Collins, Anna
|
|
|
32 |
S2 |
p. A157-A158
|
artikel
|
| 266 |
2022-RA-1344-ESGO Endometrial cancer patients with an overexpression of the orphan nuclear receptor NR2F6 show an improved survival
|
Proppe, Louisa
|
|
|
32 |
S2 |
p. A145-A146
|
artikel
|
| 267 |
2022-RA-1019-ESGO Endometrial hyperplasia and cancer: results of two reference hospitals in Ankara
|
Atalay, Funda
|
|
|
32 |
S2 |
p. A131
|
artikel
|
| 268 |
2022-RA-460-ESGO Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies
|
Castrillon, Diego H
|
|
|
32 |
S2 |
p. A96-A97
|
artikel
|
| 269 |
2022-RA-720-ESGO Endometrial stromal nodule: a rare entity. Report ot 2 cases
|
Rosales, Amina Lubrano
|
|
|
32 |
S2 |
p. A188-A189
|
artikel
|
| 270 |
2022-RA-1511-ESGO Endometrial stromal sarcomas – a 12 year single centre experience
|
Giannoulopoulos, Dimitrios
|
|
|
32 |
S2 |
p. A213
|
artikel
|
| 271 |
2022-RA-173-ESGO Endometrioid borderline ovarian tumor: clinical characteristics, prognosis and management
|
Ricotta, Giulio
|
|
|
32 |
S2 |
p. A221-A222
|
artikel
|
| 272 |
2022-RA-894-ESGO Endometrioid ovarian carcinoma – real world evidence from a large transatlantic team initiative: First results of the LEOPARD study
|
Grube, Marcel
|
|
|
32 |
S2 |
p. A275
|
artikel
|
| 273 |
2022-RA-657-ESGO ENGOT-ov65/KEYNOTE-B96: phase 3, randomized, double-blind study of pembrolizumab versus placebo plus paclitaxel with optional bevacizumab for platinum-resistant recurrent ovarian cancer
|
Colombo, Nicoletta
|
|
|
32 |
S2 |
p. A251
|
artikel
|
| 274 |
2022-RA-1583-ESGO Epidemiological & histopathological characteristics of breast cancer in Tunisia: a retrospective study
|
Chalouati, Takoua
|
|
|
32 |
S2 |
p. A215-A216
|
artikel
|
| 275 |
2022-RA-1658-ESGO Epidemy and war: lessons of cancer patients in Ukraine
|
Postupalenko, Olena
|
|
|
32 |
S2 |
p. A465
|
artikel
|
| 276 |
2022-RA-1356-ESGO Epithelial ovarian cancer and brain metastases: survival analysis according to the BRCA status
|
Sassu, Carolina Maria
|
|
|
32 |
S2 |
p. A328-A329
|
artikel
|
| 277 |
2022-RA-1441-ESGO Epithelial ovarian cancers during pregnancy: the results of a large retrospective study from the INCIP network
|
Fruscio, Robert
|
|
|
32 |
S2 |
p. A336-A337
|
artikel
|
| 278 |
2022-RA-1699-ESGO ERAS pathway for gynecological oncology – a pre-post implementation cohort with 1211 patients
|
Samouëlian, Vanessa
|
|
|
32 |
S2 |
p. A466
|
artikel
|
| 279 |
2022-RA-787-ESGO ESGO guidelines on the management of endometrial cancer. Weaknesses and controversies in france and french-speaking switzerland. Results of a delphi survey
|
Marti, Carolin
|
|
|
32 |
S2 |
p. A110-A111
|
artikel
|
| 280 |
2022-RA-717-ESGO Establishment of peritoneal dECM scaffolds for 3D culture of ovarian cancer organoids
|
Gjerde, Christiane Helgestad
|
|
|
32 |
S2 |
p. A406
|
artikel
|
| 281 |
2022-RA-1342-ESGO Ethnicity-specific spectrum of BRCA1, BRCA2 and ATM pathogenic variants in ovarian and breast cancer patients from North Caucasus
|
Imyanitov, Evgeny
|
|
|
32 |
S2 |
p. A415-A416
|
artikel
|
| 282 |
2022-RA-1496-ESGO Evaluation of cervical cytology in women on tamoxifen therapy
|
Miglani, Urvashi
|
|
|
32 |
S2 |
p. A387
|
artikel
|
| 283 |
2022-RA-1115-ESGO Evaluation of cervical dysplasia with NOVAprep-miR-CERVIX
|
Kniazeva, Margarita
|
|
|
32 |
S2 |
p. A75-A76
|
artikel
|
| 284 |
2022-RA-1032-ESGO Evaluation of intraoperative HPV test as an early marker of residual disease after HSIL surgical treatment. a prospective multicenter study. Preliminary results
|
Bradbury, Melissa
|
|
|
32 |
S2 |
p. A379
|
artikel
|
| 285 |
2022-RA-1264-ESGO Evaluation of managing CIN 3 plus diagnosed pregnant women by methylation assessment using FAM19A4/miR124 methylation test
|
Hampl, Monika
|
|
|
32 |
S2 |
p. A382-A383
|
artikel
|
| 286 |
2022-RA-994-ESGO Evaluation of one step nucleic acid amplification (OSNA) method for rapid detection of lymph node metastases in women with endometrial cancer
|
Fera, Eleonora La
|
|
|
32 |
S2 |
p. A125-A126
|
artikel
|
| 287 |
2022-RA-635-ESGO Evaluation of serum HE4 and CA125 levels in the early postpartum period
|
Delić, Ratko
|
|
|
32 |
S2 |
p. A173
|
artikel
|
| 288 |
2022-RA-1314-ESGO Evaluation of the concentration of the soluble form of programmed cell death-ligand 2 in patients with endometrial cancer
|
Kuryło, Weronika
|
|
|
32 |
S2 |
p. A143
|
artikel
|
| 289 |
2022-RA-1417-ESGO Evaluation of the gynaecology oncology surgeries complications at UHL
|
Abdelrasol, Mostafa
|
|
|
32 |
S2 |
p. A210-A211
|
artikel
|
| 290 |
2022-RA-1688-ESGO Evaluation of the impact of HRT on endometrial thickness and the diagnosis of endometrial cancer
|
D’Souza, Natasha
|
|
|
32 |
S2 |
p. A167-A168
|
artikel
|
| 291 |
2022-RA-1581-ESGO Evaluation of the relationship between patient characteristics and obesity with survival in epithelial ovarian tumors
|
Kayım, Sebahettin Oguzhan
|
|
|
32 |
S2 |
p. A351
|
artikel
|
| 292 |
2022-RA-1559-ESGO Expert ultrasound examination, MRI or ROMA for discriminating benign from malignant in inconclusive adnexal masses as determined by IOTA simple rules
|
Vara, Julio
|
|
|
32 |
S2 |
p. A82
|
artikel
|
| 293 |
2022-RA-1679-ESGO Expert ultrasound examination, MRI or ROMA for discriminating benign from malignant in inconclusive adnexal masses as determined by IOTA Simple Rules
|
Almandoz, Isabel Brotons
|
|
|
32 |
S2 |
p. A84-A85
|
artikel
|
| 294 |
2022-RA-830-ESGO Expression of COL5A2 in ovarian tumor microenvironment and its mechanism of promoting ovarian cancer
|
Zhu, Hongming
|
|
|
32 |
S2 |
p. A267-A268
|
artikel
|
| 295 |
2022-RA-1023-ESGO Expression of P16 and Ki67 in cervical high grade squamous intraepithelial lesion in women up to 30 years old
|
Rosin, Giovana Fontes
|
|
|
32 |
S2 |
p. A370
|
artikel
|
| 296 |
2022-RA-576-ESGO Expression VIII – first study of individual perception and level of information of patients with low grade ovarian cancer and borderline tumor of the ovary in 321 patients
|
Beckmann, Laura Naomi
|
|
|
32 |
S2 |
p. A239-A240
|
artikel
|
| 297 |
2022-RA-855-ESGO External validation of the ADNEX model to triage adnexal masses in Greece: A tertiary center study conducted by non-expert sonographers
|
Anthoulakis, Christos
|
|
|
32 |
S2 |
p. A74
|
artikel
|
| 298 |
2022-RA-684-ESGO Factors affecting survival outcomes of patients with clear cell endometrial carcinoma
|
Pergialiotis, Vasilios
|
|
|
32 |
S2 |
p. A104
|
artikel
|
| 299 |
2022-RA-1506-ESGO Factors affecting survival rates of patients with uterine clear cell carcinoma
|
Christodoulou, Theano
|
|
|
32 |
S2 |
p. A155
|
artikel
|
| 300 |
2022-RA-1357-ESGO Factors associated with an increased risk of recurrence in endometrial cancer patients: a retrospective cohort study
|
Teixeira, Natalia
|
|
|
32 |
S2 |
p. A147
|
artikel
|
| 301 |
2022-RA-741-ESGO Factors influencing short-term postoperative health-related quality of life deterioration in patients undergoing gynecologic oncologic surgery
|
Tanturovski, Mile Dragan
|
|
|
32 |
S2 |
p. A394
|
artikel
|
| 302 |
2022-RA-1039-ESGO Factors predisposing to more severe pain and a significant influence of patients’ anxiety prior to the procedure – a study on a perioperative care in gynecologic oncology
|
Bałdyga, Paulina
|
|
|
32 |
S2 |
p. A458
|
artikel
|
| 303 |
2022-RA-442-ESGO Fallopian tube cytological findings in women undergoing salpingectomy and correlation with the adnexal pathology
|
Psomiadou, Viktoria
|
|
|
32 |
S2 |
p. A368-A369
|
artikel
|
| 304 |
2022-RA-1020-ESGO Family history in BRCA mutation carriers affected by breast and ovarian cancer and its role in identifying subjects at high risk
|
Negri, Serena
|
|
|
32 |
S2 |
p. A378-A379
|
artikel
|
| 305 |
2022-RA-1165-ESGO Feasibility and safety of inguinofemoral sentinel lymph node biopsy for previously excised vulvar cancer
|
Pascoal, Erica
|
|
|
32 |
S2 |
p. A443
|
artikel
|
| 306 |
2022-RA-819-ESGO Feasibility and safety of real-time near-infrared fluorescence tracer imaging in sentinel node biopsy for vulva cancer patients
|
Frøding, Ligita Paskeviciute
|
|
|
32 |
S2 |
p. A432-A433
|
artikel
|
| 307 |
2022-RA-1312-ESGO Feasibility of carboplatin monotherapy versus carboplatin-paclitaxel in frail elderly epithelial ovarian cancer patients
|
Yu, Tamara
|
|
|
32 |
S2 |
p. A322-A323
|
artikel
|
| 308 |
2022-RA-1155-ESGO Feasibility of hand assisted laparoscopic sentinel node biopsy in vulvar cancer using combined radioactive and fluorescence guidance
|
Fais, Giuseppina
|
|
|
32 |
S2 |
p. A442
|
artikel
|
| 309 |
2022-RA-936-ESGO Feasibility of laparoscopic extraperitoneal pelvic lymphadenectomy in obese endometrial cancer patients
|
Hamdy, Mohamed
|
|
|
32 |
S2 |
p. A120
|
artikel
|
| 310 |
2022-RA-1427-ESGO Fertility outcomes following radical trachelectomy for cervical cancer – a single centre ten year retrospective cohort study
|
Braden, Victoria
|
|
|
32 |
S2 |
p. A180
|
artikel
|
| 311 |
2022-RA-160-ESGO Fertility preservation in patients with early cervical cancer after organ-sparing surgery: retrospective monocentric study
|
Matylevich, Olga P
|
|
|
32 |
S2 |
p. A169
|
artikel
|
| 312 |
2022-RA-1520-ESGO Fertility sparing operative hysterescopy for patients with stage ia g1/g2 endometriod endometrial carcinoma- farghaly’s technique
|
Farghaly, Samir
|
|
|
32 |
S2 |
p. A156-A157
|
artikel
|
| 313 |
2022-RA-187-ESGO Fertility-sparing radical trachelectomy for early-stage cervical cancer: 12 cases series and literature review
|
Doan, Nghia Trong
|
|
|
32 |
S2 |
p. A3
|
artikel
|
| 314 |
2022-RA-689-ESGO Fertility-sparing treatment in patients with IB1 cervical cancer – results of the international multicentre retrospective FERTISS study (ENGOT Cx14; CEEGOG Cx-03)
|
Slama, Jiri
|
|
|
32 |
S2 |
p. A174
|
artikel
|
| 315 |
2022-RA-1640-ESGO Fertility-sparing treatment in patients with stage I ovarian dysgerminoma: an analysis of pregnancy outcomes
|
Vicini, Debora
|
|
|
32 |
S2 |
p. A357
|
artikel
|
| 316 |
2022-RA-911-ESGO 18F-FDG-PET/CT in orthotopic mouse models of endometrial cancer: multiparametric characterization and evaluation of treatment response
|
Lyngstad, Jenny
|
|
|
32 |
S2 |
p. A409
|
artikel
|
| 317 |
2022-RA-601-ESGO Fighting cervical cancer in cameroon
|
Jimenez, Cristina Juan
|
|
|
32 |
S2 |
p. A16-A17
|
artikel
|
| 318 |
2022-RA-1256-ESGO First experiences of implementing ‘enhanced recovery after surgery’ (ERAS) at two German ESGO centers of excellence – KORE-INNOVATION: the first prospective clinical trial to assess a perioperative pathway to reduce postoperative complications in ovarian cancer patients
|
Inci-Turan, Melisa Guelhan
|
|
|
32 |
S2 |
p. A314
|
artikel
|
| 319 |
2022-RA-1134-ESGO First real-life data on niraparib maintenance in newly-diagnosed advanced ovarian cancer: a descriptive analysis of the Temporary Authorisation for Use (ATU) cohort
|
Rouge, Thibault de la Motte
|
|
|
32 |
S2 |
p. A303-A304
|
artikel
|
| 320 |
2022-RA-637-ESGO Five-year universal tumor screening of BRCA1/2 in epithelial ovarian carcinoma;is histotype-directed hr-deficiency testing justified?
|
Kramer, Claire JH
|
|
|
32 |
S2 |
p. A248
|
artikel
|
| 321 |
2022-RA-1173-ESGO Follow-up in gynecological cancer survivors: an EORTC QLG-GCG survivorship study- trial in progress
|
Greimel, Eva
|
|
|
32 |
S2 |
p. A399
|
artikel
|
| 322 |
2022-RA-823-ESGO FOXL2 mutation detection in circulating tumor DNA of adult granulosa cell tumors as a potential biomarker for disease monitoring from the randomized ALIENOR trial, a GINECO study
|
Treilleux, Isabelle
|
|
|
32 |
S2 |
p. A267
|
artikel
|
| 323 |
2022-RA-1617-ESGO Frailty influences complications following robot assisted surgery in the elderly
|
Bharathan, Rasiah
|
|
|
32 |
S2 |
p. A164
|
artikel
|
| 324 |
2022-RA-1083-ESGO FraStROC —frailty stratification for recurrent ovarian cancer development and prospective validation of a frailty score for chemotherapy associated toxicity in relapsed ovarian cancer
|
Chekerov, Radoslav
|
|
|
32 |
S2 |
p. A295-A296
|
artikel
|
| 325 |
2022-RA-768-ESGO Free cancer cells in fallopian tubes (floaters) as artifacts of uterine manipulator use in minimally invasive surgery (MIS) for endometrial cancer: Does it matter? A retrospective cohort study
|
Côté, Maxime
|
|
|
32 |
S2 |
p. A108
|
artikel
|
| 326 |
2022-RA-1046-ESGO Frequency of bowel anastomosis leakage after modified posterior exenteration – comparison of two surgical Methods: classic surgery in patients with ovarian cancer and minimal invasive modified ‘tailored’ technique in deep infiltrating endometriosis patients
|
Kasperski, Mariusz
|
|
|
32 |
S2 |
p. A397-A398
|
artikel
|
| 327 |
2022-RA-1468-ESGO Frequency of MMR deficiency for primary endometrial neuroendocrine carcinoma and its therapeutic outcome in Japan
|
Terao, Junna
|
|
|
32 |
S2 |
p. A152
|
artikel
|
| 328 |
2022-RA-803-ESGO Functional characterization of nrip1 in endometrial cancer; mutations associates with aggressive features while low expression levels predict poor survival
|
Bredin, Hanna Kosberg
|
|
|
32 |
S2 |
p. A407
|
artikel
|
| 329 |
2022-RA-1561-ESGO GATA3 expression is significantly correlated with oestrogen receptor expression, but not clinico-pathological features in breast cancer
|
Crnobrnja, Bojana
|
|
|
32 |
S2 |
p. A215
|
artikel
|
| 330 |
2022-RA-831-ESGO Gender-related differences in career development among gynecologic oncology surgeons in europe. European network of young gynecologic oncologists’ survey based data
|
Nikolova, Tanja
|
|
|
32 |
S2 |
p. A192
|
artikel
|
| 331 |
2022-RA-141-ESGO Genomic characteristic analysis in squamous cell carcinoma and adenocarcinoma of cervix identifies Alpelisib as a therapeutic option for PIK3CA mutational cervical carcinoma
|
Cao, Canhui
|
|
|
32 |
S2 |
p. A1-A2
|
artikel
|
| 332 |
2022-RA-1222-ESGO Germ cell tumours: relevance of prompt diagnosis
|
Buruiana, Felicia Elena
|
|
|
32 |
S2 |
p. A311
|
artikel
|
| 333 |
2022-RA-1169-ESGO Germline genetic test for ovarian cancer. is it important to be available?
|
De Ferreira, Caroline Oliveira
|
|
|
32 |
S2 |
p. A380-A381
|
artikel
|
| 334 |
2022-RA-890-ESGO Gestational trophoblastic disease in Portugal: retrospective analysis of the last 10 years in two institutions
|
Ferreira, André
|
|
|
32 |
S2 |
p. A422
|
artikel
|
| 335 |
2022-RA-1578-ESGO Gestational trophoblastic neoplasia about 62 cases
|
Abbou, Jihad
|
|
|
32 |
S2 |
p. A426
|
artikel
|
| 336 |
2022-RA-1234-ESGO Gestational trophoblastic neoplasia: multimodal approach to diagnosis and treatment
|
Rouiss, Hadhami
|
|
|
32 |
S2 |
p. A424
|
artikel
|
| 337 |
2022-RA-1400-ESGO GI-RADS versus O-RADS as classification reporting system for adnexal masses. A prospective comparative study
|
Vara, Julio
|
|
|
32 |
S2 |
p. A79-A80
|
artikel
|
| 338 |
2022-RA-854-ESGO Giving prognostic information by using scenarios – attitudes of women with gynecological cancer
|
Reinertsen, Maren Paus
|
|
|
32 |
S2 |
p. A365
|
artikel
|
| 339 |
2022-RA-1555-ESGO Grade 3 endometrioid endometrial adenocarcinomas- Management and outcome analysis: A six year review
|
Sehra, Divya
|
|
|
32 |
S2 |
p. A160
|
artikel
|
| 340 |
2022-RA-1363-ESGO Gynaecological oncology surgical techniques in complex pelvic surgery and management of intractable pelvic abscesses on a background of severe crohn’s disease
|
Loganathan, Shanghavie
|
|
|
32 |
S2 |
p. A400-A401
|
artikel
|
| 341 |
2022-RA-1653-ESGO Gynaecological pelvic masses presenting with venous thromboembolism; what is the risk and what is the underlying pathology?
|
Palmer, Emilia
|
|
|
32 |
S2 |
p. A84
|
artikel
|
| 342 |
2022-RA-1421-ESGO Gynaecological skills training impact assessment of trainees in Northern Ireland
|
McMullan, Josh Courtney
|
|
|
32 |
S2 |
p. A211
|
artikel
|
| 343 |
2022-RA-1507-ESGO Gynaecologic oncology meets hepatobilliary surgery; unexpected findings during surgical exploration
|
Giannoulopoulos, Dimitrios
|
|
|
32 |
S2 |
p. A212
|
artikel
|
| 344 |
2022-RA-1457-ESGO Gynecological cancer detection using fourier-transformed infra-red spectroscopy in urine samples: potential and accuracy of machine learning processing
|
Vigo, Francesco
|
|
|
32 |
S2 |
p. A417
|
artikel
|
| 345 |
2022-RA-570-ESGO Gynecological cancer treatment and couple’s sexuality
|
Nowosielski, Krzysztof
|
|
|
32 |
S2 |
p. A392-A393
|
artikel
|
| 346 |
2022-RA-1589-ESGO Gynecomammary cancer in young adults, about 8 cases and a literature review
|
Abbou, Jihad
|
|
|
32 |
S2 |
p. A374
|
artikel
|
| 347 |
2022-RA-1128-ESGO Has endometrial cancer treatment changed during the last years? A cancer registry data-based approach to monitor expected treatment changes after the release of the corresponding S3 guideline
|
Schultz, Annemarie
|
|
|
32 |
S2 |
p. A135-A136
|
artikel
|
| 348 |
2022-RA-696-ESGO Health behind bars: a woman’s right
|
Singla, Anshuja
|
|
|
32 |
S2 |
p. A376-A377
|
artikel
|
| 349 |
2022-RA-744-ESGO Hepatitis B screening to reduce the risk of viral reactivation in gynecologic oncology patients receiving chemotherapy at a regional tertiary cancer centre: a quality improvement initiative
|
Mah, Sarah Jill
|
|
|
32 |
S2 |
p. A189
|
artikel
|
| 350 |
2022-RA-694-ESGO Hereditary cancer predisposition in Brazilian public health system: is it possible to identify?
|
Gomes Carneiro, Vandré Cabral
|
|
|
32 |
S2 |
p. A376
|
artikel
|
| 351 |
2022-RA-1007-ESGO High expression of FAP+ cancer-associated fibroblasts predict poor outcome in patients with high-grade serous ovarian cancer with high CD8-postive T-cell infiltration
|
Fernebro, Josefin
|
|
|
32 |
S2 |
p. A411
|
artikel
|
| 352 |
2022-RA-728-ESGO High expression of vacuolar-ATPase subunit ATP6V1B1 predicts a poor prognosis and correlates with cell cycle progression in epithelial ovarian cancer
|
Yun, Hee
|
|
|
32 |
S2 |
p. A259
|
artikel
|
| 353 |
2022-RA-756-ESGO High grade squamous intraepithelial lesions in pregnancy: case series of 35 patients
|
Matylevich, Olga P
|
|
|
32 |
S2 |
p. A174-A175
|
artikel
|
| 354 |
2022-RA-1425-ESGO High-intermediate and high risk endometrial cancer is associated with increased rates of lymph node invasion
|
Margioula-Siarkou, Chrysoula
|
|
|
32 |
S2 |
p. A151
|
artikel
|
| 355 |
2022-RA-984-ESGO High-Risk Human Papillomavirus (HR-HPV) viral load: a new approach for high-grade Cervical Intraepithelial Neoplasia (CIN) treatment?
|
Torre, Francesco La
|
|
|
32 |
S2 |
p. A37
|
artikel
|
| 356 |
2022-RA-1383-ESGO High visceral fat percentage is linked to upregulated inflammatory tumour signalling and predicts poor outcome in uterine cervical cancer
|
Eide, Agnes Jørgensen
|
|
|
32 |
S2 |
p. A56
|
artikel
|
| 357 |
2022-RA-1637-ESGO HIPEC as a safe and useful tool for the treatment of ovarian cancer
|
Ramirez, Andres Rave
|
|
|
32 |
S2 |
p. A356
|
artikel
|
| 358 |
2022-RA-922-ESGO Histo-molecular characteristics of platinum-sensitive advanced endometrial cancer: data issued from the population included in the GINECO UTOLA study
|
Joly, Florence
|
|
|
32 |
S2 |
p. A118-A119
|
artikel
|
| 359 |
2022-RA-1492-ESGO Homologous recombination deficiency (HRD): a new ovarian cancer biomarker – validation of decentralized genomic profiling, with a focus on genomic large rearrangements (LRs)
|
Denkert, Carsten
|
|
|
32 |
S2 |
p. A343
|
artikel
|
| 360 |
2022-RA-1298-ESGO Hormonal replacement therapy after gynecological malignancies – critical literature review
|
Jansa, Vid
|
|
|
32 |
S2 |
p. A399
|
artikel
|
| 361 |
2022-RA-779-ESGO How frequently benign uterine myomas appear as suspicious sarcomas on ultrasound examination
|
Manzour, Nabil
|
|
|
32 |
S2 |
p. A74
|
artikel
|
| 362 |
2022-RA-918-ESGO How the intense thromboprophylaxis meets the needs of high thrombotic burden gynecological cancer patients undergoing surgical treatment? Intermediate results from the methos study
|
Lekka, S
|
|
|
32 |
S2 |
p. A195-A196
|
artikel
|
| 363 |
2022-RA-1705-ESGO How to differentiate between true positives and false positives in the diagnosis of borderline ovarian tumors
|
Rodriguez, Nadiezhda
|
|
|
32 |
S2 |
p. A86
|
artikel
|
| 364 |
2022-RA-1299-ESGO How to predict preoperative risk of lymph node metastasis in vulvar cancer patients the Morphonode Predictive Model
|
Fragomeni, Simona Maria
|
|
|
32 |
S2 |
p. A445-A446
|
artikel
|
| 365 |
2022-RA-1373-ESGO ‘hsa-miR-124 & EPB41L3 DNA methylation analysis in liquid-based cytology for cervical cancer screening: a preliminary data in Northern Greek population.’
|
Derdas, Stavros Peter
|
|
|
32 |
S2 |
p. A55
|
artikel
|
| 366 |
2022-RA-656-ESGO H-SIL in young patients
|
González, Elga López
|
|
|
32 |
S2 |
p. A19-A20
|
artikel
|
| 367 |
2022-RA-1543-ESGO Human papillomavirus-associated and -independent vulvar squamous cell carcinomas: clinical, pathological and prognostic distinct entities
|
Carreras-Dieguez, Núria
|
|
|
32 |
S2 |
p. A448-A449
|
artikel
|
| 368 |
2022-RA-1131-ESGO Human papillomavirus genotype and prognostic factors of vaginal cancer
|
Lai, Chyong-Huey
|
|
|
32 |
S2 |
p. A441
|
artikel
|
| 369 |
2022-RA-824-ESGO Human papillomavirus in vulvar carcinoma patients in Norway: its prognostic role and changes in prevalence and genotype distribution in two time periods, 1970–75 and 2000–05
|
Meltzer-Gunnes, Christin Julia
|
|
|
32 |
S2 |
p. A433
|
artikel
|
| 370 |
2022-RA-1107-ESGO Hysterectomy after radical vaginal trachelectomy – is this a ‘must’ in early stage cervical cancer? Our 15 years clinical experience benchmarked with the current state of science
|
Cepraga, Irina
|
|
|
32 |
S2 |
p. A43
|
artikel
|
| 371 |
2022-RA-221-ESGO Hysterectomy alone vs. hysterectomy plus sentinel node mapping in endometrial cancer: long-term results from a multi-institutional study
|
Bogani, Giorgio
|
|
|
32 |
S2 |
p. A93
|
artikel
|
| 372 |
2022-RA-876-ESGO Hysterectomy, pelvic or paraaortic lymphadenectomy: results of an outpatient pathway for surgery in gynecologic oncology
|
Boscher, Adrien
|
|
|
32 |
S2 |
p. A457
|
artikel
|
| 373 |
2022-RA-1197-ESGO ‘Iavazzo score’, an effort to preoperatively predict the duration of robotic assisted gynecological surgeries
|
Iavazzo, Christos
|
|
|
32 |
S2 |
p. A460
|
artikel
|
| 374 |
2022-RA-1534-ESGO ICG mapped sentinel lymph-node biopsy in endometrial cancer: analysis of surgeons’ learning process
|
Gedgaudaite, Migle
|
|
|
32 |
S2 |
p. A158
|
artikel
|
| 375 |
2022-RA-1092-ESGO Identification and validation of microRNAs as endogenous controls in epithelial ovarian cancer
|
Lopacinska-Joergensen, Joanna
|
|
|
32 |
S2 |
p. A297
|
artikel
|
| 376 |
2022-RA-654-ESGO Identification of clinicopathologic factors related to PD-1/PD-L1 expressionand > forsurvival analysis in endometrial cancer patients
|
Kim, Yeorae
|
|
|
32 |
S2 |
p. A102-A103
|
artikel
|
| 377 |
2022-RA-1590-ESGO Identification of groin node metastasis in squamous vulval cancer using preoperative [18F] FDG-PET/CT. Can unnecessary lymphadenectomy be prevented?
|
Batog, Wiktoria Irena
|
|
|
32 |
S2 |
p. A449-A450
|
artikel
|
| 378 |
2022-RA-671-ESGO Identification of risk factors of recurrence among patients with vulvar Paget`s disease treated with conservative surgery: a retrospective cohort
|
Pergialiotis, Vasilios
|
|
|
32 |
S2 |
p. A429-A430
|
artikel
|
| 379 |
2022-RA-371-ESGO Immature teratoma of the ovary diagnosed after normal delivery: a case report
|
Farazestanian, Marjaneh
|
|
|
32 |
S2 |
p. A229
|
artikel
|
| 380 |
2022-RA-1009-ESGO Immune-related endpoints in patients with advanced or recurrent endometrial cancer treated with dostarlimab in the GARNET study
|
Tinker, Anna V
|
|
|
32 |
S2 |
p. A130
|
artikel
|
| 381 |
2022-RA-1318-ESGO Immunohistochemical profiling of macrophage subtypes in the microenvironment of ovarian tumours in young women
|
Fox, Emily Miranda
|
|
|
32 |
S2 |
p. A323-A324
|
artikel
|
| 382 |
2022-RA-1393-ESGO Immunohistochemistry should be applied in classification of high-grade endometrial carcinomas
|
Boros, Monica
|
|
|
32 |
S2 |
p. A150
|
artikel
|
| 383 |
2022-RA-968-ESGO Immunotherapy response monitoring using personalized circulating tumor DNA analysis in patients with relapsed gynecologic malignancies
|
Castaneda, Kayla
|
|
|
32 |
S2 |
p. A410-A411
|
artikel
|
| 384 |
2022-RA-1551-ESGO Impact of age on first line treatments of ovarian cancer and their outcomes: results from the Unicancer ESME OVR real-world database
|
Lefevre, Leïla Bengrine
|
|
|
32 |
S2 |
p. A348-A349
|
artikel
|
| 385 |
2022-RA-1099-ESGO Impact of age on surgical resection margins of vulvar squamous cell carcinoma: multicenter descriptive study
|
Raimond, Emilie
|
|
|
32 |
S2 |
p. A440
|
artikel
|
| 386 |
2022-RA-1110-ESGO Impact of comorbidities, postoperative complications and center volume on overall survival in a real-life cohort of 29,879 ovarian cancer patients
|
Jochum, Floriane
|
|
|
32 |
S2 |
p. A300
|
artikel
|
| 387 |
2022-RA-719-ESGO Impact of COVID-19 on radical (chemo)radiotherapy for locally advanced cervical cancer in the West of Scotland, April 2020 – March 2021
|
Patrick, Jennifer
|
|
|
32 |
S2 |
p. A23
|
artikel
|
| 388 |
2022-RA-1242-ESGO Impact of COVID-19 on stage of locally advanced cervical cancer at diagnosis in the West of Scotland, April 2020 – March 2021
|
Grech, Joanna
|
|
|
32 |
S2 |
p. A47-A48
|
artikel
|
| 389 |
2022-RA-880-ESGO Impact of COVID-19 on waiting times in the gynaecological cancer patient pathway, a comparative study
|
Craig, Natasha Victoria
|
|
|
32 |
S2 |
p. A194
|
artikel
|
| 390 |
2022-RA-1696-ESGO Impact of ERAS implementation for vulvar cancer surgery
|
Warkus, Thomas
|
|
|
32 |
S2 |
p. A452-A453
|
artikel
|
| 391 |
2022-RA-799-ESGO Impact of imaging- and pathology findings for stage migration and prognostication using the FIGO (2018) staging system in cervical cancer
|
Wagner-Larsen, Kari Strøno
|
|
|
32 |
S2 |
p. A27-A28
|
artikel
|
| 392 |
2022-RA-1462-ESGO Impact of minimally invasive radical hysterectomy on survival outcomes in early-stage usual-type adenocarcinoma and adenosquamous carcinoma of the cervix: A two-center study with pathologic review
|
Kim, Se Ik
|
|
|
32 |
S2 |
p. A60-A61
|
artikel
|
| 393 |
2022-RA-179-ESGO Impact of morbid obesity on the outcomes of type II endometrial cancer: a cohort study
|
Gaballal, Khaled
|
|
|
32 |
S2 |
p. A90
|
artikel
|
| 394 |
2022-RA-1311-ESGO Impact of obesity on the management of patients with ovarian cancer: analysis of data from the Francogyn group
|
Ilic, Johanna
|
|
|
32 |
S2 |
p. A322
|
artikel
|
| 395 |
2022-RA-1672-ESGO Impact of sepsis on the oncologic outcomes of advanced epithelial ovarian cancer patients: a multicenter retrospective pilot study
|
Said, Sherin Abdo
|
|
|
32 |
S2 |
p. A360
|
artikel
|
| 396 |
2022-RA-805-ESGO Impact of surgery and chemotherapy timing on outcomes in older versus younger epithelial ovarian cancer patients: a nationwide Danish cohort study
|
Ekmann-Gade, Anne Weng
|
|
|
32 |
S2 |
p. A264
|
artikel
|
| 397 |
2022-RA-1515-ESGO Impact of surgical staging on survival of low grade endometrioid ovarian cancer apparently confined to the ovary
|
Bizzarri, Nicolò
|
|
|
32 |
S2 |
p. A344-A345
|
artikel
|
| 398 |
2022-RA-177-ESGO Impact of therapeutic strategy on disease-free and overall survival of early stage cervical cancer: surgery alone versus pre-operative radiotherapy
|
Mahiou, Katia
|
|
|
32 |
S2 |
p. A2
|
artikel
|
| 399 |
2022-RA-1647-ESGO Impact of tumor volume on survival of patients with lymph node metastasis in endometrial cancer
|
Gorostidi, Mikel
|
|
|
32 |
S2 |
p. A166-A167
|
artikel
|
| 400 |
2022-RA-1614-ESGO Impact of various cervical cancer treatments on sexual functioning and quality of life of women: a systematic review and meta-analysis
|
Jiboc, Nicoleta Monica
|
|
|
32 |
S2 |
p. A403
|
artikel
|
| 401 |
2022-RA-762-ESGO Implementation case study of image guided adaptive high dose rate brachytherapy for cervical cancer: workflow impact analysis of upgrading to image based brachytherapy within National Cancer Grid of India cervix cancer resource stratified guidelines
|
Chopra, Supriya
|
|
|
32 |
S2 |
p. A456-A457
|
artikel
|
| 402 |
2022-RA-1094-ESGO Implementation of a tri-modal prehabilitation intervention – KORE-INNOVATION: the first prospective clinical trial to assess a perioperative pathway to reduce postoperative complications in ovarian cancer patients
|
Inci-Turan, Melisa Guelhan
|
|
|
32 |
S2 |
p. A297-A298
|
artikel
|
| 403 |
2022-RA-1366-ESGO Implementation of day case minimal access hysterectomy
|
Pierce, Hannah
|
|
|
32 |
S2 |
p. A461
|
artikel
|
| 404 |
2022-RA-1022-ESGO Implementation of machine learning in a care pathway for advanced epithelial ovarian cancer: a National Cancer Institute experience
|
Boscher, Adrien
|
|
|
32 |
S2 |
p. A290
|
artikel
|
| 405 |
2022-RA-1364-ESGO Implementation of molecular classification in endometrial cancer and its impact on indication of adjuvant therapy
|
Puiggrós, Laura Cárdenas
|
|
|
32 |
S2 |
p. A147-A148
|
artikel
|
| 406 |
2022-RA-843-ESGO Implementation of opportunistic salpingectomy for prevention of ovarian cancer: retrospective study
|
Gelderblom, Malou
|
|
|
32 |
S2 |
p. A377
|
artikel
|
| 407 |
2022-RA-1402-ESGO Implementing HRD testing in routine clinical practice among patients with primary high-grade advanced ovarian cancer
|
Heitz, Florian
|
|
|
32 |
S2 |
p. A333
|
artikel
|
| 408 |
2022-RA-1368-ESGO Implementing sentinel lymph node biopsy in all risk groups in endometrial cancer: our experience at Dr. Josep Trueta university hospital
|
Puiggrós, Laura Cárdenas
|
|
|
32 |
S2 |
p. A148
|
artikel
|
| 409 |
2022-RA-806-ESGO Implication of FDG-PET/CT parameters for predicting prognosis of high grade neuroendocrine cervical cancer patient
|
Song, Changho
|
|
|
32 |
S2 |
p. A28-A29
|
artikel
|
| 410 |
2022-RA-612-ESGO Improving endometrial cancer assessment by combining the new techniqUe of GENomic profiling with surgical extra uterIne disEase assessment. An introduction to EUGENIE
|
Amant, Frédéric
|
|
|
32 |
S2 |
p. A99-A100
|
artikel
|
| 411 |
2022-RA-743-ESGO Improving risk stratification for cervical cancer in patients treated with concurrent chemoradiation and MRI-image guided adaptive brachytherapy in EMBRACE study: results from an international collaborative translational research study (BIOEMBRACE-I)
|
Chopra, Supriya
|
|
|
32 |
S2 |
p. A25
|
artikel
|
| 412 |
2022-RA-992-ESGO Incidence and the clinical characteristics of endometrial cancer in end-bx performed with pipelle in breast cancer patients
|
Atalay, Funda
|
|
|
32 |
S2 |
p. A125
|
artikel
|
| 413 |
2022-RA-1014-ESGO Incidence of pelvic high-grade serous carcinoma after isolated STIC diagnosis: A systematic review of the literature
|
Battista, Marco Johannes
|
|
|
32 |
S2 |
p. A290
|
artikel
|
| 414 |
2022-RA-1712-ESGO Inconclusive ovarian tumours by IOTA simple rules and application of O-RADS MRI scores in a tertiary referral centre
|
Matas Barcelo, Isabel
|
|
|
32 |
S2 |
p. A86-A87
|
artikel
|
| 415 |
2022-RA-995-ESGO Independent prognostic significance of substantial lymphovascular space invasion (LVSI) in a consecutive series of primary LVSI-positive endometrial carcinoma (EC)
|
Kommoss, Stefan
|
|
|
32 |
S2 |
p. A126
|
artikel
|
| 416 |
2022-RA-1405-ESGO Indocyanine green in near-infrared light for intra-operative imaging of residual ovarian cancer after neoadjuvant chemotherapy. Initial experience
|
Kubelac, Paul
|
|
|
32 |
S2 |
p. A333
|
artikel
|
| 417 |
2022-RA-939-ESGO Influence of cancer and surgery to immunosuppressive and proinflammatory factors in ovarian cancer patients’ PBMCs
|
Ulevicius, Jonas
|
|
|
32 |
S2 |
p. A281
|
artikel
|
| 418 |
2022-RA-246-ESGO Influence of depth of excision on test of cure following loop excisional treatment for high grade CIN
|
Dokmeci, Melin
|
|
|
32 |
S2 |
p. A374
|
artikel
|
| 419 |
2022-RA-1582-ESGO Inhibition of the Wnt/β-Catenin pathway with DKK3 protein – a new viral therapy for treatment of ovarian cancer?
|
Naskretski, Adam
|
|
|
32 |
S2 |
p. A419
|
artikel
|
| 420 |
2022-RA-1100-ESGO Inoperable malignant bowel obstruction in advanced ovarian cancer: a retrospective analysis of prognostic radiological features in patients supported with parenteral nutrition
|
Wight, Rebecca Kate
|
|
|
32 |
S2 |
p. A298
|
artikel
|
| 421 |
2022-RA-998-ESGO Intermediate-risk endometrial cancer: isolated tumor cells (ITC) versus node-negative in sentinel lymph node mapping. An international multi-institutional comparative study
|
Cucinella, Giuseppe
|
|
|
32 |
S2 |
p. A127-A128
|
artikel
|
| 422 |
2022-RA-648-ESGO Interpretable deep learning provides clues for prognostic refinement of the molecular endometrial cancer classification
|
Fremond, Sarah
|
|
|
32 |
S2 |
p. A101
|
artikel
|
| 423 |
2022-RA-1326-ESGO Interval disease surgery by robotic approach in ovarian cancer
|
Ortega, Carlos
|
|
|
32 |
S2 |
p. A324-A325
|
artikel
|
| 424 |
2022-RA-1408-ESGO Intracardiac intravenous leiomyomatosis with malignant hystological features
|
Soto Troya, Dianelle A
|
|
|
32 |
S2 |
p. A80
|
artikel
|
| 425 |
2022-RA-1327-ESGO Intrathecal morphine, a way to achieve opioid-free pain management within an ERAS
|
Klat, Jaroslav
|
|
|
32 |
S2 |
p. A208
|
artikel
|
| 426 |
2022-RA-217-ESGO Intravenous leiomyomatosis of the uterus with intracardiac extension: a case report
|
Matylevich, Olga P
|
|
|
32 |
S2 |
p. A184-A185
|
artikel
|
| 427 |
2022-RA-881-ESGO Introduction of a sentinel lymph node protocol for endometrial cancer at a regional cancer center in UK
|
Mohamed AlWahaibi, Fatma
|
|
|
32 |
S2 |
p. A116
|
artikel
|
| 428 |
2022-RA-1376-ESGO Introduction of care bundle in vulval cancer
|
AlWahaibi, Fatma Mohamed
|
|
|
32 |
S2 |
p. A446-A447
|
artikel
|
| 429 |
2022-RA-1005-ESGO Invasive cervical cancer of one cervix in uterus didelphys type of uterine anomaly – a case report and review of the literature
|
Popovic, Miroslav
|
|
|
32 |
S2 |
p. A38-A39
|
artikel
|
| 430 |
2022-RA-958-ESGO Invasive stratified mucin-producing intraepithelial lesion (iSMILE) a rare entity of cervical cancer
|
Zemni, Zeineb
|
|
|
32 |
S2 |
p. A35-A36
|
artikel
|
| 431 |
2022-RA-655-ESGO Involvement of the margins after excisional treatment
|
González, Elga López
|
|
|
32 |
S2 |
p. A19
|
artikel
|
| 432 |
2022-RA-850-ESGO Iron prehabilitation in endometrial cancer patients waiting for surgery: a feasibility pilot study
|
Zachariou, Eleftherios
|
|
|
32 |
S2 |
p. A115
|
artikel
|
| 433 |
2022-RA-893-ESGO Is ethnicity a risk factor for differential outcomes in mucinous ovarian cancer? experience from a UK gynaecological oncology centre
|
Olaoye, Tejumola
|
|
|
32 |
S2 |
p. A274-A275
|
artikel
|
| 434 |
2022-RA-1439-ESGO Is it time to perform radiochemotherapy and brachytherapy for cervical tumors higher than 3 cm?
|
Cordoba, Abel
|
|
|
32 |
S2 |
p. A60
|
artikel
|
| 435 |
2022-RA-1067-ESGO Is laparoscopic radical hysterectomy safe in cervical cancer with tumor size ≤2 cm, even if parametrial invasion or lymph node metastasis is found after surgery?
|
Kim, Junhwan
|
|
|
32 |
S2 |
p. A40-A41
|
artikel
|
| 436 |
2022-RA-753-ESGO Is laparoscopy a safe approach for treatment of stage II endometrial cancer? A single centre 10 years experience
|
Zouridis, Andreas
|
|
|
32 |
S2 |
p. A106-A107
|
artikel
|
| 437 |
2022-RA-1470-ESGO Is neoadjuvant chemotherapy effective as prehabilitation program in advanced epithelial ovarian cancer?
|
Ghirardi, Valentina
|
|
|
32 |
S2 |
p. A340
|
artikel
|
| 438 |
2022-RA-860-ESGO Isolated lymph node recurrence in epithelial ovarian cancer- management and outcome
|
Jain, Vandana
|
|
|
32 |
S2 |
p. A270
|
artikel
|
| 439 |
2022-RA-1593-ESGO Isolated para-aortic lymph node metastases in high risk endometrial cancer
|
Laseca, Maria
|
|
|
32 |
S2 |
p. A162
|
artikel
|
| 440 |
2022-RA-453-ESGO Is omental cake associated with higher risks of incomplete debulking surgery in advanced stage ovarian cancer?
|
Bacalbasa, Nicolae
|
|
|
32 |
S2 |
p. A235
|
artikel
|
| 441 |
2022-RA-1157-ESGO Is still possible to treat ovarian cancer in a district general hospital? Considerations from our experience
|
Comerci, Giuseppe
|
|
|
32 |
S2 |
p. A307
|
artikel
|
| 442 |
2022-RA-1572-ESGO Is the number of lymph nodes harvested in radical hysterectomy affected by preoperative chemoradiation therapy in locally advanced cervical cancer? Comparative study
|
Flores, Guillermo Moreno
|
|
|
32 |
S2 |
p. A65
|
artikel
|
| 443 |
2022-RA-1232-ESGO Key aspects of fertility preservation in cancer patients
|
Lavrinovich, Olga
|
|
|
32 |
S2 |
p. A178-A179
|
artikel
|
| 444 |
2022-RA-952-ESGO Knowledge and awareness about cervical cancer and its prevention among premenopausal women: WhatsApp messenger as a platform to enhance awareness and knowledge
|
Md Noh, Raha Binti
|
|
|
32 |
S2 |
p. A197
|
artikel
|
| 445 |
2022-RA-1615-ESGO Laparoscopic radical hysterectomy without uterine manipulator: oncological outcome
|
Kavallaris, Andreas
|
|
|
32 |
S2 |
p. A67
|
artikel
|
| 446 |
2022-RA-845-ESGO Laparoscopic sentinel lymph node mapping in endometrial cancer: A retrospective single center observational study
|
Bagiasta, Anastasia
|
|
|
32 |
S2 |
p. A114
|
artikel
|
| 447 |
2022-RA-1106-ESGO Laparoscopic versus open abdominal hysterectomy in endometrial cancer patients: Analysis of outcome according to risk group
|
Auletta, Valentina
|
|
|
32 |
S2 |
p. A135
|
artikel
|
| 448 |
2022-RA-196-ESGO Laparoscopic versus open hysterectomy in type I endometrial cancer, a tertiary referral center experience
|
Gaballa, Khaled
|
|
|
32 |
S2 |
p. A91
|
artikel
|
| 449 |
2022-RA-971-ESGO Laparotomy spared rate in two steps surgery for early stage cervical cancer
|
Vidal, Blanca Segarra
|
|
|
32 |
S2 |
p. A36-A37
|
artikel
|
| 450 |
2022-RA-425-ESGO L1CAM as a predictive factor in early-stage cervical cancer patients
|
Romanová, Martina
|
|
|
32 |
S2 |
p. A9
|
artikel
|
| 451 |
2022-RA-619-ESGO Less is more? Simple hysterectomy versus radical hysterectomy in FIGO 2018 stage IA2 cervical carcinoma: a pan-birmingham gynaecological cancer centre population-based longitudinal cohort study
|
Audrey Kwong, Fong Lien
|
|
|
32 |
S2 |
p. A17
|
artikel
|
| 452 |
2022-RA-373-ESGO Less radical surgery for patient with early-stage cervical cancer
|
Mottaghi, Mansoureh
|
|
|
32 |
S2 |
p. A8
|
artikel
|
| 453 |
2022-RA-1073-ESGO Local expression of insulin-like growth factor 1 (IGF1)-related components might influence the prognosis of endometrioid endometrial cancer (EEC)
|
Shafiee, Mohamad Nasir
|
|
|
32 |
S2 |
p. A133
|
artikel
|
| 454 |
2022-RA-201-ESGO Locally advanced cervical carcinoma patients treated with chemoradiation followed by radical surgery: clinical response and oncological outcomes according to histotype after propensity score analysis
|
Bizzarri, Nicolò
|
|
|
32 |
S2 |
p. A3
|
artikel
|
| 455 |
2022-RA-1195-ESGO Longitudinal study of vaginal microbiome pre- and post-treatment identifies biomarkers for cervical intraepithelial neoplasia 3 (CIN3)
|
Scibior-Bentkowska, Dorota
|
|
|
32 |
S2 |
p. A413-A414
|
artikel
|
| 456 |
2022-RA-1488-ESGO Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer
|
Terra, Lara
|
|
|
32 |
S2 |
p. A386-A387
|
artikel
|
| 457 |
2022-RA-1075-ESGO Long term follow-up and outcomes of borderline ovarian tumours – a ten year review of the south east wales gynaecological oncology centre (SEWGOC)
|
Zeinah, Hassan
|
|
|
32 |
S2 |
p. A202
|
artikel
|
| 458 |
2022-RA-642-ESGO Long term follow-up in patients treated with electrochemotherapy for vulvar cancer
|
Perrone, Anna Myriam
|
|
|
32 |
S2 |
p. A429
|
artikel
|
| 459 |
2022-RA-605-ESGO Long term quality of life after chemotherapy among rare ovarian cancer survivors: the national gineco case-control Vivrovaire Rare Tumors study
|
Joly, Florence
|
|
|
32 |
S2 |
p. A393
|
artikel
|
| 460 |
2022-RA-466-ESGO Long-term responders (LTR) to rucaparib in recurrent ovarian cancer: a sub-group analysis from the rucaparib access (RAP) program in Spain by GEICO
|
Yubero, Alfonso
|
|
|
32 |
S2 |
p. A238
|
artikel
|
| 461 |
2022-RA-950-ESGO Low grade and high grade serous ovarian cancer: comparison of surgical outcome after secondary cytoreductive surgery
|
Cappuccio, Serena
|
|
|
32 |
S2 |
p. A284
|
artikel
|
| 462 |
2022-RA-1573-ESGO Low grade endometrial stromal sarcoma: case series of one single institute
|
Jellali, Amani
|
|
|
32 |
S2 |
p. A161
|
artikel
|
| 463 |
2022-RA-1076-ESGO Low pressure laparoscopic procedures in morbidly obese gynecological patients using a new subcutaneous abdominal wall-retraction device: a safety and feasibility study
|
Ditto, Antonino
|
|
|
32 |
S2 |
p. A202-A203
|
artikel
|
| 464 |
2022-RA-1052-ESGO Low-risk endometrial cancer and no adjuvant treatment: do isolated tumor cells (ITC) have an effect on recurrence? An international multi-institutional comparative study between ITC and node-negative in sentinel lymph node biopsy
|
Cucinella, Giuseppe
|
|
|
32 |
S2 |
p. A132-A133
|
artikel
|
| 465 |
2022-RA-997-ESGO Lung recurrence of endometrial adenocarcinoma: impact of molecular profile and role of local therapies on prognosis
|
Luzarraga, Ana
|
|
|
32 |
S2 |
p. A126-A127
|
artikel
|
| 466 |
2022-RA-917-ESGO Lymphedema in Gynecological cancer survivor; A Nationwide Cohort Study
|
Lee, Su Jeong
|
|
|
32 |
S2 |
p. A457
|
artikel
|
| 467 |
2022-RA-443-ESGO Lymph node involvement in early-stage cervical cancer: is the lymphangiogenesis a risk factor? Results of MICROCOL study
|
Tantari, Matteo
|
|
|
32 |
S2 |
p. A11-A12
|
artikel
|
| 468 |
2022-RA-582-ESGO Lymphoepithelioma-like carcinoma of the uterine cervix: A-three case study
|
Bouguerra, Fadoua
|
|
|
32 |
S2 |
p. A14
|
artikel
|
| 469 |
2022-RA-767-ESGO Machine learning to implement the accuracy of magnetic resonance imaging (MRI) in the detection of lymph node metastasis in patients with locally advance cervical cancer treated with neoadjuvant chemotherapy
|
Arezzo, Francesca
|
|
|
32 |
S2 |
p. A73
|
artikel
|
| 470 |
2022-RA-1591-ESGO Major determinants of survival in recurrent endometrial cancer: The role of secondary cytoreductive surgery and relapse pattern. A Multicenter Study
|
Vargiu, Virginia
|
|
|
32 |
S2 |
p. A162
|
artikel
|
| 471 |
2022-RA-1622-ESGO Malignant brenner tumor of the ovary: case series of one single institute
|
Jellali, Amani
|
|
|
32 |
S2 |
p. A354-A355
|
artikel
|
| 472 |
2022-RA-910-ESGO Malignant struma ovarii: an up-date on the current literature
|
Giovannopoulou, Eirini
|
|
|
32 |
S2 |
p. A195
|
artikel
|
| 473 |
2022-RA-1459-ESGO Malignant struma ovarii in an asymptomatic nulliparous 20-year-old patient: a case report
|
Klonos, Eleftherios G
|
|
|
32 |
S2 |
p. A339
|
artikel
|
| 474 |
2022-RA-1187-ESGO Management and outcomes in high risk GTN – a regional cancer center experience
|
Jain, Neha
|
|
|
32 |
S2 |
p. A423
|
artikel
|
| 475 |
2022-RA-1531-ESGO Management of clear cell carcinoma of the endometrium: experience of salah azaiez institute
|
Sakhri, Saida
|
|
|
32 |
S2 |
p. A158
|
artikel
|
| 476 |
2022-RA-1044-ESGO Management of early stage vulval cancer with groin sentinel lymph node sampling. A retrospective study in a cancer centre
|
Katsanevakis, Emmanouil
|
|
|
32 |
S2 |
p. A438-A439
|
artikel
|
| 477 |
2022-RA-1144-ESGO Management of immune-related adverse events in patients with solid tumours treated with dostarlimab in the GARNET study
|
Berton, Dominique
|
|
|
32 |
S2 |
p. A204-A205
|
artikel
|
| 478 |
2022-RA-1205-ESGO Management of late presentation of advanced cervical neoplasia in pregnancy during the COVID-19 pandemic – an ethical dilemma
|
Smyth, Sarah Louise
|
|
|
32 |
S2 |
p. A45-A46
|
artikel
|
| 479 |
2022-RA-1639-ESGO Management of primary & secondary breast lymphoma
|
Jellali, Amani
|
|
|
32 |
S2 |
p. A218
|
artikel
|
| 480 |
2022-RA-784-ESGO Medically unfit women with early-stage endometrial cancer treated with the levonorgestrel intrauterine system
|
Kouklidis, George
|
|
|
32 |
S2 |
p. A110
|
artikel
|
| 481 |
2022-RA-1126-ESGO Mesenchymal prognostic signature in ovarian cancer
|
Lisowska, Katarzyna Marta
|
|
|
32 |
S2 |
p. A411-A412
|
artikel
|
| 482 |
2022-RA-1557-ESGO Mesenteric lymph node involvement in patients undergoing a bowel resection during debulking surgery in advanced ovarian cancer
|
Galli, Federica
|
|
|
32 |
S2 |
p. A349
|
artikel
|
| 483 |
2022-RA-127-ESGO Mesenteric retraction in ovarian cancer on ultrasound
|
Elagwany, Ahmed
|
|
|
32 |
S2 |
p. A221
|
artikel
|
| 484 |
2022-RA-1560-ESGO Mesonephric-like adenocarcinoma of the ovary: a case report
|
Soto Troya, Dianelle A
|
|
|
32 |
S2 |
p. A350
|
artikel
|
| 485 |
2022-RA-437-ESGO Meta-analyses reveal serum or plasma interleukin-6 as a biomarker for malignant ovarian neoplasia
|
Pasca, Andrei
|
|
|
32 |
S2 |
p. A233-A234
|
artikel
|
| 486 |
2022-RA-1066-ESGO Metabolomics showed LSR promoted lipid metabolism in EOC
|
Sakaguchi, Hitomi
|
|
|
32 |
S2 |
p. A293
|
artikel
|
| 487 |
2022-RA-1163-ESGO Metastatic adenoid cystic carcinoma gland bartholini: a case report
|
Krsic, Vesna
|
|
|
32 |
S2 |
p. A443
|
artikel
|
| 488 |
2022-RA-1112-ESGO MFAP5 is related to ovarian cancer progression but not suitable as prognostic biomarker
|
Kujawa, Katarzyna Aleksandra
|
|
|
32 |
S2 |
p. A301
|
artikel
|
| 489 |
2022-RA-1257-ESGO MILACC Study: Is the manipulation with LN containing undetected micrometastases the underlying cause of higher rate of local recurrences in the LACC trial?
|
Cibula, David
|
|
|
32 |
S2 |
p. A50
|
artikel
|
| 490 |
2022-RA-930-ESGO Minimally invasive inguinal lymph node dissection – Egyptian experience
|
Mageed, Hisham Abdel
|
|
|
32 |
S2 |
p. A436
|
artikel
|
| 491 |
2022-RA-1430-ESGO Minimally invasive surgery in early stage cervical cancer
|
Soare, Diana Elena
|
|
|
32 |
S2 |
p. A58-A59
|
artikel
|
| 492 |
2022-RA-156-ESGO Minimally invasive versus open abdominal approaches for early-stage cervical and endometrial cancer: a meta-analysis of prospective randomised controlled trials (RCTs)
|
Ongenda, Inès
|
|
|
32 |
S2 |
p. A183
|
artikel
|
| 493 |
2022-RA-1341-ESGO Minimally invasive versus open pelvic exenterationin gynecological malignancies: a propensity-matched survival analysis
|
Bizzarri, Nicolò
|
|
|
32 |
S2 |
p. A208-A209
|
artikel
|
| 494 |
2022-RA-1375-ESGO Minimally invasive vs. open interval debulking surgery in advanced ovarian cancer patients: pattern of recurrence and oncological outcome in a propensity matched population
|
Conte, Carmine
|
|
|
32 |
S2 |
p. A331
|
artikel
|
| 495 |
2022-RA-214-ESGO Minimum deviation cervical adenocarcinoma (adenoma malignum) with unusual presentation: a case report
|
Kalampokas, Emmanouil
|
|
|
32 |
S2 |
p. A3-A4
|
artikel
|
| 496 |
2022-RA-195-ESGO miRNA-125b expression in epithelial ovarian cancer
|
Shekhar, Shashank
|
|
|
32 |
S2 |
p. A222
|
artikel
|
| 497 |
2022-RA-1571-ESGO ‘Mirror conversation’ as part of the quality assurance of a regional gynaecological comprehensive cancer care network in the Netherlands
|
de Kroon, Cor D
|
|
|
32 |
S2 |
p. A464
|
artikel
|
| 498 |
2022-RA-1649-ESGO Mirrors study: a prospective cohort study assessing the feasibility of robotic interval cytoreductive surgery for advanced-stage ovarian cancer
|
Uwins, Christina
|
|
|
32 |
S2 |
p. A357-A358
|
artikel
|
| 499 |
2022-RA-905-ESGO Mismatch repair deficiency is not applicable as biomarker in cervical cancer, yet MSH-2 has strong prognostic value
|
van den Berg, Madeleine Charlotte
|
|
|
32 |
S2 |
p. A32
|
artikel
|
| 500 |
2022-RA-1540-ESGO MITO 25.1: a randomized, molecular driven phase II trial of carboplatin-paclitaxel-bevacizumab vs carboplatin-paclitaxel-bevacizumab-rucaparib vs carboplatin-paclitaxel-rucaparib, selected according to HRD status, in patients with advanced (Stage III B-C-IV) ovarian, primary peritoneal and fallopian tube cancer
|
Musacchio, Lucia
|
|
|
32 |
S2 |
p. A347-A348
|
artikel
|
| 501 |
2022-RA-781-ESGO MLH1 promoter hypermethylation in mismatch repair deficient endometrial cancer. Defining a new subgroup?
|
Pauly, Nina
|
|
|
32 |
S2 |
p. A109
|
artikel
|
| 502 |
2022-RA-807-ESGO MLH1 promoter methylation analysis in patients with endometrial cancer stage I-II
|
Tripac, Irina
|
|
|
32 |
S2 |
p. A407-A408
|
artikel
|
| 503 |
2022-RA-987-ESGO Molecular characterization of endometrial cancer with low volume metastasis in the sentinel lymph node: a multicentric international study
|
Schivardi, Gabriella
|
|
|
32 |
S2 |
p. A124
|
artikel
|
| 504 |
2022-RA-1569-ESGO Molecular profile in endometrial carcinoma: can we predict the lymph node status?
|
Luzarraga, Ana
|
|
|
32 |
S2 |
p. A160
|
artikel
|
| 505 |
2022-RA-1304-ESGO Molecular testing of endometrial carcinoma brings growing opportunity to identify patients with inherited risk of cancer
|
Bednarikova, Marketa
|
|
|
32 |
S2 |
p. A142
|
artikel
|
| 506 |
2022-RA-643-ESGO Mucinous ovarian cancers – a single institution analysis of clinicopathologic profile and survival outcomes
|
Bose, Deepak
|
|
|
32 |
S2 |
p. A248-A249
|
artikel
|
| 507 |
2022-RA-1300-ESGO Multicenter experience on Sentinel Node Mapping in vulvar melanoma evaluation of clinical impact
|
Fragomeni, Simona Maria
|
|
|
32 |
S2 |
p. A446
|
artikel
|
| 508 |
2022-RA-1512-ESGO Multidisciplinary and tailored management in young patients with borderline ovarian tumor recurrence: a case series
|
Fais, Maria Luisa
|
|
|
32 |
S2 |
p. A181
|
artikel
|
| 509 |
2022-RA-1371-ESGO Multiple-agent chemotherapy as first-line treatment for low risk gestational neoplasm: is it time or not?
|
Yarandi, Fariba
|
|
|
32 |
S2 |
p. A425
|
artikel
|
| 510 |
2022-RA-1502-ESGO Multiplexed biomarker detection using the QuantiGene assay in women living with HIV for cervical dysplasia detection
|
Skof, Anna Sophie
|
|
|
32 |
S2 |
p. A418
|
artikel
|
| 511 |
2022-RA-1461-ESGO Nectin4 as a novel prognostic marker for endometrial carcinoma
|
Choi, Jung-A
|
|
|
32 |
S2 |
p. A151-A152
|
artikel
|
| 512 |
2022-RA-588-ESGO Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients with advanced solid tumours: ARTISTRY-1
|
Vaishampayan, Ulka
|
|
|
32 |
S2 |
p. A241
|
artikel
|
| 513 |
2022-RA-948-ESGO Neoadjuvant Chemotherapy (NACT) and Interval Debulking Surgery (IDS) in a Group of Patients with Advanced Stage Epithelial Ovarian Cancer, Unsuitable for Upfront Surgery
|
Siddiqua, Ayesha
|
|
|
32 |
S2 |
p. A283
|
artikel
|
| 514 |
2022-RA-1477-ESGO Neoadjuvant platinum-based dose-dense chemotherapy in patients with locally advanced cervical cancer
|
Smirnova, Olga
|
|
|
32 |
S2 |
p. A62
|
artikel
|
| 515 |
2022-RA-597-ESGO Neuroendocrine carcinoma of the breast: a case report
|
Selmane, Asma
|
|
|
32 |
S2 |
p. A186
|
artikel
|
| 516 |
2022-RA-1501-ESGO Neuroendocrine tumors of the female genital tract; a rare entity
|
Giannoulopoulos, Dimitrios
|
|
|
32 |
S2 |
p. A212
|
artikel
|
| 517 |
2022-RA-1700-ESGO New ultrasonographic markers of borderline ovarian tumours (BOT)
|
Rodriguez, Nadiezhda
|
|
|
32 |
S2 |
p. A85-A86
|
artikel
|
| 518 |
2022-RA-1192-ESGO NOGGO ov44 – PERCEPTION What is the role of immunotherapy in low grade ovarian cancer? A NOGGO phase II trial of pembrolizumab in combination with chemotherapy in recurrent low-grade serous ovarian cancer
|
Grabowski, Jacek
|
|
|
32 |
S2 |
p. A309
|
artikel
|
| 519 |
2022-RA-652-ESGO Non-clipping methods during distal external iliac lymphadenectomy reduce the incidence of lower leg lymphedema in patients with cervical cancer
|
Yoon, Joo Hee
|
|
|
32 |
S2 |
p. A19
|
artikel
|
| 520 |
2022-RA-1180-ESGO Nonfunctional complications associated with radical hysterectomy
|
Alonso-Espías, María
|
|
|
32 |
S2 |
p. A44-A45
|
artikel
|
| 521 |
2022-RA-1120-ESGO Non-inferior survival outcomes from minimally invasive radical hysterectomy in conization-skipped, 2018 FIGO stage IB1 cervical cancer: A two-institutional retrospective cohort study
|
Kim, Nae Ry
|
|
|
32 |
S2 |
p. A43
|
artikel
|
| 522 |
2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial)
|
Sehouli, Jalid
|
|
|
32 |
S2 |
p. A453
|
artikel
|
| 523 |
2022-RA-902-ESGO Novel methylated genes as a second triage step after hrHPV testing to improve colposcopy referral in HPV infected women with cervical lesions (cancer)
|
Li, Lei
|
|
|
32 |
S2 |
p. A408-A409
|
artikel
|
| 524 |
2022-RA-1338-ESGO NTRK1-TPM3 fusion positive cervical sarcoma – case report of a novel subset of gynaecological sarcomas, and successful treatment of recurrent disease with TRK-inhibition therapy
|
Lowe-Zinola, Jack
|
|
|
32 |
S2 |
p. A54
|
artikel
|
| 525 |
2022-RA-1040-ESGO Nutritional supplementation with myo-inositol-D-chiro-inositol: effect on reproductive system functionality in long-term survivors of lymphoma
|
Dellino, Miriam
|
|
|
32 |
S2 |
p. A397
|
artikel
|
| 526 |
2022-RA-848-ESGO Obstetric and neonatal outcomes after breast cancer: a population-based study
|
Jorgensen, Kirsten
|
|
|
32 |
S2 |
p. A176
|
artikel
|
| 527 |
2022-RA-1084-ESGO Oncological outcomes in patients having neoadjuvant chemotherapy who do not undergo intended interval debulking surgery
|
Yao, Si Liang
|
|
|
32 |
S2 |
p. A296
|
artikel
|
| 528 |
2022-RA-1715-ESGO Oncological outcomes of laparoscopy in patients who underwent a conservative fertility treatment in ovarian borderline tumours
|
Tortajada, Marta
|
|
|
32 |
S2 |
p. A363-A364
|
artikel
|
| 529 |
2022-RA-1659-ESGO Oncological outcomes of unexpected uterine leiomyosarcomas: a single centre retrospective analysis
|
Granato, Vincenzo
|
|
|
32 |
S2 |
p. A218
|
artikel
|
| 530 |
2022-RA-865-ESGO Oncologic and fertility outcomes in advanced stage immature teratomas
|
Marino, Giuseppe
|
|
|
32 |
S2 |
p. A271
|
artikel
|
| 531 |
2022-RA-651-ESGO Oncologic safety of minimally invasive surgery in non-endometrioid endometrial cancer
|
Lee, Jiwoo
|
|
|
32 |
S2 |
p. A101
|
artikel
|
| 532 |
2022-RA-1702-ESGO Opioid prescription adequacy in endometrial cancer patients undergoing hysterectomy under ERAS protocol
|
Samouëlian, Vanessa
|
|
|
32 |
S2 |
p. A466
|
artikel
|
| 533 |
2022-RA-1089-ESGO Opportunistic salpingectomy (OS) for prevention of ovarian cancer has become a de facto standard in Germany
|
Kather, Angela
|
|
|
32 |
S2 |
p. A380
|
artikel
|
| 534 |
2022-RA-1072-ESGO Optimal cytoreduction for advanced epithelial ovarian cancer: non invasive predictive factors
|
Candotti, Giorgio
|
|
|
32 |
S2 |
p. A294
|
artikel
|
| 535 |
2022-RA-1607-ESGO Optimal time interval between neoadjuvant platinum-based chemotherapy and interval debulking surgery
|
Andrikopoulou, Angeliki
|
|
|
32 |
S2 |
p. A353-A354
|
artikel
|
| 536 |
2022-RA-1057-ESGO Outcomes of gynaecological cancer surgery during the covid-19 pandemic: results from the international, multicenter, prospective covidsurg-gynaecological cancer study
|
Fotopoulou, Christina
|
|
|
32 |
S2 |
p. A458-A459
|
artikel
|
| 537 |
2022-RA-1329-ESGO Ovarian cancer hospitalization rates during the COVID-19 pandemic in the state of Sao Paulo and correlation with pandemic-related variables
|
Moterani, Vinicius Cesar
|
|
|
32 |
S2 |
p. A325
|
artikel
|
| 538 |
2022-RA-1154-ESGO Ovarian cancer management. Who cares for the Patient? A single case observational study
|
Krankenberg, David Johannes
|
|
|
32 |
S2 |
p. A459
|
artikel
|
| 539 |
2022-RA-1456-ESGO Ovarian cancer metastases in the liver area: a retrospective analysis of surgical, intraoperative and postoperative outcomes according to a standardize anatomo-surgical classification
|
Rosati, Andrea
|
|
|
32 |
S2 |
p. A338-A339
|
artikel
|
| 540 |
2022-RA-1505-ESGO Ovarian cancer retrospective European (O’CaRE) observational study: analysis of first-line (1L) outcomes in patients with ovarian cancer (OC) stratified by number of risk factors for progression
|
Krell, Jonathan
|
|
|
32 |
S2 |
p. A344
|
artikel
|
| 541 |
2022-RA-1652-ESGO Ovarian cancer treatment planning and computer tomography interpretation skills of oncogynaecologist
|
Postupalenko, Olena
|
|
|
32 |
S2 |
p. A83
|
artikel
|
| 542 |
2022-RA-1711-ESGO Ovarian epithelial cell population as a novel cell and therapeutic tool for small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)
|
Pejovic, Tanja
|
|
|
32 |
S2 |
p. A363
|
artikel
|
| 543 |
2022-RA-705-ESGO Ovarian Leydig Cell Tumor: Cause of Virilization in a Postmenopausal Woman
|
Garci, Mariem
|
|
|
32 |
S2 |
p. A188
|
artikel
|
| 544 |
2022-RA-454-ESGO Ovarian metastases from pulmonary cancer – report of two cases
|
Bacalbasa, Nicolae
|
|
|
32 |
S2 |
p. A235-A236
|
artikel
|
| 545 |
2022-RA-595-ESGO Ovarian stem cells from cryopreserved ovarian cortex: a potential for neo-oogenesis in women with cancer-treatment related infertility
|
Silvestris, Erica
|
|
|
32 |
S2 |
p. A171-A172
|
artikel
|
| 546 |
2022-RA-245-ESGO Ovarian tumor frozen section, a multidisciplinary affair
|
Asp, Mihaela
|
|
|
32 |
S2 |
p. A225-A226
|
artikel
|
| 547 |
2022-RA-188-ESGO Ovavian carcinoma metastasis breast mimicking the primary breast carcinoma: casereport and review literature
|
Doan, Nghia Trong
|
|
|
32 |
S2 |
p. A367
|
artikel
|
| 548 |
2022-RA-249-ESGO Overall survival results from ariel3: a phase 3 randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma
|
Coleman, Robert L
|
|
|
32 |
S2 |
p. A226
|
artikel
|
| 549 |
2022-RA-1305-ESGO Over-expression of multimerin1 protein in ovarian cancer progression
|
Yadav, Savita
|
|
|
32 |
S2 |
p. A320
|
artikel
|
| 550 |
2022-RA-630-ESGO Overexpression of PDEA1 is a predictive biomarker for platinum resistance and poor prognosis in epithelial ovarian cancer by regulating cell cycle
|
Han, Gwan Hee
|
|
|
32 |
S2 |
p. A246-A247
|
artikel
|
| 551 |
2022-RA-898-ESGO Overexpression of TMED9 is important prognostic biomarker for epithelial ovarian cancer
|
Kim, Hyosun
|
|
|
32 |
S2 |
p. A275-A276
|
artikel
|
| 552 |
2022-RA-1149-ESGO Oxaliplatin-based treatments are currently a valid therapeutic option in heavily pretreated ovarian cancer patientswith hypersensitivity reactions (HRs) to carboplatin in the antiangiogenics and PARPi era
|
Inoa, Jennifer Olalla
|
|
|
32 |
S2 |
p. A306
|
artikel
|
| 553 |
2022-RA-1061-ESGO Paget’s disease of the nipple
|
Saoud, Mohammed Karam
|
|
|
32 |
S2 |
p. A370-A371
|
artikel
|
| 554 |
2022-RA-1434-ESGO Palonosetron versus granisetron for prevention of nausea and vomiting during paclitaxel and carboplatin therapy: a pilot study
|
Fujihara, Risa
|
|
|
32 |
S2 |
p. A211
|
artikel
|
| 555 |
2022-RA-1567-ESGO Papillary breast carcinoma: clinicopathological characteristics & prognosis
|
Sakhri, Saida
|
|
|
32 |
S2 |
p. A215
|
artikel
|
| 556 |
2022-RA-1643-ESGO Para-aortic lymphadenectomy increases vascular lesions compared to pelvic lymphadenectomy in endometrial cancer, a study in a Mexican population
|
Moreno Flores, Guillermo
|
|
|
32 |
S2 |
p. A166
|
artikel
|
| 557 |
2022-RA-686-ESGO Paradigm shift in surgical approach in the management of advanced ovarian cancer in the university hospitals of LEICESTER
|
Barakat, Anas
|
|
|
32 |
S2 |
p. A254-A255
|
artikel
|
| 558 |
2022-RA-1443-ESGO Patient decision aids in genetic testing for women with ovarian cancer
|
Sobocan, Monika
|
|
|
32 |
S2 |
p. A463
|
artikel
|
| 559 |
2022-RA-912-ESGO Patient-reported mobility and bicycle use after vulvar cancer surgery
|
Beurden, Franciscus P van
|
|
|
32 |
S2 |
p. A435
|
artikel
|
| 560 |
2022-RA-1668-ESGO Patients’perspectives, fears and willingness to take preventive measures during second lockdown of COVID-19 pandemic. A study of NOGGO and EnGAGe Network
|
Dimitrova, Desislava
|
|
|
32 |
S2 |
p. A465
|
artikel
|
| 561 |
2022-RA-1564-ESGO Patients’ perspectives on changes in cancer care during the COVID-19 pandemic: Results of a German survey among patients with gynecological malignancies
|
Dimitrova, Desislava
|
|
|
32 |
S2 |
p. A463
|
artikel
|
| 562 |
2022-RA-1387-ESGO Patients with minimal residual disease at upfront debulking surgery have similar survival outcome than patients with complete cytorreduction after neoadjuvant chemotherapy
|
Romero, Violeta
|
|
|
32 |
S2 |
p. A331-A332
|
artikel
|
| 563 |
2022-RA-1554-ESGO Patients with PALB2 mutation followed up in a hereditary gynaecological cancer unit
|
Veiga-Fernández, Amanda
|
|
|
32 |
S2 |
p. A387-A388
|
artikel
|
| 564 |
2022-RA-1049-ESGO Patients with TP53 mutation followed up in a hereditary gynaecological cancer unit
|
Veiga-Fernández, Amanda
|
|
|
32 |
S2 |
p. A379
|
artikel
|
| 565 |
2022-RA-1258-ESGO Patient walk to the operating theatre as a new tool for patient empowerment – KORE-INNOVATION: the first prospective clinical trial to assess a perioperative pathway to reduce postoperative complications in ovarian cancer patients
|
Lee, Marlene
|
|
|
32 |
S2 |
p. A460
|
artikel
|
| 566 |
2022-RA-1265-ESGO Patterns of recurrence and prognostic factors in locally advanced cervical cancer
|
Guijarro Campillo, A Rafael
|
|
|
32 |
S2 |
p. A51-A52
|
artikel
|
| 567 |
2022-RA-1725-ESGO Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer- results of a multicentre NOGGO phase I and II study (TOPAZ)
|
Arndt, Tjadina
|
|
|
32 |
S2 |
p. A364
|
artikel
|
| 568 |
2022-RA-1251-ESGO P-cadherin: a promising prognostic biomarker for homologous repair proficient high grade serous ovarian carcinoma
|
Canario, Rita
|
|
|
32 |
S2 |
p. A415
|
artikel
|
| 569 |
2022-RA-1484-ESGO Peculiarities of breast cancer in young women at the medical oncology department- Tlemcen
|
Benzebida, Hanane
|
|
|
32 |
S2 |
p. A211-A212
|
artikel
|
| 570 |
2022-RA-1436-ESGO Pelvic exenteration – boon or a bane ? Analysis from tertiary care cancercentre
|
Mishra, Ashutosh
|
|
|
32 |
S2 |
p. A59-A60
|
artikel
|
| 571 |
2022-RA-465-ESGO Pelvic exenteration with neurovascular and bony resections for gynaecological tumours: a systematic review
|
Denys, Andreas
|
|
|
32 |
S2 |
p. A392
|
artikel
|
| 572 |
2022-RA-267-ESGO Pelvic hydatidosis when is not an ovarian cancer in endemic region: about 5 cases
|
Garci, Mariem
|
|
|
32 |
S2 |
p. A68
|
artikel
|
| 573 |
2022-RA-959-ESGO Pelvic sentinel lymph nodedistribution; the final outcome of the Sentix trial (CEEGOG-CX01; ENGOT-CX2; NCT02494063)
|
Kocian, Roman
|
|
|
32 |
S2 |
p. A36
|
artikel
|
| 574 |
2022-RA-1276-ESGO Pembrolizumab monotherapy for advanced clear cell gynaecological cancer: phase II PEACOCC trial
|
Miller, Rowan E
|
|
|
32 |
S2 |
p. A316
|
artikel
|
| 575 |
2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer: the PRIMMO phase II trial
|
De Jaeghere, Emiel A
|
|
|
32 |
S2 |
p. A187-A188
|
artikel
|
| 576 |
2022-RA-872-ESGO Percutaneous uterine needle biopsy with microscopic and array-CGH analyses in patients with suspicious myometrial tumors on MRI: a prospective study
|
Smadja, Jeremy
|
|
|
32 |
S2 |
p. A74-A75
|
artikel
|
| 577 |
2022-RA-900-ESGO Performance of a LAMP-based electrochemical bioassay for determination of high-risk HPV infection in clinical settings
|
Anton, Milan
|
|
|
32 |
S2 |
p. A75
|
artikel
|
| 578 |
2022-RA-727-ESGO Performance of the IOTA ADNEX model in differentiating between benign and malignant adnexal lesions in a Portuguese population
|
Borges, André
|
|
|
32 |
S2 |
p. A71-A72
|
artikel
|
| 579 |
2022-RA-1224-ESGO Perioperative morbidity in gynecological oncology: a single-center prospective study
|
Anjana, JS
|
|
|
32 |
S2 |
p. A206-A207
|
artikel
|
| 580 |
2022-RA-1391-ESGO Perioperative non-invasive advanced hemodynamic monitoring of patients with primary ovarian cancer undergoing multivisceral debulking surgery
|
Middel, Charlotte
|
|
|
32 |
S2 |
p. A332
|
artikel
|
| 581 |
2022-RA-1415-ESGO Perspective on the future of the sentinel lymph node in cervical cancer
|
Manu, Andrei
|
|
|
32 |
S2 |
p. A58
|
artikel
|
| 582 |
2022-RA-797-ESGO PET/CT negative predictive value in locally advanced cervical cancer
|
Gonzalez, Elena Rodriguez
|
|
|
32 |
S2 |
p. A27
|
artikel
|
| 583 |
2022-RA-1263-ESGO Phase II randomized BGOG-CX3 trial comparing atezolizumab in combination with doxorubicin versus doxorubicin alone in second-line or later recurrent cervical cancer
|
Loverix, Liselore
|
|
|
32 |
S2 |
p. A51
|
artikel
|
| 584 |
2022-RA-324-ESGO Phase 2 results from the LIO-1 STUDY (NCT04042116; ENGOT-GYN3/AGO/LIO): efficacy and safety of lucitanib + nivolumab in patients with advanced gynaecological malignancies
|
Concin, Nicole
|
|
|
32 |
S2 |
p. A185
|
artikel
|
| 585 |
2022-RA-722-ESGO Phase 2 study assessing the efficacy of adding AL3818 (Catequentinib Dihydrochloride, Anlotinib Hydrochloride) to chemotherapies in subjects with platinum resistant ovarian carcinoma
|
Miller, David Scott
|
|
|
32 |
S2 |
p. A259
|
artikel
|
| 586 |
2022-RA-1423-ESGO Phyllodes tumors of the breast analysis of 17 patients
|
Mochtari, Houda
|
|
|
32 |
S2 |
p. A462
|
artikel
|
| 587 |
2022-RA-1218-ESGO Physiologically relevant treatment models to investigate epigenetic mechanisms driving platinum resistance in ovarian high grade serous carcinoma
|
Ergasti, Raffaella
|
|
|
32 |
S2 |
p. A414-A415
|
artikel
|
| 588 |
2022-RA-1198-ESGO Post hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer treated with dostarlimab
|
Tinker, Anna V
|
|
|
32 |
S2 |
p. A414
|
artikel
|
| 589 |
2022-RA-1546-ESGO Potential approach to overcome checkpoint inhibitor resistance in a long-term survivor patient with recurrent endometrial carcinoma
|
Schott, Sebastian
|
|
|
32 |
S2 |
p. A159
|
artikel
|
| 590 |
2022-RA-368-ESGO Potential role of para-aortic lymph nodes dissection in early-stage cervical cancer
|
Iavarone, Irene
|
|
|
32 |
S2 |
p. A7-A8
|
artikel
|
| 591 |
2022-RA-1460-ESGO Potentials and challenges of individualized aromatherapy for women with gynecological cancers in aftercare – It’s like one part of the puzzle: Results from an explorative pilot study
|
Czakert, Judith
|
|
|
32 |
S2 |
p. A401
|
artikel
|
| 592 |
2022-RA-681-ESGO POU2F3 driven subset of small cell carcinoma exists in the uterine cervix
|
Cockenpot, Vincent
|
|
|
32 |
S2 |
p. A21
|
artikel
|
| 593 |
2022-RA-171-ESGO Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer
|
Bogani, Giorgio
|
|
|
32 |
S2 |
p. A2
|
artikel
|
| 594 |
2022-RA-1605-ESGO Precision-predicting risk of endometrial cancer in asymptomatic women
|
Kitson, Sarah Joanne
|
|
|
32 |
S2 |
p. A388-A389
|
artikel
|
| 595 |
2022-RA-1101-ESGO Prediction of incomplete cytoreduction in primary debulking surgery of advanced stage ovarian cancer patients: Usefulness of the entire peritoneal cancer index (PCI) versus exclusive assessment of small intestine/mesentery/hepatoduodenal ligament carcinosis
|
Goerdt, Clara E
|
|
|
32 |
S2 |
p. A298
|
artikel
|
| 596 |
2022-RA-1346-ESGO Predictive factors for adnexal involvement in Endometrial Cancer, with a focus on FIGO Stage IIIA, an uncommon entity
|
Dinoi, Giorgia
|
|
|
32 |
S2 |
p. A146-A147
|
artikel
|
| 597 |
2022-RA-760-ESGO Predictive model of severe complications in patients who underwent an open gynecological cancer surgery on an enhanced recovery after surgery (ERAS) program
|
Fumagalli, Diletta
|
|
|
32 |
S2 |
p. A456
|
artikel
|
| 598 |
2022-RA-846-ESGO Predictive value of DNA methylation markers as an invasive diagnostic tool for pathological upgrading cervical lesions
|
Kang, Yanan
|
|
|
32 |
S2 |
p. A408
|
artikel
|
| 599 |
2022-RA-986-ESGO Predictive value of 18F-FDG accumulation in visceral fat activity to detect epithelial ovarian cancer metastases
|
Suleimanov, Amil
|
|
|
32 |
S2 |
p. A289
|
artikel
|
| 600 |
2022-RA-1124-ESGO Predictors of invasive carcinoma in endometrial hyperplasia and its influence on surgical management
|
De Méndez, Carmen la Fuente
|
|
|
32 |
S2 |
p. A135
|
artikel
|
| 601 |
2022-RA-262-ESGO Predictors of oncologic outcome in recurrent cervical cancer patients receiving phase 1 cancer therapy
|
Son, Ji
|
|
|
32 |
S2 |
p. A6-A7
|
artikel
|
| 602 |
2022-RA-1237-ESGO Predictors of PARP inhibitors toxicities and the toxicity impact on overall survival in advanced ovarian cancer
|
Silva Lima, Julianne Maria Da
|
|
|
32 |
S2 |
p. A312
|
artikel
|
| 603 |
2022-RA-985-ESGO Predictors of recurrence in adult granulosa cell type ovarian cancer: a retrospective cohort study
|
Huddart, Daniel
|
|
|
32 |
S2 |
p. A288
|
artikel
|
| 604 |
2022-RA-1599-ESGO Pregnancy associated breast cancer: about 10 cases
|
Chermiti, Amal
|
|
|
32 |
S2 |
p. A182
|
artikel
|
| 605 |
2022-RA-1396-ESGO Pregnancy- related vulvar cancer
|
Aur, Cristina
|
|
|
32 |
S2 |
p. A179
|
artikel
|
| 606 |
2022-RA-732-ESGO Prehabilitation program in ovarian cancer patients – towards more objective measurement of compliance – preliminary results
|
Nowosielski, Krzysztof
|
|
|
32 |
S2 |
p. A455-A456
|
artikel
|
| 607 |
2022-RA-274-ESGO Prehabilitation to improve outcomes of patients with gynaecological cancer: a new window of opportunity?
|
Keidan, Nathaniel
|
|
|
32 |
S2 |
p. A453
|
artikel
|
| 608 |
2022-RA-1274-ESGO Preliminary data about correlation between CA125 increase and recist progression in patients with relapsed ovarian cancer treated with maintenance PARP inhibitors or bevacizumab after response to platinum based chemotherapy
|
Sabetta, Giulia
|
|
|
32 |
S2 |
p. A315-A316
|
artikel
|
| 609 |
2022-RA-891-ESGO Preoperative assessment of non-resectability in patients with ovarian cancer using imaging (ISAAC study) – an interim analysis
|
Pinto, Patrícia
|
|
|
32 |
S2 |
p. A274
|
artikel
|
| 610 |
2022-RA-627-ESGO Preoperative circulating tumor DNA level is associated to poor overall survival in patients with ovarian cancer
|
Dobilas, Arturas
|
|
|
32 |
S2 |
p. A405
|
artikel
|
| 611 |
2022-RA-1597-ESGO Preoperative conization of early cervical carcinoma associated with improved progression free survival
|
Klapdor, Rüdiger
|
|
|
32 |
S2 |
p. A66
|
artikel
|
| 612 |
2022-RA-796-ESGO Preoperative neutrophil lymphocyte ratio in ascites as a prognostic factor in epithelial ovarian cancer
|
Park, Jung Hyun
|
|
|
32 |
S2 |
p. A263
|
artikel
|
| 613 |
2022-RA-1609-ESGO Pre-operative risk factors of concomitant endometrial carcinoma in women with hysteroscopic diagnosis of complex atypical hyperplasia: a multicenter study
|
Vargiu, Virginia
|
|
|
32 |
S2 |
p. A163-A164
|
artikel
|
| 614 |
2022-RA-1563-ESGO Pre-Operative ultrasound assessment of rectosigmoid infiltration in advanced ovarian cancer
|
Carballo, Silvia Gómez
|
|
|
32 |
S2 |
p. A82
|
artikel
|
| 615 |
2022-RA-1565-ESGO Pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for metastatic ovarian cancer, fallopian tube cancer and primary peritoneal carcinoma: a systematic review by the UK PIPAC collaborative
|
Naskretski, Adam
|
|
|
32 |
S2 |
p. A350
|
artikel
|
| 616 |
2022-RA-1087-ESGO Prevalence of exposure to cancer risk factors among apparently healthy childbearing age women
|
Ng, Chiat Yin
|
|
|
32 |
S2 |
p. A203
|
artikel
|
| 617 |
2022-RA-679-ESGO Prevalence of HPV infection among young women in Almaty, Kazakhstan
|
Satanova, Alima
|
|
|
32 |
S2 |
p. A376
|
artikel
|
| 618 |
2022-RA-965-ESGO Prevalence of low anterior resection syndrome in patients with advanced stage epithelial ovarian cancer
|
de Smit, Noa S
|
|
|
32 |
S2 |
p. A286-A287
|
artikel
|
| 619 |
2022-RA-463-ESGO Prevalence of sexual dysfunction in patients with gynecological cancer
|
Soto-Martínez, Blanca Angélica
|
|
|
32 |
S2 |
p. A391-A392
|
artikel
|
| 620 |
2022-RA-703-ESGO Primary and interval debulking surgery in advanced ovarian cancer: real-world clinical outcomes of patients in 1st line setting, analysis from the french national ESME-unicancer database
|
Costaz, Hélène
|
|
|
32 |
S2 |
p. A256-A257
|
artikel
|
| 621 |
2022-RA-791-ESGO Primary debulking surgery versus neoadjuvant chemotherapy and interval debulking surgery for advanced epithelial ovarian cancer
|
Gea, Lorena Gonzalez
|
|
|
32 |
S2 |
p. A262-A263
|
artikel
|
| 622 |
2022-RA-1547-ESGO Primary Leiomyosarcoma of female genital tract: Salah Azaiez institute experience
|
Sakhri, Saida
|
|
|
32 |
S2 |
p. A159
|
artikel
|
| 623 |
2022-RA-269-ESGO Primary malignant follicular lymphoma of the uterine cervix, two case reports
|
Zarragoitia, Janire
|
|
|
32 |
S2 |
p. A368
|
artikel
|
| 624 |
2022-RA-1426-ESGO Primary malignant melanoma of the female genital tract About 5 cases
|
Mekkaoui, Nour el Houda
|
|
|
32 |
S2 |
p. A447
|
artikel
|
| 625 |
2022-RA-1684-ESGO Primary neuroendocrine tumors of the breast: a series of five cases
|
Jellali, Amani
|
|
|
32 |
S2 |
p. A219
|
artikel
|
| 626 |
2022-RA-1562-ESGO Primary ovarian large B cell lymphoma: About six rare cases
|
Jellali, Amani
|
|
|
32 |
S2 |
p. A350
|
artikel
|
| 627 |
2022-RA-593-ESGO Primary ovarian non-hodgkin lymphoma: report of three cases and the role of international online meetings in clinical decision making
|
Soliman, Mahmoud
|
|
|
32 |
S2 |
p. A242
|
artikel
|
| 628 |
2022-RA-374-ESGO Primary ovarian non-Hodgkin’s lymphoma: a case report
|
Shirinzadeh, Laya
|
|
|
32 |
S2 |
p. A229-A230
|
artikel
|
| 629 |
2022-RA-1071-ESGO Primary treatment and prognostic factors of neuroendocrine carcinoma of the uterine cervix
|
Lee, Seoyoon
|
|
|
32 |
S2 |
p. A41-A42
|
artikel
|
| 630 |
2022-RA-1162-ESGO Proactive management in vulvar radiotherapy facilitates treatment completion
|
Golomb, Inbal
|
|
|
32 |
S2 |
p. A442-A443
|
artikel
|
| 631 |
2022-RA-598-ESGO Prognostic factors for adverse obstetric outcomes in pregnant cancer patients an update on 2174 cases registered in the INCIP registry
|
Maggen, Charlotte
|
|
|
32 |
S2 |
p. A172-A173
|
artikel
|
| 632 |
2022-RA-602-ESGO Prognostic factors for recurrence in adult-type granulosa cell tumours of the ovary and survival outcomes after secondary and tertiary cytoreductive surgery: a UK population-based cohort study
|
Tranoulis, Anastasios
|
|
|
32 |
S2 |
p. A243
|
artikel
|
| 633 |
2022-RA-706-ESGO Prognostic impact of vagus nerve activity at initial management of ovarian cancer
|
Cherifi, Francois
|
|
|
32 |
S2 |
p. A257-A258
|
artikel
|
| 634 |
2022-RA-568-ESGO Prognostic Relevance of FIGO grading is Limited to NSMP Endometrial Cancers
|
Vermij, Lisa
|
|
|
32 |
S2 |
p. A97-A98
|
artikel
|
| 635 |
2022-RA-457-ESGO Prognostic role of TGF-β signalling pathway alterations in endometrial cancers – a prospective clinical study
|
Bose, Deepak
|
|
|
32 |
S2 |
p. A404-A405
|
artikel
|
| 636 |
2022-RA-577-ESGO Prognostic significance of signs for metastatic involvement of lymph nodes in cervical cancer according to magnetic resonance imaging
|
Zhuk, Elena G
|
|
|
32 |
S2 |
p. A69
|
artikel
|
| 637 |
2022-RA-166-ESGO Prognostic signifience of molecular genetic factors in endometrial cancer. a modern approach to the problem
|
Tripac, Irina
|
|
|
32 |
S2 |
p. A88
|
artikel
|
| 638 |
2022-RA-430-ESGO Prognostic value of systemic inflammatory markers in cervical cancer
|
Vitkauskaite, Agne
|
|
|
32 |
S2 |
p. A10
|
artikel
|
| 639 |
2022-RA-903-ESGO Prophylactic radical fimbriectomy with delayed oophorectomy in women with a high risk of developing an ovarian carcinoma: results of a prospective phase 2 national study
|
Leblanc, Eric
|
|
|
32 |
S2 |
p. A377-A378
|
artikel
|
| 640 |
2022-RA-402-ESGO Proteomic analysis of exosomes secreted during mesenchymal-epithelial transition for potential diagnosis of mesenchymal subtype of high grade ovarian serous carcinoma
|
Ferreira, Germano Aguiar
|
|
|
32 |
S2 |
p. A230
|
artikel
|
| 641 |
2022-RA-1118-ESGO Pseudomyxoma peritonei arising from mature ovarian teratoma: a case report and review of current literature
|
Ha, Minah
|
|
|
32 |
S2 |
p. A203-A204
|
artikel
|
| 642 |
2022-RA-1686-ESGO Pure ductal carcinoma in situ in the male breast: an uncommon entity
|
Jellali, Amani
|
|
|
32 |
S2 |
p. A219
|
artikel
|
| 643 |
2022-RA-1395-ESGO Quality assessment as part of the quality assurance of a regional gynecological comprehensive cancer care network in the Netherlands
|
de Kroon, Cor D
|
|
|
32 |
S2 |
p. A461-A462
|
artikel
|
| 644 |
2022-RA-747-ESGO Quality of end-of-life care and patterns of palliative care use by women with gynaecologic malignancies in Ontario, Canada: a 13-year population-based retrospective analysis
|
Mah, Sarah Jill
|
|
|
32 |
S2 |
p. A364-A365
|
artikel
|
| 645 |
2022-RA-222-ESGO Quality of life after extended pelvic exenterations
|
Lednický, Štefan
|
|
|
32 |
S2 |
p. A390
|
artikel
|
| 646 |
2022-RA-1270-ESGO Quality of Life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis
|
Wei, Xia
|
|
|
32 |
S2 |
p. A383
|
artikel
|
| 647 |
2022-RA-223-ESGO Quality of life following pelvic exenteration for cervical cancer
|
Capilna, Mihai Emil
|
|
|
32 |
S2 |
p. A390-A391
|
artikel
|
| 648 |
2022-RA-972-ESGO Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: results from the randomized SCORPION Trial
|
Marchetti, Claudia
|
|
|
32 |
S2 |
p. A395-A396
|
artikel
|
| 649 |
2022-RA-620-ESGO Querleu-Morrow type A hysterectomy for low-risk early-stage (FIGO 2018 IA2-IB1) cervical cancer: a UK population-based retrospective cohort study
|
Audrey Kwong, Fong Lien
|
|
|
32 |
S2 |
p. A17-A18
|
artikel
|
| 650 |
2022-RA-1579-ESGO RACE: retrospective study on rare types of cervical cancer- CEEGOG CX-06
|
Dovnik, Andraž
|
|
|
32 |
S2 |
p. A65
|
artikel
|
| 651 |
2022-RA-785-ESGO Radical surgical procedures in advanced ovarian cancer and differences between primary and interval debulking surgery
|
Kouklidis, George
|
|
|
32 |
S2 |
p. A262
|
artikel
|
| 652 |
2022-RA-964-ESGO Radioguided occult lesion localisation (ROLL) for gynecologic tumor relapses: development of a technique
|
Bebia, Vicente
|
|
|
32 |
S2 |
p. A197-A198
|
artikel
|
| 653 |
2022-RA-610-ESGO Radiomics and transvaginal ultrasound in adnexal masses: is the next future of diagnostics here?
|
Chiappa, Valentina
|
|
|
32 |
S2 |
p. A70
|
artikel
|
| 654 |
2022-RA-1465-ESGO Randomised trial of population based BRCA testing in Ashkenazi Jews: long term secondary lifestyle behavioural outcomes
|
Burnell, Matthew
|
|
|
32 |
S2 |
p. A402
|
artikel
|
| 655 |
2022-RA-1473-ESGO Randomized phase II CLIO study on olaparib monotherapy versus chemotherapy in recurrent ovarian cancer – results of the Leuven HRD test
|
Loverix, Liselore
|
|
|
32 |
S2 |
p. A340-A341
|
artikel
|
| 656 |
2022-RA-1638-ESGO Randomized phase III trial on Niraparib-TSR-042 (dostarlimab) versus physician’s choice in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33)
|
Salutari, Vanda
|
|
|
32 |
S2 |
p. A356
|
artikel
|
| 657 |
2022-RA-883-ESGO Rare Cancers in Gynecologic Oncology, ENGOT initiative for a European Registry
|
Ceppi, Lorenzo
|
|
|
32 |
S2 |
p. A273
|
artikel
|
| 658 |
2022-RA-778-ESGO Rare gynecological cancers in a gynecologic cancer center: 11-year experience of KEM
|
Moubarak, Malak
|
|
|
32 |
S2 |
p. A189-A190
|
artikel
|
| 659 |
2022-RA-1140-ESGO Rare ovarian tumors not a rarity anymore
|
Singla, Anshuja
|
|
|
32 |
S2 |
p. A305
|
artikel
|
| 660 |
2022-RA-1690-ESGO Rare uterine cervical adenocarcinomas in salah azaiez institute: clinicopathological features
|
Jaouadi, Souha
|
|
|
32 |
S2 |
p. A68
|
artikel
|
| 661 |
2022-RA-647-ESGO Real-word therapy and clinical and patient-reported outcomes in patients with newly diagnosed advanced ovarian cancer: first description of the SCOUT-1 study centers (NOGGO ov54, NCT04830709)
|
Sehouli, Jalid
|
|
|
32 |
S2 |
p. A250
|
artikel
|
| 662 |
2022-RA-708-ESGO Real-world assessment of patients with ovarian cancer who received niraparib as second-line maintenance therapy in the United States: did first-line maintenance approval change the patient profile for second-line maintenance therapy?
|
Backes, Floor
|
|
|
32 |
S2 |
p. A258-A259
|
artikel
|
| 663 |
2022-RA-285-ESGO Real world data of treatment and outcome of patients with early ovarian cancer (FIGO I) in Germany (QS Ovar of the AGO Study Group)
|
Sehouli, Jalid
|
|
|
32 |
S2 |
p. A228
|
artikel
|
| 664 |
2022-RA-712-ESGO Real-world prevalence of microsatellite instability testing and related status in patients with recurrent or advanced endometrial cancer initiating first line of therapy in Europe
|
Ogando, Yoscar M
|
|
|
32 |
S2 |
p. A105-A106
|
artikel
|
| 665 |
2022-RA-961-ESGO Real-world prospective characterization of homologous recombination deficiency in advanced ovarian cancer
|
Salko, Matilda
|
|
|
32 |
S2 |
p. A286
|
artikel
|
| 666 |
2022-RA-702-ESGO Real-world treatment patterns and outcomes in recurrent or advanced endometrial cancer patients initiating 1st-line systemic therapy in Europe: a retrospective chart review study
|
Prabhu, Vimalanand S
|
|
|
32 |
S2 |
p. A104-A105
|
artikel
|
| 667 |
2022-RA-1654-ESGO Recurrence patterns in patients with ovarian cancerafter neoadjuvant chemotherapy, with and without HIPEC. Report of 33 first cases
|
Salcedo-Hernández, Rosa Angelica
|
|
|
32 |
S2 |
p. A358
|
artikel
|
| 668 |
2022-RA-1117-ESGO Recycling of discarded ovarian cancer ascites to monitor therapy resistance
|
Nunes, Mariana Oliveira
|
|
|
32 |
S2 |
p. A302
|
artikel
|
| 669 |
2022-RA-1527-ESGO Reliability of IOTA adnex model in borderline ovarian tumors, a single center study
|
Aziz, Humaira
|
|
|
32 |
S2 |
p. A347
|
artikel
|
| 670 |
2022-RA-1433-ESGO Reproductive outcomes after conservative treatment in malignant ovarian germ cell tumors (MOGCTs) patients: a MITO-9 study
|
Bergamini, Alice
|
|
|
32 |
S2 |
p. A180
|
artikel
|
| 671 |
2022-RA-649-ESGO Response to treatment and prognostic significance of supradiaphragmatic disease in patients with high-grade serous ovarian cancer
|
Roberti Maggiore, Umberto Leone
|
|
|
32 |
S2 |
p. A250
|
artikel
|
| 672 |
2022-RA-185-ESGO Results after conservative surgery of stage II/III serous borderline ovarian tumors
|
Gouy, Sebastien
|
|
|
32 |
S2 |
p. A169-A170
|
artikel
|
| 673 |
2022-RA-1060-ESGO Retroperitoneal paraortic lymph node staging in advanced cervical cancer: Tunisian experience
|
Jaouadi, Souha
|
|
|
32 |
S2 |
p. A40
|
artikel
|
| 674 |
2022-RA-869-ESGO Retrospective analysis of patients with endometrial stromal sarcoma in a tertiary hospital
|
Minaya, María Ruiz
|
|
|
32 |
S2 |
p. A193
|
artikel
|
| 675 |
2022-RA-871-ESGO Retrospective analysis of patients with leiomyosarcoma in a tertiary hospital and comparative between incidental and suspected diagnosis
|
Minaya, María Ruiz
|
|
|
32 |
S2 |
p. A194
|
artikel
|
| 676 |
2022-RA-1568-ESGO Retrospective analysis of survival outcomes in elderly females from Northern Ireland treated with interval cytoreduction for high grade serous carcinoma (HGSC) of ovary and fallopian tube
|
Simpson, Linda
|
|
|
32 |
S2 |
p. A351
|
artikel
|
| 677 |
2022-RA-1000-ESGO Review of adherence to NICE guidance on lynch syndrome testing for patients diagnosed with endometrial cancer in BHSCT
|
Ralston, Charlotte
|
|
|
32 |
S2 |
p. A129
|
artikel
|
| 678 |
2022-RA-197-ESGO Risk factors and patterns of recurrence in patients with low-risk endometrial cancer
|
Hwang, In Sun
|
|
|
32 |
S2 |
p. A91-A92
|
artikel
|
| 679 |
2022-RA-1240-ESGO Risk factors for recurrence of endometrial cancer in Taiwanese women
|
Chang, Chi-Chang
|
|
|
32 |
S2 |
p. A138-A139
|
artikel
|
| 680 |
2022-RA-868-ESGO Risk for contralateral non sentinel metastases in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS vulva study
|
Prieske, Katharina
|
|
|
32 |
S2 |
p. A433-A434
|
artikel
|
| 681 |
2022-RA-933-ESGO Risk of venous thromboembolism and major bleeding in gynaecological cancer surgery: series of systematic reviews and meta-analyses
|
Lavikainen, Lauri I
|
|
|
32 |
S2 |
p. A196-A197
|
artikel
|
| 682 |
2022-RA-822-ESGO Risk reducing surgery in ovarian cancer
|
Loizzi, Vera
|
|
|
32 |
S2 |
p. A266-A267
|
artikel
|
| 683 |
2022-RA-1321-ESGO Robot assisted vaginal natural orifice transluminal endoscopic hysterectomy for patients with stage I/II a endometrial cancer- farghaly’s technique
|
Farghaly, Samir
|
|
|
32 |
S2 |
p. A143-A144
|
artikel
|
| 684 |
2022-RA-1377-ESGO Robotic anterior pelvic exenteration: safe and feasible?
|
Manu, Andrei
|
|
|
32 |
S2 |
p. A55-A56
|
artikel
|
| 685 |
2022-RA-878-ESGO Robotic-assisted versus vaginal radical trachelectomy in patients with cervical cancerRadicality, recurrence-free survival and cancer-specific mortality
|
Soltanizadeh, Sinor
|
|
|
32 |
S2 |
p. A30-A31
|
artikel
|
| 686 |
2022-RA-1350-ESGO Robotic compared to laparoscopic ergonomics in patients with gynecological cancer
|
Gracia, Myriam
|
|
|
32 |
S2 |
p. A209
|
artikel
|
| 687 |
2022-RA-772-ESGO Robotic sentinel lymph node detection in endometrial cancer – A pilot series at Guy’s and St Thomas’ Hospital
|
Shinde, Aditi Kishore
|
|
|
32 |
S2 |
p. A108-A109
|
artikel
|
| 688 |
2022-RA-1630-ESGO Robotic surgery and perioperative morbidity in very elderly women (≥80 years old) with intermediate and high risk endometrial cancer
|
Myriokefalitaki, Eva
|
|
|
32 |
S2 |
p. A165
|
artikel
|
| 689 |
2022-RA-929-ESGO Robotic surgery outcomes in a gynaecological oncology cancer centre
|
Nikolopoulos, Manolis
|
|
|
32 |
S2 |
p. A196
|
artikel
|
| 690 |
2022-RA-1174-ESGO Role of adjuvant therapy in intermediate-risk cervical cancer patients – SCCAN study sub-analysis
|
Cibula, David
|
|
|
32 |
S2 |
p. A44
|
artikel
|
| 691 |
2022-RA-1348-ESGO Role of computed tomography (CT) scan based reporting system ‘PAUSE’ to predict surgical resectability in epithelial ovarian cancer
|
Singhal, Seema
|
|
|
32 |
S2 |
p. A327
|
artikel
|
| 692 |
2022-RA-1533-ESGO Role of fertility sparing surgery in patients with borderline ovarian tumors
|
Westermann, Timo
|
|
|
32 |
S2 |
p. A181-A182
|
artikel
|
| 693 |
2022-RA-782-ESGO Role of follow up of stage one endometrial carcinoma for detection of recurrence
|
Kouklidis, George
|
|
|
32 |
S2 |
p. A109
|
artikel
|
| 694 |
2022-RA-1669-ESGO Role of laparoscopy in the differential diagnosis between peritoneal tuberculosis and advanced ovarian cancer: an infrequent condition to keep in mind!
|
Benito, Virginia
|
|
|
32 |
S2 |
p. A359-A360
|
artikel
|
| 695 |
2022-RA-1621-ESGO Role of PET-CT and CeCT in calculating preoperative PCI in patients with epithelial ovarian cancer
|
Martinez, Monica Gutierrez
|
|
|
32 |
S2 |
p. A354
|
artikel
|
| 696 |
2022-RA-1518-ESGO Role of Plastic surgery following resection of vulval tumours: Is collaboration the key?
|
Singhal, Maneesh
|
|
|
32 |
S2 |
p. A448
|
artikel
|
| 697 |
2022-RA-888-ESGO Role of preoperative determination of molecular classification on endometrial biopsy in preoperative allocation into a risk category in endometrial cancer
|
Puiggrós, Laura Cárdenas
|
|
|
32 |
S2 |
p. A117
|
artikel
|
| 698 |
2022-RA-1028-ESGO Role of radiotherapy in platinum sensitive oligometastatic recurrent ovarian cancer: a valid alternative to delay systemic treatment
|
Bonaldo, Giulio
|
|
|
32 |
S2 |
p. A290-A291
|
artikel
|
| 699 |
2022-RA-367-ESGO Rucaparib in clinical practice – what are the elements of patient adherence?
|
Braicu, Elena-Ioana
|
|
|
32 |
S2 |
p. A228
|
artikel
|
| 700 |
2022-RA-937-ESGO Rucaparib MAintenance after bevacizumab maintenance following carboplatin based chemotherapy in primary ovarian cancer
|
Braicu, Elena-Ioana
|
|
|
32 |
S2 |
p. A280-A281
|
artikel
|
| 701 |
2022-RA-680-ESGO Safety and efficacy of MORAb-202 in patients with platinum-resistant ovarian cancer: results from the expansion part of a phase 1 trial in Japan
|
Nishio, Shin
|
|
|
32 |
S2 |
p. A253-A254
|
artikel
|
| 702 |
2022-RA-1636-ESGO Safety of conservative surgery in small volume cervical cancer
|
Vranes, Boris
|
|
|
32 |
S2 |
p. A67-A68
|
artikel
|
| 703 |
2022-RA-1438-ESGO Safety of total paracentesis in patients with malignant ascites from ovarian cancer: Results from the prospective, randomised ATLANTIS-trial
|
Pietzner, Klaus
|
|
|
32 |
S2 |
p. A336
|
artikel
|
| 704 |
2022-RA-1645-ESGO Same day discharge protocol for gynaecological oncology robotic surgery: single institute experience of initial implementation
|
Floreskou, Alvin Michael
|
|
|
32 |
S2 |
p. A166
|
artikel
|
| 705 |
2022-RA-1086-ESGO Sebaceous carcinoma (SC) of the vulva – a case report and literature review
|
Zeinah, Hassan
|
|
|
32 |
S2 |
p. A439-A440
|
artikel
|
| 706 |
2022-RA-1575-ESGO Secondary bone localization from uterine sarcoma: a case series of a very rare condition
|
Sakhri, Saida
|
|
|
32 |
S2 |
p. A161
|
artikel
|
| 707 |
2022-RA-1196-ESGO Secondary cytoreductive surgery in endometrial cancer recurrence: how to triage patients towards surgery, a multicenter study
|
Vargiu, Virginia
|
|
|
32 |
S2 |
p. A137-A138
|
artikel
|
| 708 |
2022-RA-1661-ESGO Secondary cytoreductive surgery in platinum-sensitive relapsed ovarian cancer: real-world experience from an indian cancer centre
|
Palo, Upasana
|
|
|
32 |
S2 |
p. A358-A359
|
artikel
|
| 709 |
2022-RA-1206-ESGO Selection of preexisting BRCA1/2-proficient tumor cells in BRCA1/2-driven tubo-ovarian carcinomas treated by neoadjuvant chemotherapy
|
Imyanitov, Evgeny
|
|
|
32 |
S2 |
p. A310
|
artikel
|
| 710 |
2022-RA-827-ESGO Sentinel node biopsy diminishes de use of adjuvant therapy in women with early cervical cancer in the SUCCOR cohort
|
Gómez, Arantxa Berasaluce
|
|
|
32 |
S2 |
p. A29
|
artikel
|
| 711 |
2022-RA-1580-ESGO Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study
|
Biancotto, Giulia
|
|
|
32 |
S2 |
p. A351
|
artikel
|
| 712 |
2022-RA-812-ESGO Serum markers and cytokines in patients with ovarian cancer, borderline or benign ovarian tumors
|
Nowak, Marek
|
|
|
32 |
S2 |
p. A265
|
artikel
|
| 713 |
2022-RA-1078-ESGO Service evaluation of women with stage 1b vulval cancer who underwent groin sentinel lymph node biopsy: The South East Wales Gynaecological Oncology Centre (SEWGOC) experience
|
Zeinah, Hassan
|
|
|
32 |
S2 |
p. A439
|
artikel
|
| 714 |
2022-RA-1353-ESGO Severe anaemia following frontline maintenance with iPARP in a BRCA1 mutated high-grade serous ovarian cancer: an unexpected foe
|
Sarivalasis, Apostolos
|
|
|
32 |
S2 |
p. A400
|
artikel
|
| 715 |
2022-RA-1479-ESGO Sex hormone receptor expression, MSH2 and MSH6 loss, but not β-catenin nuclear translocation, is concordant between synchronous endometrial and ovarian carcinomas
|
Southworth, Emily
|
|
|
32 |
S2 |
p. A373
|
artikel
|
| 716 |
2022-RA-1481-ESGO Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy
|
Terra, Lara
|
|
|
32 |
S2 |
p. A386
|
artikel
|
| 717 |
2022-RA-1689-ESGO Should immunotherapy be included as first-line adjuvant treatment in high-risk vulvar melanomas?
|
Benito, Virginia
|
|
|
32 |
S2 |
p. A451-A452
|
artikel
|
| 718 |
2022-RA-435-ESGO Significance of the peritoneal washing cytology as a predictive factor of the long-term benefit of secondary debulking surgery for ovarian cancer
|
Nagano, Hiroaki
|
|
|
32 |
S2 |
p. A232-A233
|
artikel
|
| 719 |
2022-RA-862-ESGO Simultaneous 18F-FDG PET/MRI as single imaging method in the assessment of cervical cancer- a pilot study
|
Hedlund, Elisabeth
|
|
|
32 |
S2 |
p. A29-A30
|
artikel
|
| 720 |
2022-RA-863-ESGO Slovenian experience with pembrolizumab in patients with metastatic endometrial and cervical cancer
|
Gregoric, Brigita
|
|
|
32 |
S2 |
p. A193
|
artikel
|
| 721 |
2022-RA-1034-ESGO Small cell neuroendocrine carcinoma of the cervix
|
Sarac, Cosmin Paul
|
|
|
32 |
S2 |
p. A39
|
artikel
|
| 722 |
2022-RA-1616-ESGO Small cell neuroendocrine carcinoma of the vagina
|
Orlando Puentes, Luis
|
|
|
32 |
S2 |
p. A450
|
artikel
|
| 723 |
2022-RA-1541-ESGO Small cell neuroendocrine tumor of the cervix with multiple cutaneous metastasis: a report of 2 cases
|
Bonetti, Heloise Serafin
|
|
|
32 |
S2 |
p. A63-A64
|
artikel
|
| 724 |
2022-RA-1428-ESGO Solitary unusual metastasis of serous ovarian carcinoma in the gastric wall. Report of a case
|
Salcedo-Hernandez, Rosa Angélica
|
|
|
32 |
S2 |
p. A335-A336
|
artikel
|
| 725 |
2022-RA-415-ESGO Sonography in the diagnosis of primary fallopian tube cancer
|
Sumtsov, Dmytro
|
|
|
32 |
S2 |
p. A68-A69
|
artikel
|
| 726 |
2022-RA-1359-ESGO Spatial composition of the immune milieu in distinct metastatic sites in advanced serous ovarian cancer
|
Nikonov, Janna
|
|
|
32 |
S2 |
p. A329
|
artikel
|
| 727 |
2022-RA-802-ESGO Spatial TILs density correlates with locoregional spread and survival in patients with cervical cancer treated with chemo-radiotherapy
|
Del, Mathilde
|
|
|
32 |
S2 |
p. A28
|
artikel
|
| 728 |
2022-RA-583-ESGO Squamous cell carcinoma of the breast: 3 specific cases
|
Bouguerra, Fadoua
|
|
|
32 |
S2 |
p. A186
|
artikel
|
| 729 |
2022-RA-1238-ESGO Stereotactic ablative radiotherapy in oligometastatic gynaecological malignancies
|
El-Modir, Ahmed
|
|
|
32 |
S2 |
p. A366
|
artikel
|
| 730 |
2022-RA-932-ESGO Stereotactic body radiotherapy boost as an alternative for locally advanced cervical cancer when brachytherapy is not available, a prospective monocentric phase II
|
Jullian, Nicolas
|
|
|
32 |
S2 |
p. A34
|
artikel
|
| 731 |
2022-RA-915-ESGO STK11 adnexal tumors: challenge of a new tumor entity
|
Pagano, Flavia
|
|
|
32 |
S2 |
p. A409-A410
|
artikel
|
| 732 |
2022-RA-426-ESGO Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical impact in patients with cervical cancer: subgroup analysis of the SCCAN project
|
Dostálek, Lukáš
|
|
|
32 |
S2 |
p. A9-A10
|
artikel
|
| 733 |
2022-RA-729-ESGO Strengthening of pelvic floor muscles for incontinence in cervical cancer
|
Jagdish, Prathepa
|
|
|
32 |
S2 |
p. A24
|
artikel
|
| 734 |
2022-RA-1159-ESGO Stump
|
Saoud, Mohammed Karam
|
|
|
32 |
S2 |
p. A372
|
artikel
|
| 735 |
2022-RA-1513-ESGO Successful immunotherapy with imiquimod in vaginal intraepithelial lesion – a case report
|
Danolić, Damir
|
|
|
32 |
S2 |
p. A448
|
artikel
|
| 736 |
2022-RA-1182-ESGO Successful term pregnancy following radical trachelectomy in a patient with early-stage invasive cervical carcinoma: the first case reported from Vietnam
|
Doan, Nghia Trong
|
|
|
32 |
S2 |
p. A178
|
artikel
|
| 737 |
2022-RA-1217-ESGO Succor Morbidity. Intraoperative and postoperative complications inminimally invasive versus open radical hysterectomy in early cervical cancer
|
Vicente, Daniel Vázquez
|
|
|
32 |
S2 |
p. A46
|
artikel
|
| 738 |
2022-RA-1219-ESGO Succor quality: validation of ESGO quality indicators for surgical treatment of cervical cancer
|
Boria, Felix
|
|
|
32 |
S2 |
p. A46
|
artikel
|
| 739 |
2022-RA-165-ESGO Surgeon-administered transversus abdominis plane (TAP) block versus placebo after midline laparotomy in gynecologic oncology: a double-blind randomized trial
|
Bernard, Laurence
|
|
|
32 |
S2 |
p. A183-A184
|
artikel
|
| 740 |
2022-RA-1268-ESGO Surgery after primary chemo/radiation in locally advanced vulvar cancer: analysis of surgical outcomes and survival
|
Fragomeni, Simona Maria
|
|
|
32 |
S2 |
p. A444-A445
|
artikel
|
| 741 |
2022-RA-973-ESGO Surgical management of early-stage melanoma of the female lower genital tract: a case series
|
Zarragoitia, Janire
|
|
|
32 |
S2 |
p. A436
|
artikel
|
| 742 |
2022-RA-1252-ESGO Surgical management of endometrial carcinoma with a focus on the high BMI patient
|
Redmond, Aisling E
|
|
|
32 |
S2 |
p. A140
|
artikel
|
| 743 |
2022-RA-1244-ESGO Surgical paraaortic lymph node staging does not delay concomitant chemoradiation starting and completion in locally advanced cervical compared with FDG-TEP staging. A retrospective single-center cohort
|
Hudry, Delphine
|
|
|
32 |
S2 |
p. A48
|
artikel
|
| 744 |
2022-RA-1047-ESGO Surgical restaging of early-stage endometrial cancer patients with lymphovascular invasion does not significantly impact their survival outcomes
|
Petousis, Stamatios
|
|
|
32 |
S2 |
p. A132
|
artikel
|
| 745 |
2022-RA-1552-ESGO Survival after hyperthermic intraperitoneal chemotherapy in kazakhstani women with ovarian cancer: KazIOR experience
|
Kaidarova, Dilyara
|
|
|
32 |
S2 |
p. A349
|
artikel
|
| 746 |
2022-RA-849-ESGO Survival differences among surgical approach in endometrial cancer
|
Rodriguez Garnica, Maria Dolores
|
|
|
32 |
S2 |
p. A114-A115
|
artikel
|
| 747 |
2022-RA-1181-ESGO Survival outcomes and recurrence patterns of laparotomy versus minimal invasive surgery in women with intermediate- and high-risk uterine cancer at a tertiary referral center
|
Trent, Pernille Bjerre
|
|
|
32 |
S2 |
p. A136-A137
|
artikel
|
| 748 |
2022-RA-688-ESGO Survival outcomes of advanced ovarian cancer patients undergoing maximal effort cytoreduction
|
Zachariou, Eleftherios
|
|
|
32 |
S2 |
p. A256
|
artikel
|
| 749 |
2022-RA-698-ESGO Survival outcomes of patients with vaginal melanoma: an institutional case series and a systematic review with IPD analysis
|
Zachariou, Eleftherios
|
|
|
32 |
S2 |
p. A430-A431
|
artikel
|
| 750 |
2022-RA-423-ESGO Symptomatic or asymptomatic recurrence of ovarian cancer: does it influence survival?
|
Madland, Karen
|
|
|
32 |
S2 |
p. A231
|
artikel
|
| 751 |
2022-RA-921-ESGO Systematic nurse-led consultations based on electronic patient-reported outcomes among women with gynaecological cancer during chemotherapy-The CONNECT study
|
Christiansen, Mille Guldager
|
|
|
32 |
S2 |
p. A278
|
artikel
|
| 752 |
2022-RA-1504-ESGO Tamoxifen-megestrol acetate combination hormonal therapy is an effective fertility-sparing treatment in early-stage endometrial cancer patients who have failed progestin only hormonal therapy
|
Lim, Hyunji
|
|
|
32 |
S2 |
p. A154-A155
|
artikel
|
| 753 |
2022-RA-1476-ESGO Targeting androgen and estrogen receptor signaling in patient-derived endometrial cancer organoids
|
Hjelmeland, Marta Espevold
|
|
|
32 |
S2 |
p. A153-A154
|
artikel
|
| 754 |
2022-RA-1412-ESGO The association between social deprivation in Northern Ireland and treatment of ovarian cancer
|
McMullan, Josh Courtney
|
|
|
32 |
S2 |
p. A334
|
artikel
|
| 755 |
2022-RA-1331-ESGO The decrease of serum beta HCG level after hysterectomy in gestational trophoblastic neoplasia
|
Tjokroprawiro, Brahmana Askandar
|
|
|
32 |
S2 |
p. A424-A425
|
artikel
|
| 756 |
2022-RA-1673-ESGO The digital trans-african E-health network- a clinical partnership experience
|
Nasser, Sara
|
|
|
32 |
S2 |
p. A218-A219
|
artikel
|
| 757 |
2022-RA-916-ESGO The Early Detection of vulval CAncer Through self-Examination (EDuCATE) study: What women and clinicians think
|
Sivalingam, Vanitha N
|
|
|
32 |
S2 |
p. A435-A436
|
artikel
|
| 758 |
2022-RA-589-ESGO The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer
|
Angeles, Martina Aida
|
|
|
32 |
S2 |
p. A241-A242
|
artikel
|
| 759 |
2022-RA-603-ESGO The effect of oral metronomic chemotherapy on reccurrent progressive ovarian cancer
|
Banerjee, Swarna Bindu
|
|
|
32 |
S2 |
p. A243-A244
|
artikel
|
| 760 |
2022-RA-462-ESGO The effects of Cerviron on vaginal atrophy after surgically treated and adjuvant radiation therapy for cervical cancer
|
Bacalbasa, Nicolae
|
|
|
32 |
S2 |
p. A391
|
artikel
|
| 761 |
2022-RA-752-ESGO The efficacy of HPV test for cervical cancer screening
|
Song, Heekyoung
|
|
|
32 |
S2 |
p. A72
|
artikel
|
| 762 |
2022-RA-1127-ESGO The efficacy of MEK inhibitors in the treatment of low-grade serous ovarian cancers: a systematic review
|
Kulkarni, Anjali
|
|
|
32 |
S2 |
p. A302-A303
|
artikel
|
| 763 |
2022-RA-745-ESGO The efficacy of second curettage in the treatment of low-risk gestational trophoblastic neoplasia: a systematic review and meta-analysis
|
Mah, Sarah Jill
|
|
|
32 |
S2 |
p. A422
|
artikel
|
| 764 |
2022-RA-683-ESGO The ENSURE trial for women with early-stage endometrial cancer: A randomized controlled trial comparing the effect of a reduced versus usual follow-up schedule on patient satisfaction, health care use, and disease perceptions
|
Ezendam, Nicole PM
|
|
|
32 |
S2 |
p. A455
|
artikel
|
| 765 |
2022-RA-774-ESGO The follow-up of patients with high risk of ureteric postoperative complications – presentation of our prophylactic method
|
Mrugała, Maja
|
|
|
32 |
S2 |
p. A394
|
artikel
|
| 766 |
2022-RA-825-ESGO The impact of age on prognosis in women with endometrial cancer: a pooled analysis of the PORTEC-1, -2 and -3 randomised trials
|
Wakkerman, Famke Charlotte
|
|
|
32 |
S2 |
p. A113
|
artikel
|
| 767 |
2022-RA-1335-ESGO The impact of combination of systemic inflammatory and molecular markers on survival of apparent early-stage endometrial cancer
|
Bizzarri, Nicolò
|
|
|
32 |
S2 |
p. A145
|
artikel
|
| 768 |
2022-RA-451-ESGO The impact of COVID-19 infection on the rates of perioperative complications following total pelvic exenterations for gynecological malignancies
|
Bacalbasa, Nicolae
|
|
|
32 |
S2 |
p. A12-A13
|
artikel
|
| 769 |
2022-RA-631-ESGO The impact of COVID 19 on cervical cancer screening and triage
|
Velasquez, Jessica M
|
|
|
32 |
S2 |
p. A374-A375
|
artikel
|
| 770 |
2022-RA-663-ESGO The impact of COVID-19 on gynaecological oncology surgery
|
Erfiandi, Febia
|
|
|
32 |
S2 |
p. A188
|
artikel
|
| 771 |
2022-RA-1411-ESGO The impact of COVID19 on the cervical screening programme and colposcopy services in northern ireland
|
McMullan, Josh Courtney
|
|
|
32 |
S2 |
p. A385-A386
|
artikel
|
| 772 |
2022-RA-1404-ESGO The impact of COVID19 on the diagnostic and treatment pathways for patients with endometrial cancer in Northern Ireland
|
McMullan, Josh Courtney
|
|
|
32 |
S2 |
p. A150
|
artikel
|
| 773 |
2022-RA-172-ESGO The impact of COVID-19 pandemic on patterns of care of endometrial cancer patients
|
Bogani, Giorgio
|
|
|
32 |
S2 |
p. A90
|
artikel
|
| 774 |
2022-RA-1008-ESGO The impact of cytoreductive surgery in FIGO IV and recurrent endometrial cancer
|
Natalia Strojna, Aleksandra
|
|
|
32 |
S2 |
p. A129
|
artikel
|
| 775 |
2022-RA-765-ESGO The impact of delay from diagnosis to surgery in early ovarian cancer
|
Tsolakidis, Dimitrios
|
|
|
32 |
S2 |
p. A261
|
artikel
|
| 776 |
2022-RA-759-ESGO The impact of delay from diagnosis to surgery in endometrial cancer
|
Zouzoulas, Dimitrios
|
|
|
32 |
S2 |
p. A107
|
artikel
|
| 777 |
2022-RA-653-ESGO The impact of histology, prior therapy, and dMMR status on lenvatinib + pembrolizumab outcomes in patients with advanced endometrial cancer: A subgroup analysis of Study 309/KEYNOTE-775
|
Lorusso, Domenica
|
|
|
32 |
S2 |
p. A102
|
artikel
|
| 778 |
2022-RA-1301-ESGO The impact of hospital surgical volume on survival in early-stage cervical cancer treated with radical hysterectomy: a sub-analysis of the SCCAN study
|
Bizzarri, Nicolò
|
|
|
32 |
S2 |
p. A52-A53
|
artikel
|
| 779 |
2022-RA-963-ESGO The impact of low-volume metastasis on disease-free survival of women with apparent early-stage endometrial cancerunderwent sentinel node biopsy: a retrospective study
|
Buda, Alessandro A
|
|
|
32 |
S2 |
p. A122-A123
|
artikel
|
| 780 |
2022-RA-224-ESGO The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer
|
Cagetti, Leonel Varela
|
|
|
32 |
S2 |
p. A4
|
artikel
|
| 781 |
2022-RA-1161-ESGO The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations
|
Tomiczek-Szwiec, Joanna
|
|
|
32 |
S2 |
p. A76-A77
|
artikel
|
| 782 |
2022-RA-1347-ESGO The impact of the induction of anaesthesia and the opening of the abdominal cavity on haemodynamic parameters in cytoreductive debulking surgery
|
Middel, Charlotte
|
|
|
32 |
S2 |
p. A326-A327
|
artikel
|
| 783 |
2022-RA-816-ESGO The impact of the new RCOG 2019 curriculum and COVID 19 pandemic on gynaecological training amongst the specialist trainees in the United Kingdom: a prospective study
|
Barakat, Anas
|
|
|
32 |
S2 |
p. A190-A191
|
artikel
|
| 784 |
2022-RA-586-ESGO The impact of the pattern of recurrence on post-relapse survival according to surgical timing in patients with advanced ovarian cancer
|
Angeles, Martina Aida
|
|
|
32 |
S2 |
p. A240
|
artikel
|
| 785 |
2022-RA-1641-ESGO The impact on body image and quality of sexual life of transvaginal natural orifice transluminal endoscopic surgery (vNOTES) in women with high genetic risk of female cancers
|
Caretto, Marta
|
|
|
32 |
S2 |
p. A389
|
artikel
|
| 786 |
2022-RA-1246-ESGO The impact on survival of FDG-TEP versus surgical pretherapeutic paraaortic lymph node staging in locally advanced cervical cancer before concomitant chemoradiation. A retrospective single-center cohort
|
Hajj, Houssein El
|
|
|
32 |
S2 |
p. A49
|
artikel
|
| 787 |
2022-RA-1250-ESGO The MULTISENT study: a multicenter study about the sentinel lymph node biopsy in clinical stage I and II endometrial cancer
|
Gomez-Hidalgo, Natalia R
|
|
|
32 |
S2 |
p. A139
|
artikel
|
| 788 |
2022-RA-1509-ESGO The MULTISENT study: Analysis of survival according to the volume of sentinel lymph node disease
|
Cabrera, Silvia
|
|
|
32 |
S2 |
p. A156
|
artikel
|
| 789 |
2022-RA-1644-ESGO The need for a unified appraoch in patient advocacy for global women´s health: a PARSGO initiative
|
Nasser, Sara
|
|
|
32 |
S2 |
p. A464-A465
|
artikel
|
| 790 |
2022-RA-1410-ESGO The new algorithm for the risk assessment in uterine lesions (R.A.U.L)
|
Cello, Annalisa Di
|
|
|
32 |
S2 |
p. A210
|
artikel
|
| 791 |
2022-RA-611-ESGO The persistence of VPH
|
González, Elga López
|
|
|
32 |
S2 |
p. A17
|
artikel
|
| 792 |
2022-RA-1657-ESGO The potential role of human factors in the prediction of surgical effort in advanced-stage epithelial ovarian cancer patients; a study using explainable artificial intelligence
|
Laios, Alexandros
|
|
|
32 |
S2 |
p. A358
|
artikel
|
| 793 |
2022-RA-1452-ESGO The prognosis of patients with endometrial cancer is affected by obesity?
|
Milovic Kovacevic, Marijana M
|
|
|
32 |
S2 |
p. A151
|
artikel
|
| 794 |
2022-RA-1042-ESGO The prognostic impact of anaemia in cervical cancer patients treated with chemoradiation
|
El-Modir, Ahmed
|
|
|
32 |
S2 |
p. A39-A40
|
artikel
|
| 795 |
2022-RA-1215-ESGO The prognostic impact of Preoperative LMRof the body fluid in patients with epithelial ovarian cancer
|
Jeong, Min J
|
|
|
32 |
S2 |
p. A311
|
artikel
|
| 796 |
2022-RA-1449-ESGO The prognostic value of serum CA125 and HE4 in endometrial cancers stratified by molecular subgroup
|
Barr, Chloe Evelyn
|
|
|
32 |
S2 |
p. A416-A417
|
artikel
|
| 797 |
2022-RA-1510-ESGO The protective role of conization before radical hysterectomy in cervical cancer
|
Guijarro Campillo, Alberto Rafael
|
|
|
32 |
S2 |
p. A62-A63
|
artikel
|
| 798 |
2022-RA-1490-ESGO The quality of life of female refuges patients from Ukraine with malignant gynaecological tumors before and after treatment in Germany
|
Vdovichenko, Natalia
|
|
|
32 |
S2 |
p. A402-A403
|
artikel
|
| 799 |
2022-RA-1550-ESGO Therapeutic effect of t-cell-derived nanovesicles in endometrial cancer
|
Chung, Young Shin
|
|
|
32 |
S2 |
p. A159
|
artikel
|
| 800 |
2022-RA-1220-ESGO Therapeutic management of cervical cancer in elderly patients
|
Tani, Somia Chaibdra
|
|
|
32 |
S2 |
p. A47
|
artikel
|
| 801 |
2022-RA-970-ESGO There is no benefit for preoperative hyperhydratation before cytoreductive surgery and HIPEC with cisplatin when combined with sodium thiosulfate
|
Vachez, Elea
|
|
|
32 |
S2 |
p. A287
|
artikel
|
| 802 |
2022-RA-1063-ESGO There is no benefit for preoperative hyperhydration before cytoreductive surgery and hyperthermic intrapertioneal chemotherapy (HIPEC) with cisplatin when combined with sodium thiosulfate
|
Vachez, Elea
|
|
|
32 |
S2 |
p. A292-A293
|
artikel
|
| 803 |
2022-RA-427-ESGO The results of fertility-sparing treatment and obstetric outcomes in patients with atypical endometrial hyperplasia and early endometrial cancer: a case series from belarus
|
Milishkevich, Alena G
|
|
|
32 |
S2 |
p. A170
|
artikel
|
| 804 |
2022-RA-1586-ESGO The risk of endometrial cancer in women with polycystic ovarian syndrome
|
Johnson, Jean Ellen
|
|
|
32 |
S2 |
p. A161
|
artikel
|
| 805 |
2022-RA-1012-ESGO The role of inflammatory markers in the preoperative diagnosis of endometrial cancer and endometrial hyperplasia
|
Atalay, Cemal Resat
|
|
|
32 |
S2 |
p. A130-A131
|
artikel
|
| 806 |
2022-RA-1295-ESGO The role of intraoperative indocyanine green fluorescence angiography in preventing anastomotic leakage after colorectal resection for advanced ovarian cancer
|
Schivardi, Gabriella
|
|
|
32 |
S2 |
p. A319-A320
|
artikel
|
| 807 |
2022-RA-820-ESGO The role of minimally invasive secondary cytoreduction in recurrent ovarian cancer patients
|
Conte, Carmine
|
|
|
32 |
S2 |
p. A265-A266
|
artikel
|
| 808 |
2022-RA-659-ESGO The role of molecular classification in endometrial cancers with lymph nodes metastasis
|
Schivardi, Gabriella
|
|
|
32 |
S2 |
p. A103-A104
|
artikel
|
| 809 |
2022-RA-1595-ESGO The role of sentinel lymph node biopsy in the management of patients with endometrial atypical hyperplasia: a multicenter study
|
Rosati, Andrea
|
|
|
32 |
S2 |
p. A163
|
artikel
|
| 810 |
2022-RA-617-ESGO The role of systematic pelvic and para-aortic lymphadenectomy in the management of patients with advanced epithelial ovarian, tubal, and peritoneal cancer: a systematic review and meta-analysis
|
Tzanis, Alexander A
|
|
|
32 |
S2 |
p. A245
|
artikel
|
| 811 |
2022-RA-614-ESGO The role of ultrasound guided biopsy in women with pelvic mass suspected of gynecologic malignancy
|
Oge, Tufan
|
|
|
32 |
S2 |
p. A70
|
artikel
|
| 812 |
2022-RA-943-ESGO The significance of lower uterine segment involvement in endometrial cancer
|
Davidesko, Sharon
|
|
|
32 |
S2 |
p. A121
|
artikel
|
| 813 |
2022-RA-1210-ESGO The uterine sarcoma represents 1 to 5% of malignant tumors of the uterus
|
Chekman, Chemseddine
|
|
|
32 |
S2 |
p. A206
|
artikel
|
| 814 |
2022-RA-889-ESGO The vaginal microbiota composition is associated with severity of cervical dysplasia
|
Norenhag, Johanna
|
|
|
32 |
S2 |
p. A31
|
artikel
|
| 815 |
2022-RA-257-ESGO The value of different frailty indices in predicting short-term post-operative outcomes
|
Sobocan, Monika
|
|
|
32 |
S2 |
p. A93
|
artikel
|
| 816 |
2022-RA-1542-ESGO ‘Things have changed’. Laparoscopic cytoreduction for advanced and recurrent ovarian cancer: The experience of a referral center on 108 patients
|
Ceccaroni, Marcello
|
|
|
32 |
S2 |
p. A348
|
artikel
|
| 817 |
2022-RA-1153-ESGO Thromboprophylaxis in surgically treated gynecological cancer patients with tinzaparin in higher than conventional prophylactic dose: preliminary results from the Song-Tin study
|
Papadatou, Konstantina
|
|
|
32 |
S2 |
p. A205
|
artikel
|
| 818 |
2022-RA-1199-ESGO 5 times ovarian pedicle torsion due to pedunculated paratubal cyst in 15 years old girl
|
Osman Ahmed, Huda Abdelrhman
|
|
|
32 |
S2 |
p. A205-A206
|
artikel
|
| 819 |
2022-RA-1332-ESGO Timing and duration of definitive radiation therapy with or without concurrent chemotherapy for FIGO 2018 Stage IB3 – IVA cervical cancer in a tertiary referral hospital in the philippines
|
David, May Bugagao
|
|
|
32 |
S2 |
p. A53-A54
|
artikel
|
| 820 |
2022-RA-1392-ESGO Tisotumab vedotin combinations with pembrolizumab or carboplatin in patients with recurrent/metastatic cervical cancer: interim results of ENGOT Cx8/GOG-3024/innovaTV205
|
Lorusso, Domenica
|
|
|
32 |
S2 |
p. A57-A58
|
artikel
|
| 821 |
2022-RA-1260-ESGO TLR-4 as a possible new prognostic marker of advanced endometrial cancer
|
Sobstyl, Malgorzata
|
|
|
32 |
S2 |
p. A140
|
artikel
|
| 822 |
2022-RA-966-ESGO Tolerance of intraperitoneal (IP) nivolumab after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with relapse advanced ovarian carcinoma: a phase I study with expansion cohort (ICONIC)
|
Corbaux, Pauline
|
|
|
32 |
S2 |
p. A287
|
artikel
|
| 823 |
2022-RA-1667-ESGO Topical imiquimod cream for recurrent vulvar Paget disease
|
Kardhashi, Anila
|
|
|
32 |
S2 |
p. A451
|
artikel
|
| 824 |
2022-RA-1523-ESGO To study the impact of implementation of enhanced recovery after surgery (eras) protocol on perioperative outcomes in gynecology oncology surgery patients
|
Miglani, Urvashi
|
|
|
32 |
S2 |
p. A213-A214
|
artikel
|
| 825 |
2022-RA-1385-ESGO Total laparoscopic radical hysterectomy versus laparoscopic-assisted vaginal radical hysterectomy for the treatment of early-stage cervical cancer
|
Kovac, Luka
|
|
|
32 |
S2 |
p. A56-A57
|
artikel
|
| 826 |
2022-RA-1171-ESGO Total vaginectomy for recurrent gynecological cancer. Experience in kazior
|
Satanova, Alima
|
|
|
32 |
S2 |
p. A443-A444
|
artikel
|
| 827 |
2022-RA-634-ESGO Trabectedin plus pegylated liposomaldoxorubicin in patients who experienced disease progression after PARPi maintenance: a real life case-control study
|
Vertechy, Laura
|
|
|
32 |
S2 |
p. A247
|
artikel
|
| 828 |
2022-RA-1474-ESGO Traditional systemic treatment options in advance low grade serous ovarian cancer after successful cytoreduction. A systematic review and meta-analysis
|
Macías, Rosa Montero
|
|
|
32 |
S2 |
p. A341
|
artikel
|
| 829 |
2022-RA-861-ESGO Transcriptome and genetic profile of epithelial ovarian carcinoma patients sensitive and resistant to platinum derivatives
|
Hruda, Martin
|
|
|
32 |
S2 |
p. A270-A271
|
artikel
|
| 830 |
2022-RA-1480-ESGO TRANSLACOL project: digital-PCR human papilloma virus (HPV) detection for recurrence prediction in early cervical cancer patients without pelvic lymph node invasion
|
Macías, Rosa Montero
|
|
|
32 |
S2 |
p. A417-A418
|
artikel
|
| 831 |
2022-RA-1349-ESGO Treated as a skin carcinoma: recurrent, metastatic squamous cell carcinoma from a degenerated mature teratoma of the ovary
|
Sarivalasis, Apostolos
|
|
|
32 |
S2 |
p. A327-A328
|
artikel
|
| 832 |
2022-RA-420-ESGO Treatment and outcome of patients with high-grade advanced ovarian cancer (AOC) – real world data of the german quality assurance project (QS Ovar of the AGO Study Group)
|
Mahner, Sven
|
|
|
32 |
S2 |
p. A230
|
artikel
|
| 833 |
2022-RA-1339-ESGO Treatment outcome of gestational trophoblastic disease at single center of Saudi Arabia
|
Alghamdi, Jawaher Saeed
|
|
|
32 |
S2 |
p. A425
|
artikel
|
| 834 |
2022-RA-956-ESGO Treatment patterns and outcomes after progression on poly-ADP ribose polymerase inhibitor maintenance therapy
|
Tasca, Giulia
|
|
|
32 |
S2 |
p. A286
|
artikel
|
| 835 |
2022-RA-1678-ESGO Treatment patterns and outcomes for older women with ovarian cancer in ireland
|
Moloney, Carolyn
|
|
|
32 |
S2 |
p. A361-A362
|
artikel
|
| 836 |
2022-RA-704-ESGO Treatment patterns and time to next treatment among patients with OC in a real-life setting in Finland: the OCRWE-Finland study
|
Rauhamaa, Heini
|
|
|
32 |
S2 |
p. A257
|
artikel
|
| 837 |
2022-RA-725-ESGO Treatment patterns & outcomes of patients with locally advanced vulvar or vaginal cancer in British Columbia
|
Leung, Emily
|
|
|
32 |
S2 |
p. A431
|
artikel
|
| 838 |
2022-RA-1548-ESGO Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer
|
Vergote, Ignace
|
|
|
32 |
S2 |
p. A64
|
artikel
|
| 839 |
2022-RA-1369-ESGO TRICIN: A phase II trial on the efficacy of topical TRIchloroacetic acid in patients with cervical intraepithelial neoplasia
|
Schwameis, Richard
|
|
|
32 |
S2 |
p. A55
|
artikel
|
| 840 |
2022-RA-793-ESGO TROP-2 expression and the tumor immune-microenvironment in cervical cancer
|
Chiba, Yohei
|
|
|
32 |
S2 |
p. A406-A407
|
artikel
|
| 841 |
2022-RA-1662-ESGO Tumor induced stromal senescence in high grade serious ovarian cancer. A preclinical study on novel prognostic biomarkers and preliminary prospects on therapeutic potential
|
Salamina, Alessia
|
|
|
32 |
S2 |
p. A359
|
artikel
|
| 842 |
2022-RA-771-ESGO Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer
|
Hruda, Martin
|
|
|
32 |
S2 |
p. A26
|
artikel
|
| 843 |
2022-RA-591-ESGO Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer: pregnancy outcomes
|
Robova, Helena
|
|
|
32 |
S2 |
p. A171
|
artikel
|
| 844 |
2022-RA-1013-ESGO Twin pregnancy with complete hydatiform mole and coexistent fetus
|
Bouyahia, Maha Najla
|
|
|
32 |
S2 |
p. A422-A423
|
artikel
|
| 845 |
2022-RA-455-ESGO Typical recurrences of ovarian granulosa cell tumor recurrence
|
Bacalbasa, Nicolae
|
|
|
32 |
S2 |
p. A236
|
artikel
|
| 846 |
2022-RA-128-ESGO Ultrasound assessment of pathological lymph nodes in gynecologic cancers
|
Elagwany, Ahmed
|
|
|
32 |
S2 |
p. A182-A183
|
artikel
|
| 847 |
2022-RA-130-ESGO Ultrasound chemotherapy response assessment in ovarian cancer
|
Elagwany, Ahmed
|
|
|
32 |
S2 |
p. A221
|
artikel
|
| 848 |
2022-RA-1271-ESGO Ultrasound guided biopsy, a useful tool in the management of primary advanced tuboovarian carcinoma
|
Mascilini, Floriana
|
|
|
32 |
S2 |
p. A315
|
artikel
|
| 849 |
2022-RA-129-ESGO Ultrasound staging of endometrial cancer
|
Elagwany, Ahmed
|
|
|
32 |
S2 |
p. A87
|
artikel
|
| 850 |
2022-RA-1601-ESGO Ultrasound versus magnetic resonance imaging in the assessment of parametrial invasion in cervical cancer
|
Mohamed Elsersy, Mervat Ali
|
|
|
32 |
S2 |
p. A66-A67
|
artikel
|
| 851 |
2022-RA-260-ESGO UM-6 induces autophagy and apoptosis via the Hippo-YAP signaling pathway in cervical cancer
|
Xu, Tianmin
|
|
|
32 |
S2 |
p. A6
|
artikel
|
| 852 |
2022-RA-1289-ESGO Understanding clinical and pathological heterogeneity of endometrial cancer with no specific molecular profile (NSMP)
|
de Vitis, Luigi Antonio
|
|
|
32 |
S2 |
p. A141
|
artikel
|
| 853 |
2022-RA-690-ESGO Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe
|
Kolk, Willemijn L van der
|
|
|
32 |
S2 |
p. A430
|
artikel
|
| 854 |
2022-RA-1508-ESGO Universal MMR testing in endometrial carcinoma: results and clinicopathologic correlations from an Indian centre
|
Palo, Upasana
|
|
|
32 |
S2 |
p. A155-A156
|
artikel
|
| 855 |
2022-RA-1288-ESGO Unknown ovarian neoplasm with retroperitoneal involvement – Metastasis or two primary tumors? – Case report
|
Sharashenidze, Archil
|
|
|
32 |
S2 |
p. A317-A318
|
artikel
|
| 856 |
2022-RA-226-ESGO Unmet needs of women with newly diagnosed vulvar cancer – a nationwide Swedish cohort study
|
Zach, Diana
|
|
|
32 |
S2 |
p. A427-A428
|
artikel
|
| 857 |
2022-RA-1064-ESGO Unresectable peritoneal metastases from stage III ovarian cancer treated with bidirectional approach of Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy may lead to secondary complete cytoreductive surgery: a pilot study
|
Kefleyesus, Amaniel
|
|
|
32 |
S2 |
p. A293
|
artikel
|
| 858 |
2022-RA-181-ESGO Updated systematic review about results of fertility sparing surgery of cervical cancer
|
Gouy, Sebastien
|
|
|
32 |
S2 |
p. A2-A3
|
artikel
|
| 859 |
2022-RA-459-ESGO UPLIFT (ENGOT-ov67/GOG-3048) a registrational trial of Upifitamab Rilsodotin (XMT-1536; UpRi), a NaPi2b-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer
|
Concin, Nicole
|
|
|
32 |
S2 |
p. A237
|
artikel
|
| 860 |
2022-RA-439-ESGO Up-next (ENGOT-Ov71-NSGO-CTU/GOG-3049): a study of upitifamab rilsodotin (UpRi), a napi2b-directed antibody drug conjugate (ADC) in platinum-sensitive recurrent ovarian cancer
|
Mirza, Mansoor Raza
|
|
|
32 |
S2 |
p. A234
|
artikel
|
| 861 |
2022-RA-1498-ESGO Urinary incontinence in women with premenopausal risk-reducing salpingo-oophorectomy compared with women with postmenopausal risk-reducing salpingo-oophorectomy
|
Terra, Lara
|
|
|
32 |
S2 |
p. A387
|
artikel
|
| 862 |
2022-RA-604-ESGO Urine and vaginal cytology detects endometrial cancer in women with postmenopausal bleeding
|
Jones, Eleanor
|
|
|
32 |
S2 |
p. A69-A70
|
artikel
|
| 863 |
2022-RA-1469-ESGO Urological outcomes following nerve sparing radical hysterectomy for early stage cervical cancer
|
Raju K, VVN
|
|
|
32 |
S2 |
p. A61
|
artikel
|
| 864 |
2022-RA-1137-ESGO Use of an allogeneic, cell-based vaccine DCP-001 in high grade Serous Ovarian cancerpatients after primary treatment; A phase I clinical trial
|
Vledder, Annegé
|
|
|
32 |
S2 |
p. A304
|
artikel
|
| 865 |
2022-RA-1308-ESGO Use of radiotherapy planning CT scans to predict risk of insufficiency fractures following pelvic radiotherapy
|
Cooper, Amy
|
|
|
32 |
S2 |
p. A399-A400
|
artikel
|
| 866 |
2022-RA-885-ESGO Use of vacuum-assisted closure after extensive flap dehiscence in vulvectomy for Paget’s disease
|
Klikarová, Jitka
|
|
|
32 |
S2 |
p. A434
|
artikel
|
| 867 |
2022-RA-1085-ESGO Using data-driven algorithms and real-world data for updating endometrial clinical practice guidelines
|
van der Hel, Olga L
|
|
|
32 |
S2 |
p. A134
|
artikel
|
| 868 |
2022-RA-1556-ESGO Uterine cervix clear cell adenocarcinoma: Tunisian experience in post Diethylboestrol era
|
Saida, Sakhri
|
|
|
32 |
S2 |
p. A64
|
artikel
|
| 869 |
2022-RA-1062-ESGO Uterine granulocytic sarcoma as an extra-medullary relapse of acute myeloid leukaemia in an allogeneic hematopoietic stem cell transplantation recipient
|
Bandeira, Deborah
|
|
|
32 |
S2 |
p. A201
|
artikel
|
| 870 |
2022-RA-1351-ESGO Uterine involvement in epithelial ovarian cancer & its risk factors
|
Zamani, Narges
|
|
|
32 |
S2 |
p. A328
|
artikel
|
| 871 |
2022-RA-1535-ESGO Uterine PEComa and prognostic value of the proposed classification systems: a retrospective study, systematic review, and metanalysis
|
Ferrari, Filippo Alberto
|
|
|
32 |
S2 |
p. A214-A215
|
artikel
|
| 872 |
2022-RA-1158-ESGO Uterine sarcoma
|
Taghzouti, Hanae
|
|
|
32 |
S2 |
p. A372
|
artikel
|
| 873 |
2022-RA-1545-ESGO Uterine transposition: is it an option for fertility sparing in locally advanced cervical cancer
|
Ibarra, Maria Ercilia
|
|
|
32 |
S2 |
p. A182
|
artikel
|
| 874 |
2022-RA-1133-ESGO Utility values in PROC
|
Mehra, Anupriya
|
|
|
32 |
S2 |
p. A303
|
artikel
|
| 875 |
2022-RA-676-ESGO Utilization of Ligasure Maryland Jaw open sealer/divider with nanocoating improves perioperative parameters in women with advanced ovarian cancer subjected to cytoreductive surgery
|
Tsolakidis, Dimitrios
|
|
|
32 |
S2 |
p. A253
|
artikel
|
| 876 |
2022-RA-667-ESGO Vaginal brachytherapy -the patient journey
|
Rabin, Tatiana
|
|
|
32 |
S2 |
p. A454-A455
|
artikel
|
| 877 |
2022-RA-934-ESGO Vaginal changes, sexual functioning and distress of women with locally advanced cervical cancer treated in the EMBRACE vaginal morbidity sub-study
|
Suvaal, Isabelle
|
|
|
32 |
S2 |
p. A34-A35
|
artikel
|
| 878 |
2022-RA-904-ESGO Vaginal cuff brachytherapy in intermediate and intermediate high risk endometrial cancers after hysterectomy: clinical outcomes
|
Cordoba, Abel
|
|
|
32 |
S2 |
p. A117-A118
|
artikel
|
| 879 |
2022-RA-1627-ESGO Vaginal microbiome in patients with endometrial cancer
|
Barczyński, Bartłomiej
|
|
|
32 |
S2 |
p. A165
|
artikel
|
| 880 |
2022-RA-1293-ESGO Validation of a sustainable internationally monitored cervical cancer screening system using a visual smartphone inspection in Kinshasa
|
Tendobi, Celine
|
|
|
32 |
S2 |
p. A384-A385
|
artikel
|
| 881 |
2022-RA-1156-ESGO Validation of peritoneal cancer index (PCI) score as a non-invasive tool for surgical resectability in advanced ovarian cancer patients in a tertiary care center of Pakistan
|
Aziz, Humaira
|
|
|
32 |
S2 |
p. A306-A307
|
artikel
|
| 882 |
2022-RA-1093-ESGO Validation of self-sampling use for a multiplexed biomarker assay for HPV and dysplasia detection
|
Skof, Anna Sophie
|
|
|
32 |
S2 |
p. A411
|
artikel
|
| 883 |
2022-RA-873-ESGO Validation study of the ‘NOGGO-GIS ASSAY’ based on ovarian cancer samples from the first-line PAOLA-1/ENGOT-ov25 phase-III trial
|
Willing, Eva-Maria
|
|
|
32 |
S2 |
p. A370
|
artikel
|
| 884 |
2022-RA-776-ESGO Validity of whole body MRI in the preoperative assessment of ovarian cancer: systematic review and meta-analysis
|
Manzour, Nabil
|
|
|
32 |
S2 |
p. A73
|
artikel
|
| 885 |
2022-RA-276-ESGO Value of surgical cytoreduction for subsequent ovarian cancer relapse in patients previously treated with chemotherapy alone at 1st-relapse: a subanalysis of the DESKTOP III/ENGOT-ov20 trial
|
Fotopoulou, Christina
|
|
|
32 |
S2 |
p. A227-A228
|
artikel
|
| 886 |
2022-RA-1407-ESGO Variation in outcome reporting in studies of fertility sparing surgery for cervical cancer: a systematic review
|
Yong, Nathanael
|
|
|
32 |
S2 |
p. A179-A180
|
artikel
|
| 887 |
2022-RA-710-ESGO Vitamin D receptor and cellular retinol-binding protein-1 immunohistochemical expression in normal, hyperplastic and neoplastic endometrium: Possible diagnostic and therapeutic implications
|
Badary, Dalia M
|
|
|
32 |
S2 |
p. A105
|
artikel
|
| 888 |
2022-RA-949-ESGO VOCAL (views of ovarian cancer patients-how maintenance therapy affects their lives) study: patient preference for treatment formulation and administration
|
Wethington, Stephanie
|
|
|
32 |
S2 |
p. A283-A284
|
artikel
|
| 889 |
2022-RA-1683-ESGO VTE in newly diagnosed ovarian cancer patients
|
Shai, Daniel
|
|
|
32 |
S2 |
p. A362
|
artikel
|
| 890 |
2022-RA-1069-ESGO Vulvar basal cell carcinoma – 5 years experience from tertiary care centre and a case report of unusual recurrence of vulvar basal cell carcinoma in paraaortic lymph nodes
|
Jansa, Vid
|
|
|
32 |
S2 |
p. A439
|
artikel
|
| 891 |
2022-RA-1211-ESGO Vulvar ectopic localization of breast cancer
|
Chekman, Chemseddine
|
|
|
32 |
S2 |
p. A444
|
artikel
|
| 892 |
2022-RA-978-ESGO Vulvar lymphangioma associated with squamous cell carcinoma
|
Zemni, Zeineb
|
|
|
32 |
S2 |
p. A436-A437
|
artikel
|
| 893 |
2022-RA-584-ESGO Vulvar melanoma
|
Bouguerra, Fadoua
|
|
|
32 |
S2 |
p. A428
|
artikel
|
| 894 |
2022-RA-1549-ESGO Vulvar primary melanoma: Report of Six cases and review of literature
|
Jellali, Amani
|
|
|
32 |
S2 |
p. A449
|
artikel
|
| 895 |
2022-RA-960-ESGO Wait time until surgery in gynecological oncology: patient preference and experience
|
Berg, Kim van den
|
|
|
32 |
S2 |
p. A457-A458
|
artikel
|
| 896 |
2022-RA-1598-ESGO What has greatest impact on risk of recurrence in primary epithelial ovarian cancer?
|
Lischke, Emma Frederike
|
|
|
32 |
S2 |
p. A352
|
artikel
|
| 897 |
2022-RA-685-ESGO What is beyond brca mutational status in high grade serous ovarian cancer? The role of hormone receptors expression
|
Perrone, Emanuele
|
|
|
32 |
S2 |
p. A254
|
artikel
|
| 898 |
2022-RA-1345-ESGO When endometrial cancer spares no age
|
Tapia Gutierrez, Charmaine Clarisse
|
|
|
32 |
S2 |
p. A146
|
artikel
|
| 899 |
2022-RA-884-ESGO Whole-body diffusion-weighted MRI (WB-DWI/MRI) for the prediction of resectable disease at the time of secondary cytoreductive surgery for relapsed epithelial ovarian cancer
|
Dumont, Sander
|
|
|
32 |
S2 |
p. A273-A274
|
artikel
|
| 900 |
2022-RA-1517-ESGO Wroclaw comprehensive cancer centre 100 months experience in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) in patients with peritoneal carcinomatosis – indications and complications of the procedure
|
Szewczyk, Krzysztof
|
|
|
32 |
S2 |
p. A345
|
artikel
|
| 901 |
2022-VA-920-ESGO Adrenal gland recurrent cervical cancer treated by minimally invasive approach
|
Rosati, Andrea
|
|
|
32 |
S2 |
p. A33
|
artikel
|
| 902 |
2022-VA-1275-ESGO Agressive angiomyxoma of the pelvis and vagina: a robotic and vaginal combined approach
|
Luzarraga, Ana
|
|
|
32 |
S2 |
p. A445
|
artikel
|
| 903 |
2022-VA-445-ESGO Anatomy of the presacral region
|
Laufer, Joel
|
|
|
32 |
S2 |
p. A185-A186
|
artikel
|
| 904 |
2022-VA-887-ESGO A novel endoscopic surgery method: transurethral surgery – natural orifice translumenal endoscopic surgery (TUS-NOTES) using pneumocystoscopy for treatment of vesicovaginal fistula
|
Neymeyer, Joerg
|
|
|
32 |
S2 |
p. A195
|
artikel
|
| 905 |
2022-VA-1320-ESGO A novel laparoscopic approach to large malignant ovarian masses
|
Tong, Pearl SY
|
|
|
32 |
S2 |
p. A324
|
artikel
|
| 906 |
2022-VA-742-ESGO Brachytherapy for inoperable vulvar cancer: implant technique
|
Chopra, Supriya
|
|
|
32 |
S2 |
p. A431-A432
|
artikel
|
| 907 |
2022-VA-1296-ESGO Coelio-Schauta: laparoscopically assisted radical vaginal hysterectomy in early-stage cervical cancer
|
Glickman, Ariel
|
|
|
32 |
S2 |
p. A52
|
artikel
|
| 908 |
2022-VA-1146-ESGO Conservative endoscopic management of a colorectal leakage in advanced ovarian cancer
|
Boria, Felix
|
|
|
32 |
S2 |
p. A305
|
artikel
|
| 909 |
2022-VA-699-ESGO Diagnosis of lymph node micrometastasis even though methylene blue
|
Vural, Nazli Aylin
|
|
|
32 |
S2 |
p. A22
|
artikel
|
| 910 |
2022-VA-1435-ESGO ECO-LEAK: A Novell strategy for anastomotic leakage diagnosis in gynecologic cancer patients
|
Lago, Víctor
|
|
|
32 |
S2 |
p. A80-A81
|
artikel
|
| 911 |
2022-VA-1413-ESGO Extraperitoneal paraaortic lymphadenectomy in endometrial cancer patient with morbid obesity: ten steps of the technique
|
Erkilinç, Selçuk
|
|
|
32 |
S2 |
p. A150
|
artikel
|
| 912 |
2022-VA-1291-ESGO How to get out and solve a challenging surgical case of endometrial cancer entrapped in an endometriosis blanket. a systematic and replicable surgical approach
|
Notaro, Sara
|
|
|
32 |
S2 |
p. A207
|
artikel
|
| 913 |
2022-VA-572-ESGO Hudson posterior exenteration, with the use of ICG fluorescence to assess rectal anastomosis and ureteral integrity
|
Nguyen, Dong Bach
|
|
|
32 |
S2 |
p. A239
|
artikel
|
| 914 |
2022-VA-1284-ESGO Indocyanine green as a learning tool for para-aortic laparoscopic lymphadenectomy after sentinel lymph node detection in ovarian cancer
|
Adán, Ana Conde
|
|
|
32 |
S2 |
p. A317
|
artikel
|
| 915 |
2022-VA-946-ESGO Indocyanine green sentinel lymph node mapping – staging role in endometrial cancer
|
Carvalho Silva, Cátia
|
|
|
32 |
S2 |
p. A121
|
artikel
|
| 916 |
2022-VA-628-ESGO Inferior Vena Cava injury during laparoscopic para-aortic lymphadenectomy
|
Pandraklakis, Anastasios
|
|
|
32 |
S2 |
p. A100
|
artikel
|
| 917 |
2022-VA-1138-ESGO Laparoscopic anterior resection with total vaginectomy
|
Raju K, VVN
|
|
|
32 |
S2 |
p. A441
|
artikel
|
| 918 |
2022-VA-1606-ESGO Laparoscopic excision of isolated pelvic lymph metastasis of nasopharyngeal carcinoma
|
Aker, Seda Sahin
|
|
|
32 |
S2 |
p. A216
|
artikel
|
| 919 |
2022-VA-1370-ESGO Laparoscopic extraperitoneal systematic para-aortic lymphadenectomy, a step-by-step educational video
|
Pandraklakis, Anastasios
|
|
|
32 |
S2 |
p. A148
|
artikel
|
| 920 |
2022-VA-907-ESGO Laparoscopic laterally extended endopelvic resection and excision of isolated celiac trunk lymph node in recurrent low-risk endometrial cancer
|
Giovannopoulou, Eirini
|
|
|
32 |
S2 |
p. A118
|
artikel
|
| 921 |
2022-VA-1135-ESGO Laparoscopic nerve sparing radical hysterectomy
|
Raju, KVVN
|
|
|
32 |
S2 |
p. A43
|
artikel
|
| 922 |
2022-VA-780-ESGO Laparoscopic radical trachelectomyfor early cervical cancer – Safe, effective and feasible
|
Mehra, Gautam
|
|
|
32 |
S2 |
p. A175
|
artikel
|
| 923 |
2022-VA-596-ESGO Laparoscopic vaginal radical trachelectomy in the post LACC era: step by step surgical procedure
|
Guani, Benedetta
|
|
|
32 |
S2 |
p. A172
|
artikel
|
| 924 |
2022-VA-1050-ESGO Laparoscopy is a perfect method for tailored and radical surgery in DIE and multiorgans surgery with all advantages of the minimally invasiveaccess. Complete realising of the pain was huge success of the surgery
|
Milnerowicz-Nabzdyk, Ewa
|
|
|
32 |
S2 |
p. A200-A201
|
artikel
|
| 925 |
2022-VA-1204-ESGO Local myometrial resection for chemoresistant GTN
|
Hemida, Reda
|
|
|
32 |
S2 |
p. A423
|
artikel
|
| 926 |
2022-VA-182-ESGO May transvaginal natural orifice transluminal endoscopic surgery VNOTES sentinel lymph node biopsy be the future of endometrial cancer surgery?
|
Comba, Cihan
|
|
|
32 |
S2 |
p. A90-A91
|
artikel
|
| 927 |
2022-VA-808-ESGO Minimally invasive inguinal lymph node dissection technique
|
Mageed, Hisham Abdel
|
|
|
32 |
S2 |
p. A432
|
artikel
|
| 928 |
2022-VA-1522-ESGO New Keystone flap application in vulvo-perineal reconstructive surgery for vulvar cancer
|
Altieri, Alfonso
|
|
|
32 |
S2 |
p. A213
|
artikel
|
| 929 |
2022-VA-1229-ESGO Novel method of uterine traction in robot assisted total hysterectomy
|
Fujino, Kazunari
|
|
|
32 |
S2 |
p. A138
|
artikel
|
| 930 |
2022-VA-1059-ESGO Omental flap as a spacer to reduce acute bowel toxicity after adjuvant radiotherapy
|
Leung, Elaine
|
|
|
32 |
S2 |
p. A201
|
artikel
|
| 931 |
2022-VA-739-ESGO Pelvic sentinel lymph node dissection in endometrial cancer
|
Gaba, Faiza
|
|
|
32 |
S2 |
p. A106
|
artikel
|
| 932 |
2022-VA-1036-ESGO Protected laparoscopic large ovarian cyst aspiration – a five steps alternative to laparotomy
|
Hajj, Houssein El
|
|
|
32 |
S2 |
p. A200
|
artikel
|
| 933 |
2022-VA-864-ESGO Rectovaginal fistula repair by Martius flap after exclusive chemo-radiation in advanced cervical cancer patient. A case report
|
Capozzi, Vito Andrea
|
|
|
32 |
S2 |
p. A30
|
artikel
|
| 934 |
2022-VA-1445-ESGO Right diaphragmatic peritonectomy in extensive involvement of the coronary ligament: no touch principle
|
Khatib, Ganim
|
|
|
32 |
S2 |
p. A337
|
artikel
|
| 935 |
2022-VA-836-ESGO Robot assisted laparoscopic staging surgery in early stage of ovarian cancer
|
Ahn, Jung-Hwan
|
|
|
32 |
S2 |
p. A268-A269
|
artikel
|
| 936 |
2022-VA-1045-ESGO Sentinel lymph node biopsy in surgical staging for endometrial carcinoma patients
|
García, Laura Gil
|
|
|
32 |
S2 |
p. A131-A132
|
artikel
|
| 937 |
2022-VA-1152-ESGO Sigmoid neovagina and double V-Y flap reconstruction after a total pelvic infralevator exenteration
|
Boria, Felix
|
|
|
32 |
S2 |
p. A441-A442
|
artikel
|
| 938 |
2022-VA-1778-ESGO SLN mapping in high risk endometrial cancer: Relevance of surgical algorithm
|
Pineda, Virginia García
|
|
|
32 |
S2 |
p. A168
|
artikel
|
| 939 |
2022-VA-633-ESGO Standardized LEER procedure
|
Lago, Víctor
|
|
|
32 |
S2 |
p. A18-A19
|
artikel
|
| 940 |
2022-VA-1150-ESGO Step by step ileal conduit urinary diversion
|
Aker, Seda Şahin
|
|
|
32 |
S2 |
p. A43-A44
|
artikel
|
| 941 |
2022-VA-1485-ESGO Surgical anatomy of the right upper quadrant after cytoreductive surgery
|
Khatib, Ganim
|
|
|
32 |
S2 |
p. A342
|
artikel
|
| 942 |
2022-VA-1166-ESGO Suspicious lymph nodes in advanced ovarian cancer: debulking surgery
|
Castro, Cristina Celada
|
|
|
32 |
S2 |
p. A307-A308
|
artikel
|
| 943 |
2022-VA-996-ESGO Ten steps robotic intensive staging for early-stage ovarian cancer
|
Foresta, Aniello
|
|
|
32 |
S2 |
p. A289
|
artikel
|
| 944 |
2022-VA-1035-ESGO The case of laparoscopic anterior rectal resection and retransplantaion of theureter with the use of ICG
|
Milnerowicz-Nabzdyk, Ewa
|
|
|
32 |
S2 |
p. A200
|
artikel
|
| 945 |
2022-VA-1026-ESGO The case of laparoscopic retransplantaion of the ureter – Boari flap technique
|
Milnerowicz-Nabzdyk, Ewa
|
|
|
32 |
S2 |
p. A199
|
artikel
|
| 946 |
2022-VA-979-ESGO Total excision of infrarenal vena cava in a patient with recurrent endometrial cancer
|
Vatansever, Dogan
|
|
|
32 |
S2 |
p. A124
|
artikel
|
| 947 |
2022-VA-632-ESGO Total resection of aggressive pelvic angiomyxoma by combination of robotic & vaginal approach
|
Fernandez, Sergi
|
|
|
32 |
S2 |
p. A429
|
artikel
|
| 948 |
2022-VA-578-ESGO Transvaginal single port laparoscopic for left ovarian cyst removal and bilateral tubal anastomosis
|
Min, Ling
|
|
|
32 |
S2 |
p. A170
|
artikel
|
| 949 |
2022-VA-1642-ESGO Tricks to improve the laparoscopic extraperitoneal space in para-aortic lymphadenectomy
|
Carbonell Lopez, Maria
|
|
|
32 |
S2 |
p. A82-A83
|
artikel
|
| 950 |
2022-VA-1553-ESGO Ureteroureterostomy: step by step
|
Aker, Seda Şahin
|
|
|
32 |
S2 |
p. A349
|
artikel
|
| 951 |
2022-VA-730-ESGO Vulvar and clitoral reconstruction using bilateral Singapore island perforator flap after anterior vulvectomy
|
Navarro, Anne-Sophie
|
|
|
32 |
S2 |
p. A431
|
artikel
|
Tijdschrift beschrijving